var title_f13_58_14240="Cutaneous lightning injury";
var content_f13_58_14240=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lightning injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Feathering skin injuries are pathognomonic for lightning strike, and are known as Lichtenberg figures (or flowers), filigree burns, keraunographic markings, or arborescent burns. While these have not been characterized histologically, they do not appear to be true burns, and usually fade within a few hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Elsevier Science (Vega, LA, Garcia, JA, Santamaria, CT, Porras, MC. Clinical picture: An unwanted tattoo. Lancet 2001; 358:1681).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14240=[""].join("\n");
var outline_f13_58_14240=null;
var title_f13_58_14241="PA pressure PDA Doppler echo II";
var content_f13_58_14241=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Echocardiography showing pulmonary arterial pressure in a patient with patent ductus arteriosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pulsed Doppler documented systemic pressures in the pulmonary artery pressures due to a right-to-left systolic flow at the patent ductus arteriosus. The pulsed Doppler sample volume is placed in the ductus and systolic flow (arrows) is directed away from the main pulmonary artery across the ductus and into the descending aorta. In diastole, left-to-right flow is present in the patent ductus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Doyle, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14241=[""].join("\n");
var outline_f13_58_14241=null;
var title_f13_58_14242="Helicobacter pylori infection and treatment";
var content_f13_58_14242=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/58/14242/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14242/contributors\" id=\"au2391\">",
"       Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/58/14242/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14242/contributors\" id=\"se6265\">",
"       Mark Feldman, MD, MACP, AGAF, FACG",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/58/14242/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14242/contributors\" id=\"de8151\">",
"       Shilpa Grover, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?13/58/14242?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HELICOBACTER PYLORI OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Helicobacter pylori, also known as H. pylori, is a bacterium that is commonly found in the stomach. It is present in approximately one-half of the world's population.",
"    </p>",
"    <p>",
"     The vast majority of people infected with H. pylori infection have no symptoms and will never develop problems. However, H. pylori is capable of causing a number of digestive problems, including ulcers, and, much less commonly, stomach cancer. It is not clear why some people with H. pylori get these conditions and others do not.",
"    </p>",
"    <p>",
"     This article discusses the symptoms, testing, and treatment of Helicobacter pylori infections. Stomach ulcers, also known as peptic ulcers, are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/60/964?source=see_link\">",
"      \"Patient information: Peptic ulcer disease (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      H. PYLORI RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     H. pylori is probably spread by consuming food or water contaminated with fecal matter. H. pylori causes changes to the stomach and duodenum (the first part of the small intestine) (",
"     <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"      figure 1",
"     </a>",
"     ). The bacteria infect the protective tissue that lines the stomach. This leads to the release of certain enzymes and toxins and activation of the immune system. Together, these factors may directly or indirectly injure the cells of the stomach or duodenum. This causes chronic inflammation in the walls of the stomach (gastritis) or duodenum (duodenitis).",
"    </p>",
"    <p>",
"     As a result of these changes, the stomach and duodenum are more vulnerable to damage from digestive juices, such as stomach acid.",
"    </p>",
"    <p>",
"     In the United States and other developed countries, infection with H. pylori is unusual during childhood but becomes more common during adulthood. However, in developing countries, most children are infected with H. pylori before age 10.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      H. PYLORI SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most individuals with chronic gastritis or duodenitis have no symptoms. However, some people develop more serious problems, including stomach or duodenal ulcers.",
"    </p>",
"    <p>",
"     Ulcers can cause a variety of symptoms or no symptoms at all, with the most common ulcer symptoms including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Pain or discomfort (usually in the upper abdomen)",
"      </li>",
"      <li>",
"       Bloating",
"      </li>",
"      <li>",
"       Feeling full after eating a small amount of food",
"      </li>",
"      <li>",
"       Lack of appetite",
"      </li>",
"      <li>",
"       Nausea or vomiting",
"      </li>",
"      <li>",
"       Dark or tar-colored stools",
"      </li>",
"      <li>",
"       Ulcers that bleed can cause a low blood count and fatigue (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?0/60/964?source=see_link\">",
"        \"Patient information: Peptic ulcer disease (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Less commonly, chronic gastritis causes abnormal changes in the stomach lining, which can lead to certain forms of cancer. It is uncommon to develop cancer as a result of H. pylori infection. Nevertheless, because so many people in the world are infected with H. pylori, it is considered to be an important cause of stomach cancer. People who live in countries in which H. pylori infection occurs at an early age are at greatest risk of stomach cancer.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      H. PYLORI DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     There are several ways to diagnose H. pylori. The most commonly used tests include the following:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Blood tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Blood tests can detect specific antibodies (proteins) that the body's immune system develops in response to the H. pylori bacterium.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Breath tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Breath tests (known as urea breath tests) require that you drink a specialized solution containing a substance that is broken down by the H. pylori bacterium. The breakdown products can be detected in your breath.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Stool tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tests are available that detect H. pylori proteins in stool.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      WHO SHOULD BE TESTED FOR H. PYLORI?",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      If you have symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Diagnostic testing for Helicobacter pylori infection is recommended if you have active gastric or duodenal ulcers or if you have a past history of ulcers.",
"    </p>",
"    <p>",
"     Although H. pylori infection is the most common cause of ulcers, not all patients with ulcers have H. pylori. Certain medications (eg, aspirin, ibuprofen (Motrin&reg;, Advil&reg;), naproxen (Aleve&reg;)) can also cause peptic ulcers. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/60/964?source=see_link\">",
"      \"Patient information: Peptic ulcer disease (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      If you do not have symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;H. pylori testing is usually not recommended if you have no symptoms and no past history of peptic ulcer disease. However, it may be considered for selected people, such as those with a family history or concern about stomach cancer, particularly individuals of Chinese, Korean, Japanese, or Central American descent; these groups have a higher incidence of stomach cancer.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      H. PYLORI TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     People with a history of peptic ulcer disease, active gastric ulcer, or active duodenal ulcer associated with H. pylori infection should be treated. Successful treatment of H. pylori can help the ulcer to heal, prevent ulcers from coming back, and reduce the risk of ulcer complications (like bleeding).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;No single drug cures Helicobacter pylori infection. Treatment involves taking several medications for 7 to 14 days.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Most of the treatment regimens include a medication called a proton pump inhibitor. This medication decreases the stomach's production of acid, which allows the tissues damaged by the infection to heal. Examples of proton pump inhibitors include lansoprazole (Prevacid&reg;), omeprazole (Prilosec&reg;), pantoprazole (Protonix&reg;), rabeprazole (AcipHex&reg;), dexlansoprazole (Dexilant&reg;), and esomeprazole (Nexium&reg;).",
"      </li>",
"      <li>",
"       Two antibiotics are also generally recommended; this reduces the risk of treatment failure and antibiotic resistance.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Although the optimal H. pylori treatment regimen continues to be investigated, the American College of Gastroenterology has recommended four specific drug regimens that use a combination of at least three medications. These regimens successfully cure infection in up to 90 percent of people. For the H. pylori treatment to be effective, it is important to take the entire course of all medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Up to 50 percent of patients have side effects while taking H. pylori treatment. Side effects are usually mild, and fewer than 10 percent of patients stop treatment because of side effects. For those who do experience side effects, it may be possible to make adjustments in the dose or timing of medication. Some of the most common side effects are described below.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Some of the treatment regimens use a medication called metronidazole (Flagyl&reg;) or clarithromycin (Biaxin&reg;). These medications can cause a metallic taste in the mouth.",
"      </li>",
"      <li>",
"       Alcoholic beverages (eg, beer, wine) should be avoided while taking metronidazole; the combination can cause skin flushing, headache, nausea, vomiting, sweating and a rapid heart rate.",
"      </li>",
"      <li>",
"       Bismuth, which is contained in some of the regimens, causes the stool to become black and may cause constipation.",
"      </li>",
"      <li>",
"       Many of the regimens cause diarrhea and stomach cramps.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Treatment failure",
"     </span>",
"     &nbsp;&mdash;&nbsp;Up to 20 percent of patients with Helicobacter pylori infection are not cured after completing their first course of treatment. A second treatment regimen is usually recommended in this case. Retreatment usually requires that the patient take 14 days of a proton pump inhibitor and two antibiotics. At least one of the antibiotics is different from those used in the first treatment course.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Follow-up",
"     </span>",
"     &nbsp;&mdash;&nbsp;After completing H. pylori treatment, repeat testing is usually performed to ensure that the infection has resolved. This is typically done with a breath or stool test (see",
"     <a class=\"local\" href=\"#H6\">",
"      'Breath tests'",
"     </a>",
"     above). Blood tests are not recommended for follow up testing; the antibody detected by the blood test often remains in the blood for four or more months after treatment, even after the infection is eliminated.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Helicobacter pylori, also known as H. pylori, is a bacterium that is commonly found in the stomach. Most people infected with H. pylori infection have no problems. However, some people develop problems, such as stomach ulcers.",
"      </li>",
"      <li>",
"       Ulcers may cause no symptoms, or may cause pain or discomfort (usually in the upper abdomen), bloating, feeling full after eating a small amount of food, lack of appetite, nausea, vomiting, and dark or tar-colored stools. Ulcers that bleed can cause a low blood count.",
"      </li>",
"      <li>",
"       H. pylori can be diagnosed with a test of the blood, breath, or stool.",
"      </li>",
"      <li>",
"       H. pylori testing is recommended for anyone with a peptic (stomach or duodenal) ulcer.",
"      </li>",
"      <li>",
"       Anyone diagnosed with H. pylori should be treated. H. pylori treatment helps to heal the ulcer, lowers the risk that the ulcer will return, and lowers the risk of bleeding from the ulcer.",
"      </li>",
"      <li>",
"       H. pylori treatment usually includes several medicines. At least two of the medicines are antibiotics that help to kill the bacteria. The other medication causes the stomach to make less acid; lower acid levels help the ulcer to heal.",
"      </li>",
"      <li>",
"       Most people are cured after finishing one to two weeks of medicine. Some people need to take another two weeks of medicine. It is important to finish all of the medicine to ensure that the bacteria are killed.",
"      </li>",
"      <li>",
"       A breath or stool test is usually done after finishing the medication. This is done to be sure that the bacteria were killed.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784876694\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112840556\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/31/19954?source=see_link\">",
"      Patient information: H. pylori infection (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/53/5971?source=see_link\">",
"      Patient information: Peptic ulcers (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/28/32195?source=see_link\">",
"      Patient information: Stomach cancer (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112840571\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/60/964?source=see_link\">",
"      Patient information: Peptic ulcer disease (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30055?source=see_link\">",
"      Acute and chronic gastritis due to Helicobacter pylori",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44679?source=see_link\">",
"      Association between Helicobacter pylori infection and duodenal ulcer",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2634?source=see_link\">",
"      Association between Helicobacter pylori infection and gastrointestinal malignancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/16/43271?source=see_link\">",
"      Bacteriology and epidemiology of Helicobacter pylori infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/46/9959?source=see_link\">",
"      Helicobacter pylori and gastroesophageal reflux disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37817?source=see_link\">",
"      Indications and diagnostic tests for Helicobacter pylori infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12455?source=see_link\">",
"      Management of duodenal ulcers in patients infected with Helicobacter pylori",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=see_link\">",
"      Overview of the natural history and treatment of peptic ulcer disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"      Treatment regimens for Helicobacter pylori",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niddk.nih.gov/\">",
"      www.niddk.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American Gastroenterological Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.gastro.org/\">",
"      www.gastro.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American College of Gastroenterology (ACG)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.acg.gi.org/\">",
"      www.acg.gi.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?13/58/14242/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13306883\">",
"     <span class=\"h1\">",
"      ACKNOWLEDGMENT",
"     </span>",
"    </p>",
"    <p>",
"     The editorial staff at UpToDate, Inc. would like to acknowledge Dr. David A. Peura, who contributed to earlier versions of this topic review.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?13/58/14242?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14242/abstract/1\">",
"      Gisbert JP, Gonzalez L, Calvet X. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter 2005; 10:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14242/abstract/2\">",
"      Vakil N. Helicobacter pylori: factors affecting eradication and recurrence. Am J Gastroenterol 2005; 100:2393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14242/abstract/3\">",
"      Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14242/abstract/4\">",
"      Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101:848.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f13_58_14242=[""].join("\n");
var outline_f13_58_14242=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HELICOBACTER PYLORI OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           H. PYLORI RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           H. PYLORI SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           H. PYLORI DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           WHO SHOULD BE TESTED FOR H. PYLORI?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           H. PYLORI TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13306883\">",
"           ACKNOWLEDGMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\" title=\"figure 1\">",
"           Abdomen anatomy adult PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f13_58_14243="Urothelial CIS C";
var content_f13_58_14243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urothelial carcinoma in situ (CIS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14243=[""].join("\n");
var outline_f13_58_14243=null;
var title_f13_58_14244="RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Patient drug information";
var content_f13_58_14244=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/30/7653?source=see_link\">",
"     see \"RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/51/14132?source=see_link\">",
"     see \"RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F142011\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Myobloc&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad side effects have happened when this drug has spread from where it is being used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692091",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat spasms of the head. It may take 2 weeks to get better.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to rimabotulinumtoxinB, albumin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703160",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an infection where the shot will be given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703746",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a botulinum toxin product in the last 3 or 4 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698253",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness or changes in eyesight may happen. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698277",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Neck pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698643",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing or speaking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to control bladder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the muscle(s) causing the spasms.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11398 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-E9F4F161E5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14244=[""].join("\n");
var outline_f13_58_14244=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142011\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026135\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026137\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026136\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026141\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026142\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026144\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026139\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026146\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/30/7653?source=related_link\">",
"      RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/51/14132?source=related_link\">",
"      RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_58_14245="Extradural plasmacytoma";
var content_f13_58_14245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extradural plasmacytoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 584px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This study is from a patient with known multiple myeloma. The MRI of the thoracic spine in the mid-sagittal plane reveals an extradural mass in the midthoracic spine. On the T2 weighted images (A and B) the spindle shaped mass is overlaid in green (B). The mass interrupts the posterior CSF column (red arrow). The gadolinium enhanced T1 weighted images (C and D) reveal a more prominent area of involvement due to the associated hyperemia in the region (salmon overlay in D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14245=[""].join("\n");
var outline_f13_58_14245=null;
var title_f13_58_14246="Widow spider A";
var content_f13_58_14246=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Redback spider 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 426px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGqAaIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCtbyaFb3VxcQ6jevGwMcEL6eMxqMbAxDYJHTjA71FpuiGUXuot4ntZTOm1ZZreVHjAbLYBHt2JrEv5JLLU1SK5WWFSGUxDCMR97cfbn8qo6ncSLZ3EqOzxpmCMg8xhuT+Yrquc9jptOtdAM1qLzxDazbomjuo5ElxJ8xIKYXoBjvmrupXl1pN/ZDStZ0iLR2VnWKIuI2UAgBkIJJxzzXF+HbZ7aTTb52Oxg8i7sYO04/nTILuG61qVjeWMdleBo4xcSqnlOQQCw6gZ7+lNaK4PV2NyGVfFF7arrA8K3bSYdbnTLxI54EP96PaM7QOQBxWtqOmXniJLh9J1iw1OG3xGrQyE3axgfcKYBcD15rw2a6i0yaSCHYJEkMbOAOx+Yow7Z6HuK6ix167sdUT7XarHd2sjIXKhZkcDkFx1/Gk5aWZTi+h6DpHh3TJUnj195LbKH7PMw4LDuf8ACs/W/BejWepWyW/iSyltpuWm8p2EQx1IUGui0rX9Q13SIn0/7BqNvE487TJ9qTo+M+ZDn7yn0BOD2qO503RtaMkNjcSaTqJYFrW9i2xlscgyfwgY7ilvsK559faDBPdyRWmpQzFNxxHCwyoH3vmx259asroXhhYH83xRNcyI+EjtdMdXdcDkl2AHcAc9KZ4l0fVNPYzXVnIIRwbhEDxN9HHFZNvM4ZHRyWByMe1RN8pUdTptW0HSW194NE1KR9OBhW38613lyVHylAAxOSQcD861dW8PeFLAPbT6rfofvSxQWTvG03OfLYkEKp4wQfrWW8V7rC/2oJE+3AFnCnayKMYYAfpWa9uhXbggj+Ik5qeYqw/7D4fR4vJ1m9UZAZJtOJIHcgq3NaF1onhdoXB8akBYwyodGmG9j/D97t6muOuJGjuCFLfnVlLl2iCl2B7H+lVFktam3Bo2h2P2C5n8Q36wXcDyI8WlcllcoV5fpkda1dE0zRdQnWGfXzaO4wjS2LMm/PCswbIHvg9a5h47hxBA0zMIQdozkDcdxA/OtnSLWVyxGSsa73bH3VHf86GxI1J9AhjeeH7RHLcQ/KYmfyW3ZwQN45/A965m8ttl6bdbI+fu2bJHJOfTjFdjZBPLkeS6WGZMuvmRmTzCfw/nXM6ujQalbT20yTEzAoVBXLA5wR260lqx3NDxZpEej2EFhJLYXV5IscsjW+7NqQDiPd0YNnJ9CK4eaDcT2PpWt4iu5U1e5tpAQyylpfd//rVCI/tG2ROSfvf41bEjHCc4PGKsxW7yj5eg71t2+lrIQGU59a0obSG3AQgVDkOxzH9lTSq0mP8Ae+tS2NkxhvIcEs0auhHYqw/oTW7czQxyJ5i7ogw3LuxuXuM9vrVewnt4tTjQ58qZii5bseBz+Ip3bFoVoLV4oWJGPas29g3ZJGD7Vu/aNw569CKrzx5U5B5qLtFbnIyRsjnPSmmQj61qX9swbIU81REBbkjpzVqVw5SubkiTaThcYzUiu4xuBGeAex+hqSOxLyA461t2MM1sjp8nlOQXilXej4ORx/hii4rGJhiOlTW8crECNGdieAK3B9mmcxRaRaxTPja0byLtwOflLEfnV+K1dY/JtyEVhtkeMEF/bPp9KpJMTdiINFolptmtkv72eIeUzuRHaHcCTtH+sYgY54Ge9Zsl/fszEXc/zclC+Bz2x0x7V12m6Gl/JN9oVuI8xhR3HQVn3ujLaRqGOZz1Qj7tNxFzGJDPdX0yxygT3MSboUn5EqKMmP14H3eegI9Kq3E1ncOrWUb2xfrC771U/wCy3XHsenrWrJpDy28snPyAEEDIBz19qztTti0Mt8gUEybJlUjCORnO3qFbtxjPFA7lWdkVQBjcOtRwMxcEDgelVyjqQHRsn171oxwSLENkJf02gnmkxkVzcyTAIeQP1pIFcFWIAUnGT3pLm3ntyv2giNiMhM/Nj3HanK7TSQLjCJhQB+p+ppAWFZVmbLAMO57VdivksGD2lw7yMP3ikfKw9CKg8Q2cdrfbLY7ldQxzzg1nrEeveh6D3HT3CvK7rGq5OcDtUsF2FBz+IqtLCRyM1BtO7FK6CzNOW6Ixh8g8g06C6BYBgCPWqEK4BVs7T+nvVkQNE4DDJPII7ipuh8prWsqrMjqxBUir3iRDa3qkcrIoYe9ZkEJKljx7Vs6/bzXuiafLDG0kijyyF5PH+RTVpJoL2ZjQXKh1bHIOcGr1rdAsASMGsCOWRG2sN2M5DDpUglURgkFWPTBqOWxopHbzTW4tkjtV3ZAJZuoPt7VVkBC/e5NZWlyM6AK4LD1rUVGYbiDzWqMnJmeY5cnk/nRWlsP+z+VFFkF2UpIbaGCOHT7uS5mueWJjIHuAPT3qHVoIbaCKP7UGEgzKQDgMO2fauys9EguZFspobm1e5BW2vrVw8EuOgzjPTtnNYut+Fb3TrOWwuDA93buJPJSTLqh749+DVNMi6YzX9LNj4Z0ycT+Uv2ReCck7mJyPT6V5xqUcYi2xyF92c5GAOK7bxlOAbWxjfesESq3XGcdK5mS0jk025leTbIGVEHqTnNEnroOOm5hafFp97DeSXQuJrm2hCW1vEuBM+cbnbIKhRzxnJAHHNQ2Md7ukni86Rs75ZDn5fdiff1rVtlXStShvNT09JoiN/wBky0ccqHqCQcgfQ5rJ1DU7e4aZZvtARvuKkxZV9AQeoFF01qanbeFdUtri1wVWZ0URzqvy/Qg+uRkH1r1OTV4E0Oe1srqDV1jhyDOphkXI5ADHJxzyCa+dNAZ7W7MtndITjaVb5dwrv5S15pYIh+ZZSrMhDAcDjI96STRlI6fw2dY3LbeGNZisZ3kV1s72YKkpPATJBQ/Rselbus+HpELX3jXQItHjZGKaho+2W3ml6KjIhKqWPf5a4Pw5pOpT3TafZhZGv18mSBpRGjr975ieOCufwrT0nx1rXhO/ji0vUnuLSI/LG5zFKueQQexpvzFtsXbHS72WVH8OsmquSSRanLjHYxnnj8apX8TyLIhR4rsZ8yB0KlfwNel67ougeNNDsvGXhTbo175givVtm8toZfcAgfjxkEdziud8QXGuadbmfxDZReItLU7V1HayyLx0Zxh0I44cYqeRD5nc8lvAWnbHWljV14boa7VtG0HXFtH0DUWt9RlJ8y1v8KgOeAsg4/PFYutaFqekSLFqNjNCXYhJCMo+DjKsOGH0pKNh81yzo8QLKcYNdJcQx2OjRyJMDJdM3mRAYKIhGMnvuJJx/s1B4V0h7y3MxZYbdDseWQ9W9FHc1f1yJZAtvZSNcJEpA/c7CD/EMdx71LQX6GVqLtbyNEzZZQCD7EAj9DR4QsJr7xRp5Kkw+crS5GQFB6+31pb+GZtTto7oSCR7aBgr/eK7AAfpgDFen+DtGjS0Zo2aPzFCuV43D09xQnZky0R4lrGi3Z1a7ecF3kmYluuST61s2fh6fTpBHdQvDJgFt49eRXs83h21kHmsYIjEcI0n3XPb8a5K7luIHma+zLvOcS/MGH1qmJSOU1CKLTjJErxSlP8AlpGcq3uK5TUtQcE7Bk11Gtm2upXFkGhL42RO+QPUAn9M1lXOhiHyn86OVZc5C9UYfwt796llrU5MStJMhnJKFuQTgVHb28rj/SGkghYM0c+zcBIoyO/QnAJ7ZzzXRzaWM44qqdNRBzilz2KUUQu7w6jMjcciQA+jgN/WtGCdSmGwCB3pLuWS5hsopFRzaReRHIIwrFNxIDH+LGcDPQcVb0JFfVLdLqITWwbdIhGMqOTRfmYWsjLugsmcEHPpVSK1G75h1PQCtvXp4r3XJxY2qW0QICwRDpWvY+FNRltI7r7OjI3IRbiNnx7pu3c/Sk09kCZh2+mqxHQCraaeGZl4wOSTWu8X2JzBdW7wzYB2SqVOPXHcVNHfSJa3NouWt5irFG+6HB4cf7QGR9DUepRl29u0VpPawDy4JypmJA3ShTlQx/ug84HfrmrthAYJAdoJxj1qwqgR7nGPaommRCGBwRWtOeupnOJeLm0I8ptp9RXLajdu9yzSuWYnknvWrdXoKnn5q56+I3Fj+AraUlYyjF3JpLtltiobCtwQDWb9qitpleO3jIPyyZOWde657flwcGnpLmzkjdfmLAg+lRLblhjGR6msnO+xso2Jbi71I3UN1Nc3EqFSbWScA7kBx6YJHQ+9V7m8mndgbiUZ67GwD+ArcttEu7uK3tXMdrFPIBby3bmNA7cfKOuGOAcD0NU5rWy0q+mtnsrm7vIMJKuoxm3SKQfeXylbcwB6FmAPXFaJqxLTMOz0e91OYrp1u9yc/M4IVF9SzsQq++TWpZRaPo1yWvZ01q8izi2sZCLZG/258Zf6R8f7VN1e4u72GKG7uHkgjyYoFwkMWeu1BhR+VU9Et0lvhHLhV2klj2A5/ngVLfYa8yx4iv4tR1qaeG2gtYtkcaxW4IQbUAJ55yTkn3qoBxwKsNaCGdlfGRnP1qcBQAKzlI0UUZrqSCGHFVmj5JrSuSNvFUmyeQKSdxixoCK09OtRONrnCdAc9DVK2iJwa0rTzUcLH+WKLoGak1ikI+QZOBz610VldwWvhq5htJAb0fMX/u56gVjs6mJFunIfH8Pf2qbw7DbTak0UwLxup+XpzWkdDJ6nJTQq8zMTz1b3pnk7mzt4HCj2rSuEVb6VAmQHIxTbokvkptxUPcshsIWjfcPWtyF2TBBwvvWVbyc89KsG5CHHUHqaakTY1/tA/u/pRWL5ueRJxRTEdx4HstV8M211qM8DIsUW6CKZxsdyQA232GffpVvUtSj1rxGklzAsV9PbCJ/s43ZbHy57+lVPDfjxbrTLrTtchs2gkAxdeSFeLAwPu9abbWy2NhFrejzmSVZwVzjGQeOvNa37Gfqcb4l0u4uNWupowjQowVmjyQuOOnXNQ3kENppFlvjUysWdYm7Dpub346V1OvxyDXri+eS1JMhuZIYGJCg85I6de1c/d6g2oRyvfRJMwk3A42kKRjHHpgVNrFXOdubSHUkMEse52GAw68elcZqeizWkgVgCn98dK9KSyUsGs5MMOQH6j6Godas3mT5rRvMZcyDbkH/aFSrlp2PNLPSpbkFkkRVVtoXOXY4ycL1wByT0FbEXiBbCSyttKVxHbBjLK77vPkPVgOgAAAArV1TTbay0aD+z3nl1W5V1vTtxHbxg/LGhzlmbqx6AYHrXHR6dcNcAeXtXqWbgKvcn6Ve2g9z1Xw54tuY7rz47S01BJ4zHJbXcIdGVhgg9CPqCKo6hDpl1cs8F7Db3BbH2aGBjCg9EcnJ/GuUa9SzcQ2LM1t0Z2G0ze5HYegrptEspbiP7QIiMnIDDFUzO1jpfCt3/AGE8kE80sunXWEvrYAhZ4wfTOCwzkHsa6i+v9Y8H+KZLbTdW8y3SFZ7Z7kHZdW7qCo/LjHTIrkIllhATcGB6oeRXWRR2+reGIjLK/wBp0b5ArkH/AEaRuAD1+V/XoGqW+gDGHgzW33lZvDGrFg3nRoZrNieWDJ1X2xWlolrcaRE895qUt9pTuRb21qQ8N0w56P8AcHrxmsixtIJLlI4YvOuDxHCFJLH1Ndbo3hHXHbjT7mJH6ttxuIqbsB1pfW8lzby3XhdLeC0Tasg3BA3JC9QB1OPWprc2NrPFfR21uJQwKxqzA57k5OMCrp8I61DbS2xMNqThnM042hR3wO4rndYjsrSZbSzlkdVUF5HG3c3fHtTd0riVjT13UIL6O61BNLneUuBdCC5IZk7c4yVHTHSrmg+KdGezkjht75DbIZEhecde+OOfpXNaPC6XnmW9xNGjDY6hTh1PBGen5100mi31hot6urabFJbKh8m9TEbYPbjqT60LUGitqHiWxu7U75LyOTa2BsGwn0H+Ncius3qXEZtGczZCxxqu7J9AD1qdYHmhQzku0YwNx6D2rO1KMxRS7X2ow+bGOg9+tZSlfYcYpE+qaodWvIxeG2LRIIvNjiVAxHXoAOvGazLjxLoVhHIq39oWCEMqgOH5+7x19vzrjPHF/LaWcNpbOfMmIaTYMkICD0759K4vxHZMt/LcWiw/ZZn3RNbg+XjHAGen07dDVJN6lqNz2iz17R78Aabo7XMUrIyb5XMgbb8yDHUEgkZ5qy+oaBcq7DRpI1b7pjuz8v5ivDtD1a70y4Vi0iqpz8rEMD2I9D716TY6rbaxZi489l1MuTIr7Qky8YYEfdcd88Hr1olcErG4YNDnlAjkv7YEj74Vwo7nitd7Gzsr+1Wx1KO8idGaP90YiFycbvUnFc6bWa3kC3cM1vIy7gsqFcjseeoPqK0oFijuA8pYqqYDD/d4FSt9UUyrpct3qU4sUtLe7MbO0MblycsRnaAwBPfmtG+tjat5E9hp4ZGO+NLfy2Qk9N4+Y47ZJrF0WHbrVoHl8lZmK+YSQBkEZyBnrVuC7n+yq/mSbpB8xz1qt0Q9GadtdKtuLK5a8e3YgeSwRhEM9VYjI45+XHoam1C3heBJ7GzMSSuVcB2byXHVBngqwwwPXqKhtPEUkTKbpLadUGMyxg5HpWhpviaJ47m2tNOiuJZXWPbboSVLZxk9F5GM9galR5tCua2pinchYPlR/tDGazbhssdzdOuK6ywk0LV4Le01OC7sb6Z3VY4pzIy4+6CMd88CuSjs9OuN1to99qNxdRTFXadV2svIOc42hTjnJzz0rT2DQlNSKkjptyc/nVYbZQABmQnAA5P4Cr82j+TA8lzNBOykjFs42PyQMSE+xOQDWe939gijFvPaxRSr5m+Bz5pPOULHpgdfqKHSkNSXQu2VgzhjdzwWNsjBnklBZ1B9EHJPt/KrkWpWNvFImmWQYs3F9eqHmI/2U+5GD3+8feuHTXpnaSR1tk8pCwjLjgdMD1Ofxqca15yhbaS23s4TZnA24+9n0zUWZXKzV1W9lvruSW6keeR8AvKxZiAMDk9sVatrtb+QLq9zL5ojSKG4kO7YF4VXJ52gcA54+lJpnhzV9RtrWaEWUhuJjCiRygsD6kZ4HvWBqUmoaXNPDf2hieOQxkFSQMHk+4o9nLcNHojX1awurG/nsr6IxXUJAZCQQQejKRwykYIIyDU9hZWMWg6ncTvI2rM0MVpGMgIN26SQnoflG3B7tmsOy8aPBFFZanDFf6fBuMVu8pQx7uWMTjlG4HByueo5zW3eSXUUPmW0az2UEQE0gKmQSt8+2QKSEbacDsdpwc5FPlfQWqdmJqLLqEzThVhkCgbB3+lUGjmTHmIQvrW3q9xYxaRaS29oZblwdwV8knsMVLp8V/FaRyanBaQWdyuUSaTDn6DqKPZye4cyRzMiAj0NNhtiW+Yf/XrW1K0hE2bR1eELubDZK1BDKsRDAKxHHIyKhpx0ZV77EcUXl5BzgVagu2hR0ijBZuN2MkVA8rsDz9aFYnA3HB7CpAu2cEk5+YMW6kmuh0yzUNC3npDdK52NJgRv/slux+vFZGmMY8ZHHcVohy0e3gpnODyK0UiGind2rRayzXqG3m8z5o2B6f3gehHuDWbqjRtfS7X3Jng1uSTSpEkM+6SzDZCcbkz12k9Pp0qnNpIlha5hUyWqsA8qD7hPQSL1U+/Q0bhsQXulC1S3dG3JKm7mqF2mxOK6e7fz9HjTAYwHbuU5wP6Vz8sQnHyHmplpqOLuZHze9Fan9nH3oqOYdkRRK+V8uGKBR0Krkn8609RnYpAts0nyDkk9TVyx02B7tXlDbBywz0pbi0tTI5UOFJ45ros0YF7WPGmoaj4Sh0eS0sVUkCSZIQsjBegLVxu2WNsr19hXSRxWqWjBYssrg5PIxVS4lTP7tAMd8CnYEygrsFBeEhvT1qxbz3wn3xMsangR5yuPTFSSSb0G9lB9xk1HbxSTyrHDuZ24CqhJJotYZZtdGtb67RJYvs7SHqjjb+R6Vl+IvBDShxpBjkC4Z1jYkye4zz+Fei6T4VFvYrfeIre5trVmCxu7rGG9Rg8n8BWhZpommokmnieZ9xJlZfLVR6Anr+VVYFI8SsPCF1HIpuY5FmPEcbIck+pFdh4f+HniW5kkuLRJ3CjJY9Ppk8V3Hi3xVeSW26wkjkuHTbI82HZgOgB7V55N4zs7too9Ut9SidT8zadcsA59NpOP5VcWtgbb1sdHqHhTU7SN7nW5LbT7dSoZ5ZQOT0AHcn0Fa3hseGdJv2j1Qz3lxMnlKiNtjIfux9uDiuC8QWeka5pdzqOia7NJfIRHFaagTubHUh8kEgADtVDQ9TuY9LH9t2jRqAAs0yFVkXpuRvXNTNW2Ban0T4XstP0qW/Ig063jgkKM1xOHZXA5Rj6/SsnxB4jN42bZwhxhQshEa+4FeeeI9Tiv7jT9Zjici/tUaUA5Uyx/u2Ix6hVP1NSw3wKhn2ELzhhwfYiolOwuU6Aak6InmTfMSEPqw7ZqGa4S5u2eBwTH8gJAPH41StvEUlpaXNupRVnjKKRGvy+/17deBWXpc5SQHnPcZrNyKSOwtvtLhd1w5Uc7ScCtG/a4/sq3jlmlaORpdoL5HG3Ix7VnW96nkhl4PcetVNa1gTWyGPfJ5AfzDj7isRj8OKSbsKxBLcJGQu8KoPWue1i8a3RpXTMZ6P2as/VL6R8hWOD6dq43xdqdxZ2cMKzOomblc5DDvSj2KUWc/rV4b/VJ5VJCKSsfsvpTtJhnv5/s6ZEBO5ic4X3+tZ8l1bzW+wW5jmAwJEbr9RXoXgPRJG0M3kcqTCWQ5Cn5gBjHFayfKtCzPvPDsE1viEtG4HDHnP1rN0PR9Zm8R22kaRbPPqVy/lwxRkDecZJyeAAASSeMCvQZLQovI5rPvrSG6iKXA27fuyKdrRn1BHTFRGYMf4a8RztClot7JEyvseAuGQOGPRTkdj0r0LTrgPZCa5WKVgjLzEn3gflPTpgn8q+e5Ir+3klOmpJcWsTl1miiODzjdn8q9J0LX5dV8K7pL200+ZDK0kTSxIJNoHKKT5jEgH7ufm4rVwIfkat5cQR3ipJIqt5m+IxLgxue6qOx7gfWhbO78uJpYksbbdhp7k7V69V/vD3FYdn4gNi0k+i2yoXTyXmtz583JyWweUJ4HTpToL2e6jVNQF0tu+Q4I3zqe2wHp246cmtFCMdyG5MnuEsYIzJIJZZlbcGvR5cYUYyAo6nPPNWrTXbC3ku0tZL64ilj8oGFhb28ZwNw35yS3Q98cVAmhTXaSXc80l9cRvkfa25z/wBcumOPU1XTw/aT3Ze+kmlnwQAx2BfovbFKVdR2HGnc1oPHlxaWcltbafaLpgljIsUt9y/ukABEmdzvnHJwARXE63/a+sXGLqeO10iUsYI7ePapyeQwH8Yzzn8MjFd1faal/htPiBuymZoFADu2PmdB/FwMnHPU1i6Vc3yzfY7SH7fHc/L9m27vMPbHow9e1ZSq82hpGPJqjO0/Q9PS2fzJbhooVCqjSEk+gHpVeaLkqscYTG0Iy5CL6Ct++t7ZJFhsLyKe3CLKhxtLbhknB/Lj0qjHbF5hlWbtwCTWbb2KRSsdNtXw0lvG2PVMCrTW1jExYadBtAxhRjPvWwljd7dsVjdFgpc4hbhR1PTpQNNvLn5YbYkgEne6oMDk8sRUOTK3OWNwbVwYFERByNvFdDpnjXVPsI0+4kSeyLbjHIgb9TUNx4anJJnutLg4z89/ET+Skmo4tDhhwRqdi53bSsfmOQMfe+5gj6HNUpNEuKZ0cMvhy6gK6tpFlJ02yRptf8QOtXrXU/DWlmQ6OstvPOCkxVBukQnlGP8AEpwODxxWBdaRaQ2VzLDqqTujbIVFpJH5wxktub7vHYjk1najYta6jJGijZlXTDZG1lDDn6Gq9oxcp7B4esdG8W6pENNitEniG4Quu0jA+8D3+nWuB8Y+HdRW/v8A+1LDFwLjEZAyAM9vaqUEN3BKtxpk0sE0ZBWRTtz689q9B8NeM7nWbdk1mK21CONhFO5OGOQSCCPXBq4y5tGQ046o8w1bSTa3YVI0WQRjdsHWsuUKf4cPnr2r2TWrDw3Pp80umxnzSMLEZTuU+2eteSanA8FzhkZVbpkVlUi9zSEkzMuAQM5NJbsVO44x2q9th8qTf9/tVFrqVLeS3jVdjHJJHIqUUzXsLnDerVs28yAHgYIrkLV3HJBGK14ZHZc8iqeiIu7m25DgYIIB6UWbNbXRmgZo3CkEqeo9CO49jVO2WTdu5NakFvuhZiOvSkpAyvpdsl7euYyttOVLD5iEkYf3T/CfY8VLbWu2Rku7ciUE/OBtb6+hq5psK29zFJjhTk/StvUgiS+TLGHhJ3o4++n0PcexpOV0K9jF+yW/ebB9PL/+vRWhtT/n4i/FDn+VFQPmOWGo6hpsU2VVRL8oOP1rAu7m5SQxzOysOxrWTV9ILqky3Nxbjsx+YfQ1rAeENTtMzXV9bzIAEDKDx7muzfqYGDpEUstlepISrSRAwkn7xDDp+tatv4ZWwVm8Vakmk4AkSFgWklU+gH9apeJNR0vTdS26FcTXAjiVVlcYAYegrlrm6utQujPezSTynje7bjilzWHY7K61bw7ZSFdKtLi+OMeZcnYCfZR/jUGn+I9VViunyx2KA7i0KBSv/Autc5EoCYq5dOiMIYH3RKASQMZOOahzbLUUb41iWQ75ZJLmfp59wxcj/dB4FUbi7eWTMkjH6nNZazlVNSISVMknCjp71F2wasbFsPM3kybCBlfU1xviOz3rJNDEyyyKRlWAQn1Pp+Fakt5I8oZSQB0xU0xBt0kYZj6FcdCaq/Ya0PPrq8n1HU4XvfLg2RrEBBGI0QKmFwAME8Z6ZJ6mvVvh3PPo3hyG5trLSNcs40TV703TeXJaM0hSG3WYFsySbM+WVx82DwTXGX+nQTuJLdFinUgrIByP/rVSgOpabcvbaZPPbRXMkc81qpIhldG3I2OjBTk4PStIzG48x7T4m8M2s9hpaTW03g4i6kG9ACrSTIJOedoQBWAGRz2FZGv+F/EnhxsTQi/sREZhOjoJ3RdoaQxZJ2gsvQmob7xydK8K31lrzQa5Lf3jq88U5ktjIUDE7SACE3gYUgZGK88ttXtkt7iCKQ2aOFKlQQ/BI2q2TgZIbHoPUCuhqLMrM6pL1Gu5oHJE0TYZHUqw/A81u20pk2s6qw2gAgY4HTp/OuVk8b3mpyh9ZtNP1YvDHHKLmLyjlTjIaPB79cgnnNWIdR8O3TxrpN1eaVduhZ4nlFxEWCFh5ZJBwxwuCflwTk9KwdBfZZXO1ujs31tbNFNpbRwyhSrSK7F2B68ngenAqhHc+ZOt3axElTh4y2QwPVSPQiudW5uZ/M2iK5RWEYaOQK7HbnhDyeAeRnpVjS7tPMVY51DScNGeCDzwQeh4rNwlHcaaZduINNa5kbN8tkSwjKKjyKewYEjp+tcT8QdOW2voLvTtQhvbJQRueFkkAxyXiOcDryCR716V9k88pLbKrMyhGjAwHA6Z9/euE+JWmXNvHYX9grGBAyM/8atn7rAdMe/Wkt7lI4l7G4gubYanC1nbXDCTzzCfuZ++oOCfrXsnhiG2062jSxBWOMBo3Jz5gP8AF75rzix1rT9UQya9BfXmqq+YpXukWJFA5EgZTuB4GAVrSsNQs9MaSTQ5nfSUMe9Jz85Yg79ijO1R83c8LmtJ0+b4Qcrbnpt1Et6JLiHHmDmRB29xXJPqmgrqFxa6zBLcWkCHzYo5dhkYdFz1xnrW3o11DepFPbsjHBH7phgbeOQOmR69a8t1fVZYdfvx5aRZmOPLVQRz345Pv1NTSVnqTLU6/UNWF/awnTYH00ToLd57wiKFIw3yxxHOXHTOAaoLa+GI5ok0xLzWLyOXzFZ0+y2ER4yMHdJJkjn7g9BWbDqL6l4jg1HWbqW9YfeuHZmKjG1Rz0H0rubeGCOFRbKvlnoQe3atKlRoIxItN0zTkljeYTWqM++RbKNQVPpGSR07ZxXURPo0Ik8q+vHEi4K3emI7kHrmRJM5HY81zg2hgBxirEykx5Xn+tYSm+pSiad7J4Z/diAa3IVBysrpGjHsQwBYfTH41Pp4uZ7Z1tNKl1YLHyHmE5Uc8hANw4z0NYS+Q0cm2OUMrZ27wcj0zirOkEx3Uc1rLLDcIwaN0O1gfqDUORaiaI1a0aCOe30TREupCSTLC0sIxgBQrH5G/i3Z5z2rMvGknklupdNso7vfiVY4NgYMCQ4UHA4BHHFdQbOG8DPJHKzyMfNLDGxf7zNjBIH1zVd0sSIbKTUhbaaT92SIhkPTJYE9evp7U0waRgR3MzWTiBo4TGd5WOJR8ntxwAew7Gkk1C6kAE93cEr8+6N9rexrpT4c0+COS8gudQubaFyjT28Kyx8DnOwn5SO/Tmm2+gaDdECC61PdJEXhAty/qPmxyACDVqLJucfdBJ41k+23csxHzxzBiM56K245GOeQKptbAkF1BB7svFbtroGqSSBLexuZucBljPzU/UrS7sHS2vkMbR5/ds4bbnrgdqylFlpla108Iyq8JRmUOBt25B6Eexq8bQN8qRszZx93ofeqlq6Bx5gD+gJ6fSte1liXfwql1IJdmKj8OmeP1qbBzWKMtv5ahXGxuoDcE/nVS9Z5kj3sG8iMQJ/e2AkgD1xk1sXup3MCJcrKrCbO+G5t0dPkOAACOQc+1c41zCXYLAHH8JyVOf1FOwJluOzulWJzBIUlUtCoBYStj7ox35GfTvVPw1pt34X+16LeCCWbUinmGOTcbYQEtkkcFiWxgZ461oTagJILeGC9vUVEZHWRAiKrAFgoQkckde/en6dY21zNbzzorSwEmE7iNmeDj6+9NJpA5dC1cwGSLoxP94Zz9ah1CS1n0mRLjzWuUwI947VsSMEU5GfcVz+rzbRn+XpVJtEHOLCuCpGSe5qVdPQjcBVF7zy5jkDAOKlGqELlcgfWosyrmnb2EY7Yq9DZRjnjArBh1Pecg81JPrBVOvFHKI6aCKJONwxV75ViAyBnmvOx4g3ShQWJJrTOuYkVGYggciq5CG7s6/cD0q3czhraLPLj5feuftNSijlQXaGQfxRB9p6cZPatjSZ4Z0mjXaCRuAznFK1hlkS2ygKzzEjgkAUVQ85RwXHHFFK7HY8wX5Qc1estJvb4R/YYnluHJ2xqOwGSSe3Sr0MFraSOXtp7yRMY+Ro4wffIyf0qhqOo6lelYYUnjgX7scaEfyre3chMrS2N048x7eRQ+SrFeGA4zUIRkIByKs2cV8gzClyuAQygEfWpwkh+WeORW91NSAyAmNkdl3KOcHoaeMnJwMk5pjKQeQwHYEVZij2jzJAdvYetFhjoYBy8nC9h61DOfM6cL2FE11uJHRR2xWfc3uAQKPQXqWGIQg5HSqoun8xkLHY/BFVhM88qxxqzO3AVRkk/QVq22nWdrG761etFcDmOzhTe5PH+sOQEH5n2ojFjbsEdnMX2FSnbLcZ9MetRXuyRBaojHJ28feY+n59q2oRNrN2ttpUE0rlcKu3e5H16AU618M3jajap9q02B2YOvn3ka4wc888VSj2FzHL6nBAXjtfLeKO3Ux7G6q38fHb5v5VUbRN6OUuNoPPTknp19MV0uo6VHFexXGoXULC5cyu3nLtGWOc7CSPoeazZXimu5INJuLeYHIUSsVye3PpV+8CMGXRrohiqLIT/AAhjiq01leIywvCSqvnDLlce+O1Xbu71a0uXjnEVr5ZIPmtuUD6j734ZqzY6rdi2ilXXrWOdQxKXVvIgU8/LvCkMMY64o98rQitfE0mh209otvb3kUo27bhBIsJzktFkfLzgZz2q/J4quftO149P1EnK+RLkluApwwPoB0P0rH1G5vo38rVtNgLsgdTtCE55BDDggis24j06ZsBJ7M7c/N84B9MjtVKpJaMTgnqdpYeLVt5po4oJYnAym9mCsOMcGulg8WmSBEntobsOCGCsQzLnjzB35Bx6CvI4ftVsQFl3xgglw25een6Vu2HnTziAIY23bmO/YpOOoPbp9KpNS3Jcbaou+JtK0qcveaLaTIEY+bavJiSMnsOOR71gaTdW1peKIbW/S43A7FYEsQeuMdq6q7nfzHnfU/tN8cQ+WyttZccZdvvZ6EH2NSy2kUtrb3cdu5srrMTASFZYpRgMm7rjJGB6U+W2wX01Lvhe38PzlbzVb640yRG2N9mjUPLjHLgEAnOPbmmeMbPw+929zFa6obggiQTbPLcjjhlPPrmuK1HQrqy1MwW8V2AfvRToVdPUHPXBre0O5uUig05sXQWRibe3hMu9mG0Zx3HQemTTTUt0Jxa1RnStaQq6W0V2H6CJ2AYH8ByOvvWxofie1sbQL9iluFbuZuU9hx1rpL7wrDC8j6YksxspVeUlA72pGDhhyrYYEHBxx9a5/wAU6LcjVrjVNW1TTke6bzTJBEqrP6ZjjG1W/LnrSlF7ME76nXaZeWV6yvbQLIm7nLnj2NdAHjnX/RrGMZPCpubHtXlvh7W9E0W4F3Z21zqV1GQwE7mNM91KLyR+NejaZ4s1LXbeR7SxOnFcs8dvFsUAnsTz3rnqU2ldGkGrmjb6Q+VnvxZadEnQyH5n/DNdRa3vg6yghVBczzbTumSFRtPsDXnMge4bc7Ese7Nkk1JaR3E0phtopJmAJKoueO5J6Ae5rJTt0NHDzO1bX4vkIg82Js4VnAyAe/FZmo6w8qSGCztoB/DiPP4Vk3E0qXjLPLFdMiqhaJty4AwFDAYOOnH61dtYZLiKZkUbYl3PnsKm7uFkkZQ17UbF2eGZLWQDG+FAhx9RV2Lx1cyeXPOlw1w2Vd7a+kt1ZdoUEbeQxOSecH0FZdzf32nXK3WlzmG4jbKMEDFTjGRkEdCRVeygnuZobm/0eCSzmcxLKw+zxlwPmAKkLuAOcHjmruyWl2NO71G2ukhmg1jVbCbaXZJM3EY44wVw/J4JwfWuceech5ZN0i5+eRSXGffuPxrSn01NYuII7G5UTSo3k2rureWik8My4CcDPPbnNVLjc2szHUNUg1IrIBJf2t0yy5OBvDsu6QL9D04p6vcS0KcepAt8pGPWrsWoTujEMSo4/OqOpW6xXExaew1e33mNby3JgcnAOTkD/wAeXnBou7KSxtPKMgjuZ1SUR3BAYKc4wykrk+hwcCiwFm5u3mYGaQuVG0ZOcAdqWIBjweTWMtpewThL2GSIn7u4cH3B6Ee4rotPtSCvHXqaXL1YcxJHbM2COQPWtbTimx2aWJCqM21ictjHTjrz+hqC6dLaLrz0rPu7j7Fp0d2k6ebcRKyoFO9VLODz024C8nqWwOhqkrktnTCeJRuYB0Iwyjgke3v3rndekjjaZMK+5QUkUkAD+8B79we9ZcmsGRFUHnGOKrTajNJYi2LK0KyGVcqMoxGDg9cHAyPalsOMWUZ4HupkWFS0rcBeBms45zjkfWrf2n7NcCR8ELk4654PrVG0udpUPGkoC7cOMj9O4pJNmz0RahBVCQapXkjtxurotK0KfVHggsZoPMmbaBPKECn/AGieBWe+iTrczLdFCLeQLNDbyq8pXcASvY5zgEZ9atKxne5iWMchuUKqSQcjHrWhrklrp8Vt5dxLPrT5a6GMRWYBwsa93cjkngDOOTzVqSSG1mmNkjQMrnapk3mIZ6F/4m9SMD0rl79d7Fhyev1q7aE21Llrqsqt97Pc5Oa6DRvEjW93Ezk4J2n6GuEjJRs1fgzJjA5pWBo9Dk1MGRju6kmisSHT7lokbaOVB60Vdokamw19NJE4m1a9hkxuEhZnVjn7uc8etV7fU9atGEltql2uDnzIpSefrVCJ3iJ2ng9QRkGlQYfcjGJvY4FZCTuaUWuat82NUu8tnP7085qU6tqXmr517LMjYVtz5IH/ANaobW2vZoN50g3UbHiYKV/AEcVMnhfUWUSBo7aNjgfaJlGPxzQrj0HWGqXou/LnmlljyehzmqGpaxci6dYndY1b5V7ituy0e2s5j5uq27Sbf4JN2fYYGD+dLpuiW2rT3E8rywadGT5t9dEQQof95slj/sqCaqzaFdHJ3GoS3BBuCJCOBkAGtqw8KxvbC+8RTx6Jp/GGnLG4mB7xQ/ef6nA96vL4g8P+HdQ8zw5pa6hPGuFvr8EqHz96OPt7Fsn2FYmpeJb3Urqa5udjXMxy8zrvkb6secD0osluO5p6jqthZxtaeDtKvrK1bh7+4IN3P9GAxGuP4V/E1jW2kiVv9UYdq+Y5muVBYZ7cdTSNPdXCxm+uZDEOFDHt7Co55FKtHbR7Iz7/ADN9TSuB0H2m1tLWdLW8htonIPkRlpGwP7zYANcrqeuaZF5scEVxcs/3Zg4VR6k4B/Ks7U380G2tJZBc5wy7Bt2/XNc+0TwN5YYYzyM1a1Go3NBr62QfJYsHPPmNLk/X0Faej69qCXqG2u5bQllzKr7VUHj5sD9O9c/HazSttiVn3YwE5Le2PWpUtLiG13yRsjSBgFKsDkH7x7HPOKdy+VnZ3nj/AFPULdrfUPs9zBKrQ4+yRYbJBzwvytx1GDWLc3mmGVzNoe3aekVy6j+tU9L0m51KWG0soXkvpH4ROc8dh/Or9xpDabqbRaqXeVDhooiG3N/dz0p2b1KsloMH/CNzxwJYxavaTBR5wdluEL5+YqFAwMduTUsmh2UtwkFleBG2bmS5lEbucn7iso9hjJNXbu3eWzkez0yewIO4PvHlonYdjuJrDv8AT9cjv0F5Z3bzROH2Sxkkcg5PGcEUNeQl5M2rTw+miaiZtVtb9Y4wCRD5c2/IyFIRjgH9PSp4NRhFpFHDp9u14VlSeYqJC4bGB5bfdwOMgZ5NT6d4KeaRH/s+WwYxuzi5lESkA8OpOCRjpV2w0/RNNS5m1jVdUmdEPkRQYddx7MzdvoKy9tGE+SWh0xwdSrSdaCuutjHe3RbAtJBdSw7ePIfMQOeAykZAGTwKk8JvqUN7JDZWcckMrBZYpRiNkBzz7D8+hzXZWfjO00ZrKO0sNPeCeDdcSAPJKrehbI5HepNT0nSPEOnNf6fNdQ38rAAxOHide4ycbTWzmk9Wcdn1R2fjK3stYtrHTodT068utVnzFaW4+2ToEHIVmbK5IJLOduFOa8r8W6ssKR3dppTqI2Me+RfktzyqgpGAgzhiOuR3NM0TR/suugaPY6bqLqwjlhe+EV6cg7k2yEY4zkgEYPeu80a9fU9CK37ul5HEY7DT7uzItWZAdobeQkuO5A9wK0i7ohrlPPrPxr4i1PVLW0mu4ykipbrBBbhIMdFyqDBA9CP5113xZ0S4gf8A4l+lJ9sCBr5NKiYRQMfuM6Mo2k89Dg4rKu9d17S9O1DSJNUhh1fTT9ot59Iliht5I8B9gdQNxGTgdc8e1a/w61JrzQ73XvFkn2i7SWENHcXhcXMUvAbylBYSYU/PnI649ZUruw7WVzy65vPF2g/2YJZtS084NzZZTaSrHl0YDOMrXX+HINV1i1bUdS1bz7t5v+PKS6FvPM2MbzLtJ2542jrjt1rk9U06wt0vPPvmkvIZ2+zISxdkz1Ynhee31ra8LT3Mek3UFlLbR3U5UCRcM5C8heckKMkk8ZOKI72CVtz0HS5Xm0xV1CGy0x0dop7S32yzhx2JydvsWI+lWTKbiBLRf3VsvIjT+Ju5c/xfjx6V5d4EuT/aN5bi6jkWR1aRs/M7525P516Xb7rcsCVOOmDXBWTi9DohqR3Fr5Rwo7cGnSv5Vorx5GV2uM96neUvbu/UIMk9gPrVBLmJ1lhDKSwyADk5FTT8xyRWvrKCOVXnujNEQHzarnPHT5sd+DWfqM2kQ6RaW7wTWr5lmW4OZBIxKhI36YUYbJGSMitiJ4bi18piTIrZXA6eoqlq+lNLot3FezukkKq1lAYywZ2YF1B/h+Xkn8K2izJo5+a5tYZVWQzMhHzKDhlHqp6MKotKjTFEO4ZOMjGR9KjjtpbYGCaAvCx+6Ryvup7fTvWvq2m3Wk6OkEU0EthqPl3qyBQZAFBUK56pjJyvfiqsnsGomnSBA2xipbAY+vpVzyIpFOdo5JJA6k9c+tc7ZR37n/R4JZFyF3Y+XJ6fN0rQSeaLh9oZTtOGBwaaRLTN/TkW3ZFjmWGMtnDjcg+q4P8AKry6haCBhJaeVPj5ZIX2rn/aQ5GOvTFcxeXjlxN5iOsnzkrxtJ6gjsagW7kxkn86HoCTZpaldGZlQFjk4wBz+FQapHI7yWV/IyRrBDLaXUSEoU2KVRx/d+Y89QxOapwKlzewRySPGkjhWI+baDxkA/hUum6fqaxyT27mIRyGJ/Nl8oKVHOSxwcdMDNReyNYQux1t4R8RSTEPpN1bqBky3C+VF90sPnbA5A49e1ZxOItzKwI/ixwf8DWncSXG/wCW8vnbHzSpcyYY/wCyrHp25/StnTNRv9UjuDrso1C1s4xdF5VXz5SpARDIBlhuYcNnHNRzJuyOn2birs47XdNn04Wv2shJ54xN5H8SIwypb6jnHpWdbFROA3TNdBq0X29/tLidr2Rne4mdwVlYnI2qANmBweTmsi4snRQ2M49KpTSYOldG3blHhxIqkEelUZz9md8D91Iu1lxuwMg8eh4xmqFtdvCdrk4q1LMJR1rW6aMeS25TlVJIP3H7qU/8sieG+hrGc5YqRhgcEHsa2tTQtEgAAGMmlluf7TtYYrmKP7dbII4Z0QK00Yz8shH3mHZuuODnilsRa5hi1DnLHAqxG3knEQx7mpY4VYPunRWUZ2ycFuegx3pzRbR8w/GqWpnIeLuUD/WsPxopnlt2B/KimI24w0jbY0LNjt2qVjFbMPM2yy/3ByB9aom6b5hE2xT1x3piBmIA6+tTYyRtDU5bkrHe3VwtomSIo2+XPoB0qhe3JuiA2EjXhUXoKpSylTgdB+tIIrggOY2SPIG5xgU7BY19BjT7aJJZRHbW6meTPIO3kKAepJwKXXPE+pa/ciTXZjeoP9WjYVYR6IBwv4Ci4SysLSK1uJxPLIRNKIByBj5U3Hp61QbVI4W/0G2hiIPDyDe/68UmuxSLdrorXy77ORVGM7ZzswPqeDVyXQ5NPmMbS2ckoAO5ZlZVzzwe5rJtmu7+VECz3Dk4VEUtnPYAVfuNG1K1cxXNlJbyqMlJyEI/A0khNj308I37y6tycZ/1maragILayld7y3jbG1SzHr+AzUsOh3zzqk7wW2eplbGB61l+I7PR7e4WC+1cTtH84FtESCfqaqw0m2c3qVpbaeYHtddivJ5PmcQo4KZHQlgKrWytOx2RzS5/ixW/awaXdSbdO0+5aNeWllYdfyrr9A8PTT7i9nE0ZwqmQsQpPcDIFc1fGUqWjevZHtYHKMRirSirR7vQ42xsJokCyIY2dgQyHcQnsB3z3z2rq9E0LUJpC8GmTXdtEdzG7fajKOmF6nmuxuLP7LewxNJaRyP8qrbIOCOMcVN4k1JRrc4jWV47bbDHHIdoGwYIx9c/nXk1c55J2SPpcPw0pWTle/8AX9aleXwh4ltJln/s6xtbvULbfD5CBVgTPIX0fA/WrOg+ELe1jvrrUbm1e7iizGbmXKx8EghFG5jweOmVro/iPr81/qdhHFdo0K2kK+XZOJFVyPmAbuaivbTU31qCyt7Z7eMY3LdJtfYEP+sI6ev41rg83c66ptNrY4MZkUVg1VXuyav8l0/I5rVb/wAIwaE1reXdxrl/LPiBRHsXeQGLMBjjnqec8dqdN4x1mGNtBjV4fssRR5bOBC4VV6ndltoGOnvXGedb2Xh6O7mnt3vIbljFJPEVklUr8oAPBAcEEdefSp4by/m8Q2lxqv2eU65AqQXEryJHH8+1iyryyDay7RjPUdq9z2rfQ+adBR0ewyx8RxW3iqO+1TRoL9ExBcC4mlZURujx4I2jBB2kHBNdNrWraZplxdW6eFdJJZtvnfvg2zAKsoZiASOScVwttefYPFd1Zasoknu1kaV0bavCkgYPP8IGOtdZc6lb+IPDtpcXMbCe1xZM3WRwBuUnuwA+XPbpXl5k2rSi9T6bh1wfPSmm1vo2vwTMI2Wn3DTvFYSbFQt/x8EBTnoOvFWbW/0/RXhube3v0tZ+J4o7hCpYD0K8cVc0zS0bTmd7hoI5GaJmdeBgZxn1qrb2VnNG8UlzuijKuxCnO0H5iPwzWCxFWLg5+jOivl2GqU6qpJ7XXqugfEebQL7w/p2oLBetHLMFkuWtY2eMY4GQwPPPX0p3h/W7PTrE29le3k7mQTQW11bEyof7+NxC5GDwc/Lz2rKXS5I9NvIJb23On3cbD94pIBHRvY8Cuc0HSJ9N1K3vxqGmzmJ9xV5yN2Oh4IJHfFe5C6ex8VJW0uejai2l2N8d7eFZ5/OmIfV9OullLAhiAvOCSSfm4O7tXPzfEaL+0IpbTw/pkcSFWENvYpHGWHVsD5sn3+lbfijSE1HSzf2ksVxKt2SyyyEmeJsuGLknu2DznoK43S9Hup5ri1/tOZbl4G8kQMcI45Ab1yAQcdMg1rJPoQknuafijV2l1CwvLKwXS/NgaNme1UCZ3ySw3ryCGAA7VZ+Eviu/0PxDeW19Fara/Z3iuGNjGrR4IIyQmScgdc/SmyWPim4sNCsL2DUgPtYjL3DieBUIXIUHPPyg11HjOKyj1ya50yE2+otueVVXCbtmxQWzguAScDpnrR1uJrTlOX0TxHf2ni2+v75bSCwgeSUH7PAjcn5cEJz1FdXbfE+z1S92NC0UxwI5Dt8s/XArzuXQb/UreFNNLTz7i9zA0QwyL8xbIwMAZJqTxvatJraRjSbG2htwEaSxOQ2eVJ2nBO0DkAe/NZyp82407PQ9Om8T6jb+Y1peyw7xhlVQob8MdKy28V6v56SSanOQvy4JAyPTpWLpPmTadHJIv3gPm5+Yjjv9KbcweYUSGAmTOPlJJbnjjtXI1aRto0b17q+p2d35Ul7OB99Bv4GRkfzrWiv4pfs9vqDST2ePNwrASZYcNu556ZH4Vy08YUpDfWdyblTlpVmwcYHy7SMcY65qWO2Uw7oJnVwf9XLGQceuRkVT30JWxavIhtI5PfpnI9ax5VeEgxfuyDklQMk+/rW/p8OqQKHigWUbtu3/AFgYdwwHVfrWtdaZpF5A0kRuNLvFHzWki+dCx77XHzKPZgcetKzKujhHL3J3XJLliTgnAJ9dvSliWOGTEcakMNrpnG4dxW7qugSIhaG+0uQbd3F0qHGcYAbGT7Csf+w7xWAmntkU8hjKu3Hs3QirV0K6Yy6Bjt0g2xCFXZ1cxgOSQAVZupHHA6Dt1qC+hSJI5oeIZQSoL7ipHBB7/Q960xFdaTKiC5tblZU8zZA0d0hH+0oyAR74IrNZLK7mLLKbeUttZNu1DnsPT6dKbBEdjE0r8ZHuDXSLaebGGuHaSTzWfY3IGQMt6An29Kj0uC0COqQztNEQZBkAqvrt6kfStxbu1VdscYZRnnd1qGtDeMlcxJoFXPAAFT6fCE03VZywVPLSHb/fLMDj8ApNOnu1ab93DED1+Y4AHvWjqmrad9n06GB4UhRAZ5IYst5jH5m2n720cD1xUxilqaSm9jnI0hkdo5Z1t1wzB3UsCQDheOeTxn86pXFs7wgrG4z0/wAKv6hczPd3Ys5VvLa3yxuIISoMYIAcqeVByOveqwvpwmx3IwejEAf/AFqLJiU2jDvrF4rbzZYSCWwCwx+tUrMgTquCT1w1dXq0INtcpPqVoZ4CoFsJPM8zJwdrr8vHU5PSsS1ijivZBOrRuqg7XGDg9/p71SuiJzTVyO5gM8hJGFA71WktNhzyMcgitK2vFhuFlQgMrblOM4x04PFQ3N0rFicEHn0oVwdkindeXdRgSqI7scLMOFlHo47N7j8aqW8strOrLlXQ9GXOPqDV4mxMKSz3JLl8GAIcqP7xb+gpkti8rQLbzW1yZm2RGGTLE5wAyHkegzVoyZExV2LlEBY5wCQPwFFRTWt7DM8UtjeJIjFWUwtlSOCOlFFmIvRW1ksatM90HPO0x7cD8auvcaVDGFjglbP3t0oz+grAuLe8DlrsTs7dWkyc/jTEUs2FBJHWiUraGSjc1v7Qijx9nt0jxkbgMt+ZqTTtZtre5knv9NTU22FVS5lbYPfgjpWYiSSAYjY9ulTx6bM80ayNHBuONzmnFsTVivaeKEuL6aNrCxeaYl/MkRiUP9wDOMDtmtIa3eBEQR2exMgAWyKfzAzXKXWn2GnasS96HdJPuxjIP411kV1p0cTD7K8kmeGZsYqmKStsRyTzu7SxXDtGccFsMp9KEN0ZVeIP5gOVbuDVrT72SObfDBEVznDLkYrYTWyyBEs7YyKcl9vSkIm0fRdX1m6a+1K7UlP+fhsgisW58LWX2i71G/1G0aFW2LGnDN9BS3us3UspWWRnyeEU7VFc7aJcXLSTSkMyOeM8da58VVVOmenldD29dJna2OrwadDs0rToEONm6Ubj9R2FXtG1W4k1i1a7SS9SOXcYFJXzBtPGB09a5q2JjcZlUFcEYPPNaFr8sgWF33A7xgYzzXy1WrNs/UMLRpKDUV5f0yzp2Ilt3VxvxuGG+YEHqfSt/wATWhs9XuYJJvNMqJceaWyW3qG69+TWRIsAn3hXUSjcBkNkjkgY+ucVs3niXSjoFrI0sS6vZMYIftQLJPEeQCByHBPHbHFckaEq1TljuzpxGLjh0qz+FXT/AAt/l8zufFNkNZ8I+F9ZsTCq28AtLhYwEKSAjb8o55IPT1zU0WrB/D0q3s5me3/0sXayM0wXzFMqMenKFgvPavK9C8f+ZcNBLbrFZTSbWMRxJE3QkZ9OuSACeKi8QWep+Gm/tOLWftlmsyPbTrEcTHBIVh/AwycgnHWvp8Bl0qdRVp6bX87dT4DM80pyovDUnfVtPaybvbz7enQXWfB8Os61qMV1L/ZmnGSS4tpY3M8NuG+ZAp6MCM55yewrD1OAJqge5MGtRWkIt1jsE2goTw647gjjjjNbdz8WLi2skR7K2inVzK/kqUVyxOCEztGMkcDvzmuDi8Z3GmQahDoMUVkL1ESWZlEsyYznY55QHJzj29K9mUYpaM+cjOTd5Imu9QsxfSatNpewp+6t4HJUA8jvycdST1NdLoesz3Hha5KW1tbo8gIZV5J5zz2ryS4uZJpiZZZJT3LtnNem2qQ2vhXTYI8rI0fmSlmBO5jnj2xjivIzSTVJW7n0/DMIzxLT6Ik07Upjomr2M0gMYuI7hA2c78EH9DzSaVMQ7DeuCNp7cVjQr5ZkZ85b5uOaveHnDXQVzkZOcivIqu6b3sfUQhyPl2u2X9LtLqfDNaNexbrpgIVLF2RBlWXsOR+ZrkJPB2o3kp/s+2kupTy0UQ5bHUoOpGCD7V654Tu0t9Q/tWGYwWwtoJLqRyqiIx25XOOud23B/iBNcdYtJd6VFqFrcraeZqEjLIyFIY4SRknHIxwQBySQBX1sI3SufmVeVm+Xuc/aGfwtcyabqtjdoHGbiGWPYZOMhFLDgEc7gOe1aPgfTNP1bUru/vL2e2WOVI4oT95UwzSMf90BVHqW9q9L8a69faVodrHreoWOtR6hCjWv9oblnQ7ipk8lvn5A2jnA5I5rkfCUcetxahbi9WF1V5ntbeJTdTKo3YRWI3nJBVSc4U9xWtraHNe6uTeKZ4JRLLZxzq52rbJFuVWXHyy4OepB4GCfauNlvLkSSDzZvmJ3szfxD+VdFrunyjS7aaC4M1o0Sfu1IlZG2L5kmV5UZGQp5ABJ9+QlV42k8oYwcbtvX61UtDNF9PEGq2lpLFb3uYZFGUCZ6etaPhLxhrE129oUs7guMCOURxhuehduAPWuVcyxkuw8zOVWQKVX8afZMq65Yuym5hEyF1CgCTkAqAeuQcc1Fx8uh6knxEnEcVle2UEUasW+zvHsCnpuU9GHuK2rrxRGLCE6ZZRQXA+ZpioJI7YFcbpulpqPh/UrW+kkEOmXbMkU7DFvAecK/OCeO3pmq2t6La6BcWElhrDXtjPL89uHaOQLgMckjABBxkd6zmrPQuKuX73VL26uJJp5y8rE7mHFQrqEyOu6VwQOGzxXnWpS32p3LPbF13OR9mjY/Jz0z1IHrXWWttPaWEaXRDy9TtHC8dMVg4mitY6vT5DJMrK7g5znJGPoa6gXEiQbXdZk4JEoDE/j1/WuD0y48lVLZxnqOtbV1rOmNlYY9SUdP9fG3OOc/KO+aVhMdfa81mXjgDQxM4d0QLIjMM4JRweeT0IrOtvFGqKYk03xAbZYixjiYNAI8nJAPK49uKo6nNp0q5Q6jvxz5gjA/SsmJrGJ8ywXki/7M6of/QTTv0YJHYSeKdWzJJqljZ6gxUK12sCpMBjqJ4cE8f3s1U03UdAlv5bW5TVba0uSqLPbyRmS35znGAHHYg4OKxDqGjIVNpo2opJzuZ9VJ3fgsYxT7fVk+0ROmiWriORWJnkklbA7ZyKaC51c9nZQwy3Ol63BqGnwTKInkEiXVupBzwRuAz25FSW6yag8tojw3FwBmKRD5MqkDOHRwNwPtz9a5AahGJWkSB7RySQYCrAZ9mGf1rUfU7HUrq0N3OI5SUjupw7BigwC6o55fHYNg47U7oauO1mKaxlETXEVwCiszQEkISPuNxkMOhFZJ1MRltyiRGG11B5I9vQ+hrpdM1g2epSXEklzZFsxRS3MO5JYuQCzElQ3AxnOM1Tu9G1P7FJea0mnabBcOJIby/IjD+oiVQS4O4E4BxilymnP3OavZmt52ME/nQPwkyqVEinsR2PqpqubhiAyjA7j0rY1OwbTLQOLvSdRguVRibGZnUEjIDxsBjGev5GsW1ezMpM0dzaLjnyMTKD/ALrEHH40coOaJYpXZcZ46YFTyX969jBBdzS3FvbKUgilbIiUnJCf3RntVlbBPs0l3pt1HewQlRMpjMMkZbphGOWX1I4BIz1FVdVjmt7SOWS3lSGUsEcqcHbjdz7ZFUomTmGnadNq8zRaZLAZlQuILmdYpH/2Y88SN6KOTWTcytG7ox+ZCQfqKqPcxk43An2Pep7e+s2Fwmp2styXhKQSpMY2gkyCHPB3gDI2n168VVieZ9SFrgccknr6U+OTkMEQ47OuQaDb22yPyrjMhHzpMnl7Gz0DZIIxg54606eGW1ZkkUjaSpKkMv4EcH8KLD5i+mrXaKFQWiqBgAW68CisQ3Az94fnRSsFzvP+E01Ioizx2s6qMYeIc0T+JtPuzEX0uG0dRhpIB1+oNcs0gPSmIu4ketJN9SXbob9zAJphIl46wOMr8vFZk6W5JJvizA4xtP51ctZXXSWt36kkx1n2OlXN03yxlUBwXbgCm2uhOphXQsFv2Ms0zAkZCL2rtrOTTbh0On6fNKu3lpn4z61x+q29np2okNMLmXOCifdBrZGoSIojX9ygAGxeKTdkaNXSN24EcLEXDDHXy4qztQ1p/I+z2sUcEYPUDLN9TWe1y0h2oCc+lN8oDJlcJ7HrWd5dB2iRR3UzSDLHrVjRkZjdRu21cnG49efWoFmSN/3a8+pqASFL2UlyoYBx9K5sTFyptHqZTUVPEJnRQskIBwX28AkdT2FFzrUdqXjmc+aBgIoPzGuP1PWnLmO1crFgZIPJNY7zyuu0yMV3bsE8g1xUss9p71Q+hxPEfsV7Ogrtdeh2Vx4snudMudP62y3P2m2cfLJDIRtYA91IxkewNZ0txdebCjTzTuXHkvHGASy85U+obj8M1iRN5qJAr7W6lm6g89PbBq090cQi2VoY4trMm4thwMsynsD6V69OjCmkktj5ivja1dtzk9Xc6nUNdGqTnWJGka/nAl1QBEijkcSYVowoGQwwWBGd2T3p+o+JtQTQW0oMsdtPiSSFXyu0ElQR6jNc5d292LO11C7MapcSOIMSK0i+XtA3JnKrgjBI55xUczrJI12CEXf5cq55QnoQD/DW/O0rI5bJvUt6ZFHeRSsIme4hYMSoyWB7YqlqSlriURjI3E7dhVwPdfSonOyUFZBHIDhZE+63oavpqmoKCpnWRzhcyRhm+ob/AOvWdzTcXwjoLa1q6xzEw2kKtPcSkhdsSDLbc9W4wB3NdXh3ih3xFLbOYVGCVXPGcd+ma4u6vZZCXupn88yZfPUj1xS2uqXduD5Ewdi2cdh6Vy4qj7eKjc9HLca8DUdRK91Yv63qE1veGJCybG+ZSMHg85rc8KSia5jk6ZBd8DOMAn+lcg2pNcho7obpnJZpW+8XPOc1a0O+8uO8jYnzJF8tNo6Mxx/Kuavgo+y5Ybndhs5n7dzqvR3+Tsbms3b3mmWsMDSKiWluJOeHkUNz9MEVoaBqMWn+HtLk1F2WxgupLjAGT0xlV43dOAeMkVlai8NnaQozKzszMQGzwOBnHTgdKx7+6uNVitrFH3RxhUjXpxkkAD6k16tOXVHztaOtmdA+q3/ifWLnxJrDPLcoPKiaQARIix4VDxjheeg5561l3mqxab4ki1DS0eyFnKv2bY2WCjrubuepycE5rodOt48w6bC13bQTRxvhMECTCxkyIfmVi24fiOK42OG+1fX7LTrO3RL0yLbpGB1cHBZ8988knsK1lojnjZs9+1H+zPEGjyfbYrW28SC5WNbmAeRFJA0e8OTkL8wJweOBzxXkd5asNpyzozMEl+6GwehPOfqDVrxBqNpqPi+00exkY6XaLHZmXJIuNkYUvgHBBO7HsRUnh26Gu203h69uo4Fsn3WVxMD+6j3HIcDqBnPrVc3QLHKTzlZnQxnepAUtkoMdcDpVcLJPexjerrgbTyMAd60ru1keeeFVLtCTv2H5sjj7pxnjv15rOcfZlkFyYkCru8s/fb245HvUthZne2N8CNV13U0SArMJI9LcODdqfmRicf6oYBJPJHQ4qHTNRk8YeI7aK/iQhfMnmWKIKgQjG1QOgPA9sCsK1fUtd0+81G+vbmW2tYVDM78uFARIhjP8PAHAwDUZg1GysJLyJUtbIgb5I2+Zxngbu57YqKjuXBHol5pWmaEJ5bURRopyZHYblHXBbvjpXF6t4ugZj9ihEyZ+8xwo5/OsnVrea98KWerRXKvHLeSW01uJQZUIAKEr1wQTz0yKn0vQp9NiE9ztV3HCnkp/9esh2NsavA1qHkCpKSfkHUDsT6Gs838bsWyo9TnFV30+BXLnc6sc9atQQW6thYk/Ki6Q2kW9PvZBMj26CUJz8yBgPqDVu7uYrnYx0+C1KrhjCCoY+pBJ5+lLaouARwQO3FOulXaSRlj1I4NQ52eiKUVYz1IV8xSLnPcc0+NH2NnzDnjJ4pjQljkEMP1H4VZiymFJyO3NU6jsRylVxgYFUpxyQea6K9fTGslEVtKl15mTM0+4FMfdKYxnPORWTLFGRlRvHfac4qE7D3M6G4ntifs00sWRg+W5UEe46Gt7TPFF5HBDZ6tDBq2kIcG0uVwFUn5tjLgoT6iscRxEn5GP/Aq0LeOzMaKYnVv4nL5B/DHFUpByli907SrltQjtGuNJWCIypHIWuUd88KWHKqc8EggdzXLPbzwthlIx6HI/MV1s1nsZSNobGQwY8j2NMZEfHmJHE443heD9R2+tPmC1zmIkmMyMGIcHg9662FtZ8Q6nd3hvyk4ty9xMJxbsvRcqBjfngFQDkc1Z0/T7RLuL+1VuBCTl1swpm29yARt/OqAkiju4TdK09vFIWWLf8yg9wegPSq5iTFn1C6l2o7xy4wT50COSR6kipdO8qI+fqHha11G23eWfJkmt2LEZABRuuAT901v6xo4FraXhlgxdJvLRuDsJJwkgH3Xxg++axIEWxnlmk81LuJc24A/5aZHzMc8ADJGO+KXNbcLXF1seHIrSBLW21q31Dbvnja9injjBxhATGp3AdfTOO1c3HJb7gY7q7h9MxBsf98tWuIySuSDgg/ONwPOTnPrSanZG8vru9t7SOCOSUyNbwL8kAJ6KOyc/hVcxPKyjlP8An7De/wBlfn9KK1f+EfuBwbnSwfQ38WR+tFGoaF8aHcE4MbD8K19K8J3tyC4iIjTkk8V7U+jQA8gE1PDpcZBBY4PYVx/Wl1NlhX0Z5HfwWVm0Bhs3eSMcg9Ca5vVJb+8mberRw54jUYAFe+z6DaMuCB+VUJvDdpnaqqd3HIzik8Uh/Vn3PlO6tZJtVdFBGX6sMCuuis7e3nY3aSXJHRUPBPrmue1h5n8SyRSnlbnZtIwD82Oa+i4PCdv5Ue4Rk7RkgcE47VVWqoJX6jVJz0PC5UuGJEURjU9ABUX2KViC24mvoEeEbfaM7M+wqrN4QiJIWNOvWpWLh1F9Vl0PEoNMLNhlasrxdYtZxW8iqQrgpu/Wvfh4RVRzGprA8Z+B3vfDt9HbKqTovmxlyduV5I/EZrX6xTkiVSqQdz52bIIpQTkHb930p7ADHOD3pYwMEnj9K6EIAxAG5Cc/3u9WUVmkdHxxyQ4POO361Epc/KVLZPIPfFOXBJKkhicDdzn8aqwidl84LJIGG1fKcuxYkgcDHUccegqTOY1KovnRDB2/xp3J9SKg8wsyuzfNnPPb/GpF2A7mAjymQVG4Z9x6Gk0Uh8jFYi20OrjcrADbx2b3o3hlwqSeX95gG3BT647elQSYWLdHNGUBB8sZBUnqcelPKhfNaN15AAXJG8HqR6/SoZomTM8ph+WVZNg5DDLBR9etVJGkKq6hWx0IUZAqVneSVHRi74Iww54HQ46iq0jDaXVnQg4AzwKSQ3LQiO13O0Yxz8tXbC5EMjTSAFwpC+7Hv+HWqG9hIW3YPqKe4O4ENncM59qbWhnGVnc1bdbjVrwIHwG4LMfuqK6bwlptjf6kYJNQTTEgfHnR27ySyEtwdwOFxjrx+NZvgbQ5NZ1O3t3SYxPIo2x9WUnn6Z6Z7V6/4tto/AGnWmo6Zp2l2N9P+4eyiujcPJaOMsXbleeOVGcE4xWtOFkRUnf1Keo+IjD4Cvb2PRtH1qKxB0y/vIJGguck7Y55QAGycRhWBOcNu615Bp97d2a6lqUDyrO9v5LSoASolOD83YkAjPU5NS67fmHV5bi1gswZ0dGSFA0LqyldwQ5wRkkehweDWZcER2ZtPMUKpDE9nwDg/rTlK7JiraHd/CmxVfNuJYVMzrmIhC8m7+EhACSN2OBgnPXFZgvW0vxZquqXlv5fmQtO8UMgUrI3QA8gfPg7eTgYrrPAnjzVNL0Yxz38L6hGmyOT7F5ksNqY2Hl+cMELuK4Xnb1HpXleuSuJWjhuJXjmw8sbtuKuCRgnAz6/jQ5JRQWd2d34Y8K33iH4cX+u2s80uo2t474ZSPlVNzYk6bjknB/u1lwSDX9Ev1lGL6OJHTFurEJGx3gNjKgAli2ST0PArvPAWtW9r8MnsLy2RrK1aVmK7g7mcbWZWU8SKoICnjGa8smaQQXVxAbiNBiMOQU80Ecg445HOO9XayVzNXbZeG+8sE1PTyttdxgR3KwnYTkYDAdOR3FZyebf6clgty37uQiO2XoZCQdze2M/lT/D0rSyTPJxC+UC5BwcZHHUD9K14bkRbgiopb75VRz+NYSNU7Frw9odrZoJJR51yDyc8celbmriO4gOz7pHAHXNc7HfsmAtb+mSpKh3kAN09jSSE31ZhqxgjZCMs397tTDMcDjmtbW7RVdnUjI4YVlCEZGc4qXGw7kyXjJ0ND3ZkxmqNyCgHNVDIQaXKPmNtXVznPzevrU371k5Q49R1rGt5juGeldLZ3cbwIM/MowKfKLmM6Azh3aBEk+Uhtyhto9cH+dOkkleNVaQgDoBwKsxW5gYs3fkNVa5mWST5lJ4xleDUuJcWNjKFv30fmcEAg7SD65qVZreOLbHBI8/I3SSfKM9wuM5/GolAVTtO8Y/EVnSz7nP5UKNht3Ni2vVAMEn3G4Gf4D2NN+1fZ5JRKpLoCFXtu9T7d6ox3TJbGOREYvhkMiZKD1H19+KsNvvIpmhj23CRebIq8Aoo5YehxyR6dKdhJo0fDt/dPczxw2gvJGgmfy3jL5AjJZu2CBk5z271QgljEYu4oxIny/fbIVj0yO/T6etZ5ZkQMrncMEHNQ3TYiS5gBERbYxIHyPjJXHp1x7UyTofD+o6gmtpFpiRzXF6fs7wzIGSUOcFWB479e3UYq3qSWesPNc6HGTYwjZ5CAtLCqjmQf3oyQWz1GayLeaXSbVr1YBFc31u0VujZJhSRdryKT0OwkDqR5mfQ1nadeT6bdw3WnzyW9xCQ0bIdrLj0ovbRit1RPMvkDOVdG5V1OVYfWkSe5SZ5rIzZZWQmIEkqR8ykDqMdRW9eX9l4hjaYJDZazIWeeAgJbXZ7GMD/VS+o+6e2OlY0H2rTJWuLG7iWIjEgZxwP7rqOaXK1sPmMwXNsB91h7DbgfpRW2PFOpxgImuaiqLwAk8m0D29qKOUVz6VMiZ55NMM6qTxxSlOCc1G0eVyMV5DPTJkcvg9R9akC88Dnk8dRxUMHyc4zUvmKTjJTJ6+nvUajPj/AFGdJvFks0e2NWvA2N24D5vU+9fWJO23gKncDGp3Y68DmvlHxTYNpHirULVtjNbXjJgHIOH9fSvrG3nWawtXaQSl4kJfGNxwMkD0J6V2YhXjExpuzZJalmXLKasCPuQaZBMiqAGqVbkAHcRk9K4mmb3KVwwR8AflUsDAAMv3lOfr7VBdvvbtUMbN0HFaIhnzp8Y/CZ8PeJXubaJU06+YvBjGAepUAdxmuBMT7cgZANfZev8Ahu18T6FNpeobRFNyHK5MbdmB7V8p+KfDmo+Gdbn0vVYpIp0J2MeVlTPDKehyK9HDVuZcr3OStCzujDMRXGwHgkl89adg7wpYMo+6V5pWGPl/hzgj0NMbIBONi4ODng12IwHK7BBxyvGDSh8qMAYxyKhY8AgYA6804MQwPOM5yOtMZJGF2Bo2JmQ5Hc4prPuCuSRgkjA4J/xpu8joxHGc4646c01pCA33QJD+VTYq5M7sw3y4ZiBhu+PwqvM2GYZBJPp6d6USAqdxO4YAx0P1pFt3aEy5UAMFxuGTnPQdSOOtArkaqW59SBz0rt/Cfgu91UCWaWOC35MH7p5XuMH5jEqj5lXBJYkKMGtLwn4Kj8Qanp0Wkw2zWrIzTzXcx2rGGCmeUDBRc52jqcc8c16Jd6hpPhbR7Jibgs9tE0tr9pcy6gY+jkYzDGdzHYcBl7d61hT6yMpz6IhvrLSvB/h+a21qEu74mtkiKYgfllCsDl0wQWI9RjvjyLUtX1DXrl7iV5ZzGAm92GY1xhRn0AAA+lM1zXNU8T3zGe4do1ydmAqRgnJ2gcLnjpUlpDFbQKkS89WYnJY1NSaeiCCcdWRWtoIS0sgBlPAHoP8AGm30MT28kroplRPkJ49gP1qy/Sq80Et0UtYuWYmV84wFXnms9x3Oo0LWbiw+Hl1ov+jRtPOZJJJox5u3jAV85GSuMH8Otcc1h9o0uS6jLNc+djbkfd6VteIFg2eTavHMqHaJlJ/esByeeQByoHA6fWodOt7kSqiQsIwo3ZwB7mtJrZAnZF7wlfRGyvbA2t/PrBjUWcFpHv3c/OWHbgdcHqelYt1Y31u01zdWwjweYmyMO3IYqOg4PWtrR7mDT/EU9692bZGGI7qJCZoJAPldPmHcYPP3Sa3PFdhcaHaWGoy+IxdXV9a+diCT95867H8zg7gQCBgkYz0prWOoddDgtMlaO9kkRFik2kuqx7VUHnA+n8qvgs7llXAJzgdqvaei/ZHufJdnZwmZDneAOP0xU7QyMSyqF9BWUhlewsJrqTaAFGM5JqWG8NtMVLcKcVSu3uIycSMB3HSqccpZwGFLYW52KXC6hGFY5Hf1qOWx8v5QxB7Z71BoFvJ5yyLkL0PFdFqemStCpV2bA6kc0cyGos4y8TDEZ596qGMelaF/C6SMsgJI9aoZxwaV7g9BFwMc1s6Cw+0KT83oKxiCx4Fdb4IskluW8w/MeMHtTFa5e1DYYSuQx69KwnRV5XBBPX+ldz4u06K1tcwuuET9cV5/FKWLAjJPX3qtGPVPUY0M0zHykOB0xTFtgjqb+GRoSfm8s7ZMex6fnXfeDtIjv9m8MFNbmueFIIkbCBt3QntVKndEOZ49crI0nmOd6sMI5OflHAH4DAxRHL87GRiW8tlU9ycYArsL/R4UR1VQMHgVzkthtk4APvU8thuVzKnLYCgcU7SjFHqlqb63SezaaPz4ZGKrIgcEqSOQCMjI6Zq4Y/n+YcCtGGyjmiY7ABjk+lLluHNYXxxfW+oajuMN7bvCg2QiUSxRb2ZmCZAYLkgDrwAK5ad3iONxxjIJHUV0uo2bS2X2rLSBYvIds8q4YFM/UVi3NqHsrZ1wGzIj/NnOCCD+RptXBStoUpb1rmWR7lUYv94ooTHbgDgVpRXIuGQTOPtIwsVyQAGX+7IO496oxWe58HFWpbMrGu1SR0x/Wps0PmuPktHEjbtLJOTko52n6e1FVfLuRwJiB25NFUK59XyyA5AqNWBIGDUW45OelSxjPSvDaPWLHlDYDnB61SlyH69KsSTEDaah28ZxmkgPmL4sQtF461pWADGQOcYwSVBz+Ne/eE7qS88IaNcofMDWse5l+bacdDivGfjxCkfjYOABI9qhkKkEHqFPHfHXNcTouuy6dbS26ZVmYNFcRuySQt3wQehHUGvQVP2sFrY53PkkfXNqwZDkg4ODjsadMR2rxz4ZfEcvqI0/xJP80qpDBeMMfdzxIR7YG7r617JIMHqMnBz1yK46lOUHZmykmVdpJyadDIBIMipyFAPFUJm2vnt2xUdCjpLa6VE5xmuW+IfhrT/GWmNbXEn2e8Rf3FyqKxUjopzzt+lWYZ2cYJP41bUbgCetKMmnoDSZ8o+KPDOp+HL1rfVIwrMcK6EMJAO4x7VhlSQDn5frX2FqNlZ31s0N7bRXEbDB3oMj6HqPwrzrxF8JrXUyZdJOy7fhQzLFEB6tgc47YA9676eMW0zllh+sT5+KEjgcd8U0jagBAJPfvj0r0K9+FviWNcwW6TjeUCCRQ5x/ERnpjvXJz+HNZimWFtOnaVio2oN5y3QcdD7GutVYPZmLhJboxmJ4z+AHGKa+CeSTWjc6PqcMbST2cscSkqZH4UkdQD0P4VbttAknW1SENc30zsotYvnLkY+VQuTnB6nj8qtPm2Jem5naZYXWpTiK0hd+CzEdFA6sT2A7mu+8HeBV1K9RLqaO308OcXu1j9pXeVPkhgAwG0ndwo6sQOK6TSPBNjpNpDeeMFhEBJNjZQ3e9I8/O6Oow7EZUfeUfKwJ6VW8TeJLvUF2xFLCzEXkhYiVZoQflTriNMYGxAFPfJrWMVHVmUpX0RqeK/EeneFtPh0bQ0tIBbvvEMEi3CKzZD+bJtzO2QMHO0ZAHAryu9ub3X7y6u767dgfnlnncs7HGAo7k+ijgfhXd+EPh+upxi+1R/senL8wZhhpfZV9Pet3WdN0q0gSHT7aMQRjCDAz9frWU632UaQpPc8nhRmVYrSBo4hjryWOOpNXreymbAJC/WtKa3mFw6xYXJ6AZpk2k3Zj35Yj61m5R6lckhFsYVZfOnG0+lSwR2ETS3rQrPDDjcZM4Iz8v684HJANZpRreJ/NIUk7QW6c+tal3G9h4ftYfLg86QGZ2YESg4+UjnDKBntxn3remupjLsZmoaptv0to40VbZQuVYEDPJ5HUc96yNT1yeU4guFCvneFQgj2Pb8qpTyFYyzID5nykAfrn1qm6bUxs54JJPOfSk2WkW9PkXybqSZw0pAWPdnrnrXY31rdv4es72OQOsge3lkUj+HaQFOBktnHHPFcRGcWcm5c7myDjqfrXcassqeDtKMsUgETyBHkVVXORkIc5Leuf/r1UNUyZbnQWUTXGgWEjxkTFSX3LzuBxn8aLyFI7Zj/EBjFTeGb+3tvClpc3ckUEaqzHJ6AHBAHeuH8Q+LpL7emnxeVGzH5m5Yjt9K5JXcmdCSURNUvraJissnzdNq8muo8FaDa63EJ4t5KNtdTjAI9xWF4M+H2r+JpEa4LW1gG3NI/U564HrXultZWHhbTY7OwhWOGMY4HLN3J9SacpJaIlQvuULfRbSzjQeUowO9Ovvsph2oArD8qxNa8WEs0ceBjpgVzcmuScvIxIrHVs3SVjQ122iYE7AG9QK4W/i2SYrrr3U4rixJDYyvbqDXE+c8l6A/K56VvFNbmE7M1tLslkjVjnk1paXdGzvGHKkHAqvZ6gglSNYyFx196mvlVyZAfmUfnW+hgk2bniDWftEBDhDjgc1ycdwokLZHXoBTbm4KgDyyTiqYmYnPlmoc1E1VOUtjv/AA14iWxGC26LpjHeuhl8QJqbCCSTB7PmvJYrh0zhTzVm2upVcOoPX1oVdPYp4Wa6HoOuxxx2xkDKSBgc9a4aRJSWdlJjHcd6vNqbXKhX+Vh60l/rUaaXJbeSdxUr7c96vmTM/ZSXQ5G/vmikHq3I9KtadrexWGeSMbW6Vi3DvJ5hZQ7LyyH+If3h6Ed6rrGDzGQw64PBrPm7F+xO30CX+17nUNN8wxz3sMYtIwvyy3KyDYpJ+6CC/NZN+0MVyYraTzYY8L5mMb2/iI9s5A9hSaJb7b+G0SSX7TcxMvmQcsjmNjHEo7ksEDH0OBUvjiIQeI5JopIja3yR3cRiQIo8yNXZQvbBYiqvoZuGtimZgvTip4rxiiZ3YyapW67uSOfer0SrjGR9TRcFCxL5yHnafzopCyA44/KinqXZH09sBXrzSxqc4zTohk+1SOFUcda8M9FEUqgt71GxIHXmnMxzyDikdD9aSGzyP4yeA5r6K48RaSm90QNewl/mKqMB1HfGORXiMFq3lCXPy7wQMctivsjeCrKc8jBwcEfjXknjb4VSGGe98JHAJMktgzfO/Ukxt/Q110K/L7sjGdO/vHiV1KB93OclsA9K9Q+G/wAVm06KLS/E5Z7JOIrkKWeMHs3qK811PTbmynNvdwvDcJ1V12nn2PWs2RGB+bv39a7JRjUjZnPzNO6Psqxv7XU7KO60y6hu7aRdyyQtkfQ9wR6Gkdd3v618k6DqOsaXcebo9zdW0nBJhYgH6joa9Z0H4r6sksY8QaZFdRs2XlgIjkx3IXpnp+tcc8JNfDqbRrx+0evKm0HAIpyOwxyT9a5fSPiV4ZurYNqEk2lz9klG9XXOMhl7+oIrZ1jxLoGk6Xb6peapB9incpC8YMnnkdfLA5ODxnoKwdKadmjVVIvVMuXUrbepq/pIaVMBSfevINU+LV1cxPJ4e8PySWyvsW4myMn3Vc4P41gQ+IPGWsWjXEmqpptkHI3pOsWGwSBt6sB7CtYYKcnqS66itD6I1i903Rbfz9YvrazTqu8gsx9FHc15P4m+J+nRyS2vhuwS4aZiWuLgYViep8teWP1NYem+Btb1LQRPqOtzJpjTyzp/abSR24cR/PPjGQWBXZx8wDc54qN/EHgTwvaLBoOnz67qAdZZLy4lMJDoE2tEVGVjYmQlTzjHPau2ngoQ1lqcs8TJ6IjtdJ1PxVJ/aeszeVZQRNM15f5htoow+z90gwBg4Xao6/nReeNNL8Lrd6Z4Otre/t5QFk1Ca3MTXDAEY2HnyxkEA9SMnPFcxrGta941vY7WBbm4heUyW2mwyM8NsTx8qnhe2D9T3NegeEvhHFGkd14qnaSQnP2KBsfg7j8eF/OtaleFJWM405VNWcBZ23iXxvq8txaLLeSMQJ7xxtjUAYGW9ABwK6Gy8LxaPfxGfde3I5LyDKqf9lT/AFr3O3hht7RbW2higtY12pDEgVVA7YFc/qukiW58wKMH0HSuT63zPXY6PYWWhzmrXV02nluSNuBXDwyzTXDqzHrXoGtApbiBVJB4Fc3Fo8kb+eEJGe9a06iSuKUHcWx0WdiHK7x9K6S10hJYwjRkMeOBVvQ7hCio64I6g1oeILyHSPDOp6kVOYISY1A5Zzwo/M5rlqycpWNovlR5Cyrf+PmW3Q/2dZyeWJgjPHHtxukYKDxkhemBuBrl9TmAuHjhVl8tyFBOeASNuM/73Oa6DRre50zwZcatFb3QhW4jWS58zCXBcSKVQYw2GHU5xg1x0DEo0+Qu0bdoHAPQV6qXJFRRwXc25FW5cLceWqho0PKvkqD9KND0i+1zUYtN0q3knuZD8qDsB1LHsB1zSm0V2WS4cpEWwzYyx9cCvRvC3jXw54NtIoYdD1AvPEWkuTcp5sinodu3AB7DPSsZya2NYxucz8RPDkXhGa20iG8FzOIi9yygbC+SPl9R6Umoa/b22iWNpFGkkyIRKGUfvMnI3Ec8cfkKzPGXieXxRrMl55At942hQcnA6ZP0rLt7MlBNKy7TyCckH8qqMmkJxTJ7Cy1HXrmO2tI3lK8JGvCqM/kBXrnhD4XGxKT6tIk0xGBHHyqj6+tb3wisLaLwdb3MVtGsspYmQDJbnpntj0ru7OFh15Gc1x1KkuayN4xXLcs2Vpa6bYEIoQADGK8/8Y6iZJWjT7tdD4m1TZGYlO1VHP1rzicyXVwXZsjNJO2o0rnNahFIXJrNcyHjmvQV0ozRhimAelNbw2qEFVHPJGarnGonA2Ucpl2uG2mt+y0D7RKrkHpzgVtNpKJKNseSK2dM3xxfLFjb7da6Keq1MZqzMFNGjiPzLt9zVG+hZOFO5exra1eedHKquM1XtLcykb+G960lJIlJmNbaW9zIvHWugs/CgZFJXJPpV4R/Y/mYgY56VuaVrMLYHy+4rCUU0ddGo0cpdeFSvIBFZsuhSRDGD/hXqrywSx7sLVIwxSvwqgYwM1gqa7nZ7VvoeXNpU0bj5SfwqG90eVxkqxwMg+lestawA5YR/iKrTW1qYjkLk9MVrGOm5jOWux4w2iStKrKjKQc7h2qxZeHlub6NTAzRjLyRpgEqoLEDPqAa9HuEgRyiFM9uK5rxDfx2M1vDbxtNqcxH2eGM4Yt2b2FaKNjCdRHLx2slvfLe7xDN53mLKrbArk5GD2rpLlp9F02O3stZO+S08p7a1VXiywZHZnYEf6vauF5z3GKoSw297bTXMSxyXKsq6jcCTfHEecpbL02txuP8J4BwRmtqN/HsG1AgAwqqOAK0+HRmCSqarRGJPviUBguB0yop1vJ5iY2Ic+q1WnulknwPpWrp9vuKnAJxzimtTNqxH9nf+6v5H/Git0RcD7v5UVpyok+hkwn5UxpdxwMCkWOVs5xu96c1sFAZmBNfPnpComQCTk1YSJSvqagjkROApJqRbnI4AFFguMktjnIWmxRE5Bbb/Snm4Y8E803a0nTqaVkVdmZrvhzQ9fRY9XtI5sc+bHhJf++gM15t4i+En2O2kuNAnW9CDItpk2y4z2IyG4+lermLY3zdqbJdZwFPStYVZQ+EycFLc+W9U0nXdPeQtplxCo67oTkcZ5H0rmbqe8P+tdwG/u8A/Svs1Z3wTvPIwc85Hp9K8v8AiL8M4dXeW/8ADwWC8Y7pLTcFjc9yn90+w6+1dNPFtu0jGdBbo+e4jJJOrfeYkE/ga9B+EeuTWvjvbaeRHJcxTQWhlsWvvszt8y+VFnO7IwMfr0rC17wrq2i4hvdOngaT7rKN4b2yuefascWF79r8m0trppSV2DyiXz7Y984xXXGaepjKDtY+gvEnh2TQNWSw8S6nPHpOr6c+25+zLpsBvo/3oBhUDflW2guAcnHVcDy211vS9FsIporeO41AQvECzHMMgdvLlTtkAqfTjpWPJ4a15vs9xcadqRNzkx74nZnIODjPXmu68N/B/UbiWKXxE62UCnLQK4aTnscZAOPypvExgrtjVFvQ5PX9f8T+MdUVbuW7ui8Udt5MUZQPHGBsUoODzhvrzXYeFvhNcSmK48RXJt0Iy1rF8z+wZu30r1nQtA0rw5beVo9osJP3pWO6Rv8AgR/pV8DeTnvXBVxkpaQN4UFHcp6HpmnaLZLbaRaJaw4G4Lyzn1Y9Sa1eFWqyoyHipycr0rjcm9WbpDY3y5FTbQxUYzT7aEMCae0HzccY96lO47FCbSYrglioB96rXGmRpCVwDitkPtGDgiq9wwZT0yegroTdjJ2OdFjHGwOQq9STwK8f+JXjWLVf+JXYSeZYQzgyN085l7eoXt71ufGbxq2nb9A0iTF4423UinmMH+AehNeNWW9IZHiVQ7EDc2GI+ma66FL7bMKk+h6n4z1ON/htoVlBeQSYkWZ7WJHR4W8ocsrAcEkncM5bca87tp40gK4EjE7sdvas10EqxpGkhuUBL5OQ3PUfhU9qpLqYxuJ49q7XO71MUrKyLUD7r6Ge4BeNJFZhxjg5xg9c1X1WZtV1O4up2hilmcuUX5VX2A6Ae1d74d+Gmr6pGk9zGtlbMQQbjhmB9F616V4d+HOkaQ6y3EUd/cLgq8kZChvXbkj8K5quIhHY2hTkeAz6LPY21vLcRFDcoJI1YclT0P0NW5Y1Ol2Kh/LBjUBNxYNIGwSfT+XFd58cIFTU9NkiXy9luUG07Rwc4H0zXE3cU0Gn2rRl4o/Md4325A3DPB79+K3oS5ocxlUVpWPoL4R6WG8BWLJLuUs+Ub7y/McZ98YrqbhRawMMZPrXLfCC6MXw80obGAKsST/F8xAIPcY4/Cuqkb7QcEYHoa4ZTSmzojF8qPLPFM8s0rjoCaydPVGwCDuHrXrGpeGbS5jMjKA3XINcRqOjPbF/IGRntTbTKjoOs7lIolEmMelR3OoxtIAnHtWDqBnjAXBDZ6UljFI0wZz+dLlKTOlsLVrqbdxz610VtpiqhDMoHtWdpCqqhs4ArUnnGzg002RKxBcaTGR8yqw9xXP6pBFbMREox29q13vZMbMkr7VRuF8184/OmpXDlscnquoybcbT0xWVY6gYpeuOfWu1vtDSWB3wORjiuSfw/IlyQAxTPHFbwd1Zkc3Kzds9WEhAzwa6K0kjJySBXKQ6DcRqCoYDHFTGSe0BWQGk4HTCumbl5ONz7W61nSXDSJgfhWbNfqQSzhFH3mPRR6k1g6hqlxd2BmjlbTtGZmQ3hTc90y4OyBepPv0HrThC7HUrKKL2o6muZUsXhluIyUZpH2RRsBk73PAAHbuSBXORWz3MbzLJMtvOuLi5fKyXg/uqP4I+2O+K3vDGivqi2VtqcYtbGA+ZDZAlhKzcmWXJ5cjHt7VpeM9PS3tBJbSAxqdoUDgfStnaK0ORe+/eOd09J/InGnqym2iMyqnREHDgj0IPNc1eyHBOMA8gVpoWVt+SHAJB/p9KytX2uRLCGERwGU87X7/ge1Rc1ehmIcSFm/CtrTL8AhAcHoTXN3Eu3p1plpcMknJpxlYykrnoouYyBkrn6UVyAvzjrRW3OjKx9cRls8k1YIDLhjzQgG3096jJ+bg189c9EHjwMgjFVwTmnPIdpHamAkNwKdwsPxnmpYpdjcU63XcuTyKZcrsfIHBosBLdvujwKy44Szk9BVjduOAamjXApbAiIx4x7UojJI4px3ZyRxUkfTnJFO4WACRFZVOFYbT6Y9KdaIsTkiOKMkYyiAE496sRx7sYHFNmiwAR2pollhWJ2ncSQODnpUTwxhcBQoHpVfzCny7uaVpCy9f1ot2C5BKoIIGDmkigwSfSn9SKewIQ4oUQbFCKTzwewqBuHAp8LYPzHjFMdgJC3YdKGguXFGI84xTTnaTyajiuegYcGpHuF7YFTyaj5ipIzAHmvNPiX4uvPD+mPLbL+/kPlRMeiE/xV6bJ8/TnP4V8z/FzxANa8VvZW2VsbR/KU9dzdGc114ePNKxhVdlc4ciW6me4nZppXLPIzHJz6k1q+FtFvvEuswWNmvdS74+WNcgZaqTQ5RmAUxqw6cZ69vTivcvg7pD6XoTGaHy57qZLhiRg7RnaCOw5ziu2tPkjoYU48z1Ibz4M6bJbK1tqNzBdckl1DJ7AYwRWt4Q+Hul6Bcx3VzIb68T/AFRdcRoem4L3Pueldy8xI6ckdqpzBx90fSvOdWTVrnSopGlb+WWLEnNSXLJ5bAHFZELyLkFqleU7Mk9utZ3NDy741wGRNPmRUC/OGdzkZJ4AHrxXAahaSP4bsruTzDCzum4qdoIAJx9M9q9R+K8K3XhlJMgeTMHLYyQMY4/OvP0s7jUPCSNHAjxWlyq7lfMgMnA4JyBlRjAxnvXrYJ3p2OHEK0z1/wCEc2/wHp67TEYg0ZU9xuyDXXzzBEOQeOa87+FU8kXg+3iZDvSeaOXcMMsgYFga7c3CgfNxnsa8qvL33Y7qS91Dor2eQFQTtqZYElLeaOvcVVjljU5TH0qcuSO4FYuTNLIrXnhy3uUztUt9K5TUtGex3MnIB7V3cEsmQN2RT7q2jukw6jJ71vTrPqRKKPN4dRaBQGB45qddQe5kxyFrpbrwysp/dgHHNZk3h6eA7k+6K6IyjIykmi5YwEplgCMdqral+5UttAz7VBFqBtUZGcbu1UL7UPOhKyNz2puHUSka9hciZAuQexrbttNjldGGCT7VxmjzBZfmHy11+nalDEdzOFQdyccVpB6GNRam+ukRCLGAcj0rzv4g3Gm6IyrKTLeScR2sQ3SOc4AA9/8AGp9f+Ikkr3Vn4Y8hhbjFzrFw3+iWpPuM7j2x6muI0LSb/XXe70xp41ZSlzr11kyz5OSLdWH7sY43dfftW8E0ryM7GNcjFxexa3B51zAFxp6S4t4cqD5lxIvOBkfIOSRg4xzj3GurLfNc3UzXl0vypK42pEv92JOir7Yrrda0Oys4PsenxbIFPc5Zj6k9zXn2raOVZjETjPStObsUaS+KZluA8DYI7itC58S3GqRrHcyAIv8ACO9cOLWVPalR5VYD361MtS4zszpbmbdkoexNZplAG5huQjDL6ipLSQbCCegP8qzLiYrN/s1NrDlK7IdRtvJmBLBo3G6N/wC8v+I6GoIYZHcbI2I9QK1Vnl/s+aFSNhdX+6CQeehPI69qpQmR2BdmYDsTQiWyT7LMP4f1FFWN496K0sjO59hDr3ppGO3FQrIc8VIHyvcV4NmenoIq5fpgVOYVHPrVfzNp/rR9oO3A60AWExGcVLcIHjbOM9uKoF2apY3bYBRcVisTtbCjJzjNTo/6UjgBznjvS5AHap1K0J0Ib8KkRB1wAKpoe+7pUjSEdKpLQlmipAHFQzMSDhelQW0jyPg9BVq8TyrcsD2zVeRJzWsaolqGzgH3rm5/ErgZGT9KpeIvMu9REYzt3Vfh0DdAGABUjFdkIRUbsyk9Saz8UJ5YOST3BrTg1+OdiAetYFp4bKlsjv0Iq7baK0E25OxqJOJSR0cchcZTkGrltEWb5uVqlETEgDLzirMEwOB0Nc0nqWkWJIEB6456VE8JA45qTd3zQ5wvHNTqPQicOEbCFm2nCj+LjpXyBr+6DWr0sCJFmcnPXOelfX4m5Bxgivm34vaINK8Y3Lqqi3ulEyEjADH7365rrwkrTszGurxujE+H1xpkXiizPiOF3sWbYp3HbHIfuuw/iAPavpy1sBDyCDkfeHcdq+SVhV4kTccNkHB/L9a+k/hd4pi13wvDvQw3lkFt50JyDgcOPqByPWt8VC9pIypSezOueLao4qtKRyOvtV7zElTg5zUBhzkkcVxNNG6ZQ5zgAetKUypHtUsyhOmPpUKZZuOKzehojnfF2mvfeHr+FR8wiLgEZGQO/tXnXg3UdKXwl4qsdUjtZbmaONrPzCR+8J2kKV5LDIcKeDg17VcL8hI+8a8p1+3Twz4vXUi13ZaPeyK80+nLGLiJlAyY2YHB/iwMV34GtyvlZzYinzLmIPhBdy2+qatpZlZo2iF0sYXgOGwSPTg16YWZhnaa86/4RxhZXGu6Dcao880GyK8tr5ZXLBy0xuFA3BmQqwUZHB561Y0/Qdem01dRttX12e1COsz+SGaKTpGu0nJBcruGM7T0rWtgZVJOaZMMXGK5bHoEJw2W7VpW8qngEe2a871bW9f8PalZWk9jBNDcruTzrCS0JwxVhsySDuB/Q9xVmPxffCJGfTLHzVbY6C8CODjJBVhlSMjg9+K5fqFZa2ua/WqbPQgdp4GKd5p7/nXGJ4xnYHOlpIFxzFfQkHIySDnnj/CoT40vP3bJo0RWT/Vk30YD8jPTJyM0lgq1/hE8TT7ndtclOe47ip/OjuYyjKOnBFedN4q1q4laK307TwoAw/2guGJOBwoJHOeT6E1Qvda1c4B1SxsIurtbRSXLAZPTaCCeDnB4FaRwFa5LxVM1PE+lvHNuQEe9YKWbjBcMfamsbrT9NtpL+78XT6rfAmLyPJ8kElihZCCyggBgrYOOe9RavqK2OrXFprl7fCwjntwrNJbjdGYjJISYs7snYFw2MMcnNdSw01aLZn7WLV0h0+qJZMIlLSyuwjSKIbmLnop7D8apXky3KTQa5Nc3N0+4W+j6cdjo2PleeUggJ3wP0qzb3Mt8wj8HabNoWkLudr6crNdSFxyqSFRtX04Jzk5rY0HTrfRoPLtrXamdzMxLM5/vEnrVJQp6LVh709SDQ/DskzWlx4kktp4bUKbfToBi3gI/2cfMfUnOa6i/1UyMU8wAAYUDgD2ArC1HWooUYYwa5ifW0eXGTjNZTbbNYU11NPUsyTs5O7nrXL6goZ8OvPY1tx36yrhSOnU1VeNJSS4BPbFJTcS3TT2OamsxJkKvzHt61QuNLZByCCfau2hsljYbxkE8e1akmm288ILYJxV8/UycGjx1vMiuTGQdoU0tzas8O4Dkc16Pd6BCZCRH2xmnweHldRlDxQqiE4M840yznmglB6cY/OtO30SQLyhJJ616Zp/hdQcqmMjJ46VtReHlwAkefQnil7S2xPL3PIf7Gk/55mivZB4dXA4T8qKPbC5Ud4iZGTxSqCSc1Gj4GD1qVW9a8tux3pXGSRgdTSpEDgg8U2ZyTxU0bgLg0r3HsKiDng1MQoXuPSq4nGcZ4FSLJu6GgRnXMhWU9eO1OikyoJ61LdRruyMVDwBzimSWVYFfUmnIASc1BG+OgqxENxx+tNAXLcJGcin3kwmjK5HIxxVFl2tjPFSQ7c9Km9h8tzlNcsTCxlUc9aTw7qDzuY2QqAe9dhdW8U8WHUHis2Gzt7aTJAB610RqXRk4lxoMoDjmmrDkcin/AGgFcA8D0pnn4GTnmokNEEsfPHWmiMjBHWpmcMaaHCnms2i7kkY6EjNMMvYDApyyrxj0pGEeAc0XAIl3Nx1rmviH4Xh8R6SIpEjE0YJSUjlfb+ddJ56qeDk1FczCSNgScGiF+a6CWx8r+LNCGgavLp/mmREwfNC43gjPA7Vt/CvVWsdentRINtynCnjLDp+OK6n4x6GWsY9WiX50fy3AH8OOCa8jtrh7e7gubbiWFw/PGcV6kHzwOOXuyPqXw5cySp++zvBxj2romxjjrXJ+Gr62v9ItNQs3VoZ0DAA5KHup9wa2RegEc1w1JanREkuoiWY9qhHydaSS+VvaqFxfcckVz2uaouXEoZSOM+lZ91aw3tpJb3MayROMbWGartdZUj1p1pMT1zTWj0HbTU8+1f4e3NpqhuvC8xhJbzFjMhRlYc4D9s9j2rmdL1Lxd4PvJJbGfU7SUy7plYmSGd92f3iEEP7k5r2i4nKqcg4zVNr7Lcscjpz0rsp4ucdHqYSoRex4zLd+LPFuu3F4JNSu7+ZSbgtnkdMZOAABwB6AV2Z8SeN7dwHt7iaRQixJcDa0WyTejBlI3NuJOT1756V1aTxxvI0SIhc7mK8bvrUv21XBV/mB9RVrHTT0WhLwsGtTk28YeLopjctoVp57NJL5gsjGAXR1lyo4bdvByc/cXAFZqeMNe3SyQ2EUUzWgtnnghMbyqGDAnA4Y429hivRn1DMY3bSccn3qSC6aYHzfmcdCRmrjj5dUQ8LE8/fxzrfmxx6fodjbxRzmWCJYmd0l2Ffvkgg89ckYxUj634yuEiiXTbeBEi+zi3EA8lASC7DPAZiMn6np0rr7yaVHVEUlOwA6UkEN3Mm2ONwp7dBTePn0QfVIdTj9GHj23df7Pura2G8zAlUVd5RoyeAT9xmGOnOe1bdp4Tin1A6p4iu21PU32llT5YV2gAADAyBgY4AAGMV0uneG7i4mzMxUE5yOtdemh29tBg7cjqTWFTE1Z9bGsKMI7HMpdwyERsiKOu0DA/Ci4NsEOPk3cUmsWUUMhdGwyniqqKJ0wDuxXK3KOpskmc/rOgPf7mh4IPBHeuH1XQr2wm/eoxX1xXsmnq9q/KllPY1rS6fa6pGV2BiRyDXRRxHRmdSHY+fImcDZkqKtwXfk4/i9zXU+OPCMlhvns0JQdUHWuCWRmJUjaRxg16EUpHM5NM2H1YEcHJ+lSQ6vLGMZyKwzFhv5Vagtw4Bzgj3qZU0VGqzfGsswwSOmTxWjY6mxdW42+tculsyk8E8VrafEEGM8jqKj2dy/aHb2F6pwyNgDqPWt6yvYpWAJGelcPCfLh+QHd1plneSx3gfJ5PIqHGyCST2PTtqetFc+uoSbR8vaioI5WdNJGynJBpMPjHWtphHtywHFQGSBSflya5nRubqdjJ8uQkDbVlYztHIAqeS6hDABRTllVgQAADU+zsVz3M8xgHPPJqZSsY6iiVMnhgarSwSEcGqtYXMSsQ/TGKVIQSeB1qqsciYJGR9ad9o2huDms22NWNCOBMjcPyqZTGp4/Ks22uwxCkkGpZWVULZII9am5RZlYE+lNjdQTk1jTXuBjNVftpJJ3HH1pDudMZAwx2+tYmtO8alkPNQx3xxy3IprzeeCH+lXFktEOl3UhbEm7r61oSXG4kBulZnyI2E61G5O/Na7mbdjVW42tyeDSSXAHVqxZZyvAwKg853B+bnvSasgWpvi7XscGlNwdvDE1zqtJnIbJqxHLKRxWTNUjUMuTuyRipGlVVBycmsZBclgT0NXI7WeQYZuKqNkJpsqaukepadd2cn3Z0ZAT2JHBr5s1CzksL64tZgfkJBPr/nFfTV3pU3k5jOD615T8TPDsgszqUaEvGcTcY4PQ/nXXh52ZhUhdXIPhFrzW5n0iVvlGZYucZ9QK9SN1leTXzjZ3slhf2t9CCTE248/eHcV9LaHaxarpNtewEGOeISLznr79/SliabUrrqOjNWsyqZcg5BxVOZyegJrefTdpxjn0qSHRQT82K5ORnRdFbwro8ut6jFbID8x5PpXuWjeB9J0+3VXgWaTHLNXCfDlYdP1/DEDdwK9lrqo01a7OStN81jhvFvgOwv7CVrGMQ3CjKgdDXhF3oN4l1Ij8FSQa+r2ICkngDrXj2v+S2r3BjCAbj+NOrBLVBSk72PN4PD8uMySfpVyHw/HuBdmrqpn2Lnco9cisqe65/1nfqBWHIdF2VP+EehUZA75yTV20sraEYITPenW8+RhpM5qreTRo3+s59qdkLU1Ta2hAZggz7U+O6sYAQNuR2zWHHcb0KiRcHgZNZd7A7SkxyDI6jNaKKsKzudl/aUQP7shajuNQjMbF5cjFedX7XtucoW/A5qtaX1xMwSSRl4701BMu1jotQuftTMEYHGe9ZljO8N4VfgVasbR5BhQHzTLm1mgkztIPuKUrS0QcrR0dtKsijOTxVyFlh+YMePQ1ycdzJCRkkH0qZtV3YDEZzxg1zOnZ3G77HUXFxb3oEdwAHA+XP8AWuG8SeA0nfz7UBGPO4dDWs0m5QyudxOeavWuoywx7cblPY1sqzp6mbpKR45qmk3OmvsmQlc/eHSpdMtQ6bmOPSvWL22ttSQqwXnqpFctq2hGyBe0zn+6R0rspYmM9GYToyjsc00QifhuMVXFx5bgbqsyW9yXKyrj0J70JZoPnfntzxXSlcyuye31F5AEzyTgYFdVo2mG8i3kpH7k9a5B57eBD0z22Vo6J4juLceXCAoBypbnmhxUtGNScdUdwNNcDG88UVzh8Q32Tmbn6UVj7KJv7VnUSa5IV6moP7SkfJLsKiCoVwB+FHlJngZrg5zSxKl85ONxqwNSeMevvVUW4booNI8JxgCmpJiNK31pSx3jgVa/tiLPY1y0kDLkA1EUZPmOaq6Cx2Fxq9ukXBUVQttUguJ8B/wrlp7W4uRhDgfWktLCeCQMGzj0pWQ7HfeVHIAyk5qC4ikcbd+RWDb6vLCQjmryaoJCuVP4UnBBZkv9nyEE8kVWls3i5JFbFvPlNw/Ws+7nZ32gflUuC6BG5lsSpwDz9Ktwq+081WmysnJwDV6CQbPTikoWNLXKUz+U2S3J7UeZvGc8VZa1Fzk5AwOtOjhSJmXcuMd6tWsTyoq+QJVztJNVjbyBioAxWziJCMydR2rPluUWYe3Si4KJHs8pQD+NaemRJKeQKxb68RiMMOaktNUWCP8AhI9SKiSuUkdj9nhC8BcikiKq2Pl59q41/Ejj5Rt60ia5OW3AcVFilE7iZ9qkYFYeqaVFqdrNb3QBhmG1hVGPVJpUzVafX5LbKuhHvVxRLdtD5817S5NG1q9024K+ZbuQCf4x2/SvSvgj4tFnHPol3IQnMtuWycf3l9vWua+J0IutV/tZFLLJjefQ1x0N3LZ3MF3bnEkTAgjt7V6K/e0zifuTPqmXUU3FuPqaauqx7SFxuHvXCadqsep6dFdQyqyyKCdueGx0p3mSrJ97I9K4L2dmdiStc7KLWpIbxJoyNyn0r0jRviZapbKl6PmUYrxq23PGCQM+tQzhlJDYq1Nx2InCMj2LxF8TLaW1eKxZQWGOa84fXzJKXLDJOTXN+UZOAM0fYpQDgfnQ53CMVDY3L/XG8s4AYe1c/LrU24nccZ6Vdgtcj94pOOtL9itvmG0DPrS5rFXRRj12RT396mXVpJj1GPpVe5sYlc7P0p1rbqp5Xn3pc6HY0ResIhyv4CmW9+3mHdhvaoXiG7jj2xSeRg7l696XOFi3LqMZbZKNoxxVcxxu26Mgg1HPa+cmV/CqILwNwT1xik2+hcZdzrtDnW3ZfNXK+tdva2tpfxZ4avIf7QkTjtWppfiC4tWHluSueVqFJop2Z3mpeGFIJiHPWuL1bRJLd+nT0713GgeKorkCObIY9jW1c2FrqKblANWnfcTeh4w73VucDJXoRWrY+ayZbK8Z5rvbnwwpJ2KMe3Ws+78M3Hk/uuCoOCe9DjEjXoYduiORk5469KXUHXymVvm46DmsPUI77T52WcMyg9ulQx6suOSQaiyWwa9SK7gL58pCPY8mue1GxmcAbmHcg13NlcwTDDD8ammtoZeysOnIrqhiWtGZOlFnnVvYhtqsMmuk0/wjK9m8wwB1BNW7jR1jk3xLx9avTa3La2Pk+V0BArshVjM5J05xZx8kUiSMuR8pIopzrO7s24cnPWitdBanWRF88dPep1cHnI/OpdYh+zZWQFTjcOMZrAiu8v0OAeleQoX3PRN0ynbhSR9KnhJKjcD9azVvFyPlH09K04nRow2cHHShxURW1I3XJzjFDqMD1qCe7iQY3EnPao1vUJYhTmktSmkW49iA8delQzXSKuMAYrOvL5yuExWY0d1cMSpOKUnYqKXU1iEmfJYZNKrRwsCX4BrJitbotgb6uDSLiVfmZh9aakJtG3FrUMabSQeKoza3GJOMY9KqR6CwGWP61PHo8a9Tz3ouQ2ind6t5h+QMfwqs2qT/AN05rYGmxDpUhs4ehUVV0LnZhW+s3Sk9SD2JqG71u4Rt3H0rYnsIwCVUVl3Om787RTTRLZFb6vdznCnH1qK6ubgtkv8AMOKv2diYQSQCaiu7ZzIMJgZrRWFzMpRPLuG44HeteIJIgyc0wwqkfzgNxVVbhY224HHpUyRrGWliylkvmMeorYs7BJnRVPNUbaN5Y9yDJ9qlgvLiyl3N2rOV2Umjr7HTBCnzLke4pbvRYLlMlVJ9KxrPxIZ3SMn5s85rqLaWOSHerjPpStYl+8eeeJvCK3NvNAg2hxgAeteB3NtJZ3k9tLHseJypU9cjjNfX0URlcblDgHNeP/HvwkltLF4hs4wIpCEulx0fs34104epyys+pz1qd1c4XwHrK2V61lLnyJmyhxja3+FenW8RLgdSOa8Y06B7+U/Zo3Z1bjy1JP8A+uvVfA1zNqNpNvYSPbsEcYwcdjWuIoL40RRqv4WddYqoTBIqzPbxFAxAPv6VmqxjfbjH1qwGeUfM3Xtmue8UjRp3IJZYk4Byc9FGKrm6Xd/qsip7iBRnjBqHyScAAVi59jSMSWG4G05DLn9KlEkbn765x3HWqrJsGTSQKHfHGKakwaNCKzjkIJX8RSS2OzkdPapEVo1BQkVYglMq4xz6UWuTdmW0I6d/pTltiVyRxWk9hNlX2/If0qe3gQDDE8dQKHGw1Ixo4yDtPQ9KhuNNd/mVT6k107x28a5AAP61A93CV2gA9iSKlLuPmOTOm4JDZzjoKkSCOPk4H061dvGd5CCSQemKgkTZHwOaOZIqzZB5rxMDF2/iPWur03xO9nCC0gKhcbT1zXKEEqciqckTbiO1HtB8p6xpfjOKYqjHBPHNdRBfieLIC4NfP0cktswZSTg/lXceHPFYXbDcnB6ZqC9DttS023vs5VQ/YkcGvPtY8FH7azQ5Rc5KjpXf2+oQyoGVgeKdcXKyDjB4xjvVJrYlxe6PKZdPl05GkMbBEALH0ycCrdpdpIv3hmu11DRxcqjtGJhn7jDg+xpNA+Fc17bvJJd+QwPAK/lTcOb4TNz5fiOSkIK8DA9qzbu2EqnYea6jxP4W1Hww4a5HmW7dJVHFY9pGJiTkdKhXg9S01JXRy5sJcngUV132KP0aitfby7i5I9izrpW6sFmEsk9wh2SAjhE7c1ziWhOWGBz2rR03UJo/Ot+XS7QRsmM89iPfNTJbmB2imQpKnBVuCDWkl1M41GtDFls2JGC2farEMUyphgfxrUYBRnFUppS0m1c5qLD52xiWLP8AeYCnGxVTyxNX7OJ2UFgKlngbGRzUSYJsx2tkDDCjPvWlZmMJgooaovL5561KI8KCvaoepYsyjJKjBqKO5YMAwIq0nzEK1Oe2BzzzTSE2IJg69vpUbgsOOtRohWTFWmj+UHBzQ9ARBEvPzCnTQZHA+lTRp2bv3q2kOQPSlcVjCMLbhuBqVLZe44rUlthkioDEwcAZOfanzBYrrbJtwFGahltlB6DP0rTUbfvdDSyQBxkc0c9ieU565s1lBUcZqg+gMDuXp710xtirgHgVdWMtEQRWymQ00c5aK1shWQdsZFJJtfOR1NdDHaq3VRTX0tC5A4o5hqRzP2JBIGTIYHtVwXtxAu1cgCth9KxjaapXenuExz+VU1dDVQsaZ4gEIPmdan1C8svEVhdaVe4aG7iMeT/C38LfgcGuYubKRGLAVVWV7eUEg8Gs+XldzXmUkeOvZ6p4f1iewkE1rcK7Ru4yuR/eBHUEV33wovbWw8QJaXtykKXcXkqz8BpOq59PTNd5qM2na/pYtNVj3kDCSfxR/Q/0ryfWvDc+m3/mG1kvNLUkh4+CB9exrthVVSPLLQ55Q5NUj3LVdI35IwkoNZM0EkHDqBj0rl/BXjeawit7fXGefTXGI7kfMYRnAD+3GMmvUruziurJbm0cTQyLlWXkEVy1IODsy4u5yEqMUzyaIExywq1PE9uxUg8dqjiiecfICM9c1zmtytdBSDt/IVWhUhxtBrRawKnLkk/lUcrRwg+3YVotSWWIQWUBiAKtRqkLCTAGPesM3zhvlXA96nhut/3myfendInlZu3GqRCIhVOT69BWW0ssrZVsA+lVbhw3SpbSVUGG4Iocrgo2EmZscsc1XV8Emprhw/Q1WIIPFZt2NVG5Z2ZGQeaRk3L83eoYZDnbjj3q2QEyRzniok+qKRnyqE4A4NR7Ny5AqxdDcpwKpRylWwQc0k7lPQjliZulReUyDK/pRqF/5ROwc0lndGQZZSoPetYLuZyfY0dP1a5s3VXYmOu10fV47jGXBPr6VwcoV1wB+NQpLLbPvjYj2pygmKM2j3DTpklC8gmu70TUI/ISB2AK/dJr598PeKCjpHcZyPevQdM1cTIpjcMp5BBog3DVCqQVQ634jyQzeGLqMFXkwSuOcGvnSyv2hmKn5SODmvZdVvxJAfN+YHg/SvN9b0ZLmUyWi5JPBFFSXtHcdKnyIrf2gf7360VnnR7wEjyzRRyIfMOtVfcrKSHHIYdRituSQSSb2Z2cgb2c5JasiBgPbFbkGpmTSxp7Rw7FfzFkC/Pn0z6Vv6nKRFAygE4zVb7KRKTjPvVxU+Vcg1et4g2M8g1mykUocphVFWlHmjaRg+9Xvsq4B24qKWPyxlcGs5M0RQktuCVpiwnH860oMMeelOmRVUlce9QWZiRd+lW4k6BulNDLk5P0qTcCeTVJkseLZDz3pfKA+U4pyMQOe1CuCxGMU5K4kMWAbjxzVpYQsZBNNQDjk5FWTjbj171i4l3MuYkNg9M1YSIEEkDnvTjFluRUsQ2Ngj5apeYmUJrYjvgDvRGNhArSuNrIemazCTnkc1MnZlJFkojr05p6RgL0qmZdjcHilNyShGeauLIaJJPlYBe9SIWHJ5qpbybpBnrnvWgQjDBPNXdkcqGK/ODTygYcAVUkbbjnpUkV0M4NWpNCcR01tEy/Mo5rEvdKidiVHBrddg65XvVfBOQapyuJRschdafLEhC9vaoLCVog8MqhomGGRhwa7BrfeSGHFUbvT4lBOM0rXLU7HGa14XSbzbzQSkMrjEtqw+SUdaZ4P13VNAkWHTDJcRud1xo1w3KgLlniPp7dfrXQyMbdjtyR3ArF1e3i1JVWYeWyn5ZUOGT8a2hUsuWeqJa5tYnp2m3ml+JbVp9NlTzR/rYWx5kZ9COv41m6hbtayHauSOuK8rubjUNNvUnvJXjuYgFi1a1XGccfv1A+ZQABkfrXa6P4yF/Haw69HHBcXC5huY2BiuBnGR6fQ80p0Le9DVDjK+ki5PI8qZJNZ7wls7a6a404SKSOMjOR0rJ+zvDMVfkHpiuZrU12MKQYYgjmmqG3ZU/hWtfWgYbkqko2cEc+tIdyMbgPmJpynPQmlZifpTMFM5qdRqxOp2rz+dM80bjVeWXg4qt5p3damTLijRLjOQOatQFplwD061mIRjOasW0/lkjqppJDeiLDKQxUjBqC4iXBPf6VI8xbDEHiqs8jEGny2ehN+pn3Fqkr5PNTJGkY2gcVLGu5sEDJ55qRoVB6gmqVxOw2NQx5PWi6tsAHNRSAowK9qkWVnXaTWqMrFUxkYZTg9q1tK1iWywUb5R2NUWiYdMcU2GM7xnmi47WO7sNdiv1EcrBXPUE9a6HTrOGJS4XIPYV5PKHgZXXOR3FdP4c8T7QsE78A4BJpWsVzXPQxZWxGcLzzRWUL+EgH5efeilcVmeczW7w8Mp570kDFSvpXUrapdplSMVl32ltC58urU31JcLbD0utoUZ+WtGwnHrxXPRsQdsg5FaNrIsZxkYp3M7G404zx0psrZQt2NZpuFUAjkGrkMnmIMYINZyVykQhyh4zS7jIMg/UUk0ZRs9jTI2wazsaXFZMZ7U0KQcjpUpBfvgH1p6ejkZ7U7WEOWRCgyxzT0Bxk1Bg59qtwAEYPSrvcm1iIOQ/Xip1l2rg85p7QCoGjIOD0qWhk6SjHbFRTycHBpiKQcBTiphAXH3TikMjhl3/K2eKhvIzt3IPwrVW3RcfLgY65qOSJWByR9KOW4Xsc65csRjNNVX9DW6LOMvkqTU3kwonAUY9aahYHK5kwRs2ODT5TMgCngepq680aZOT+ArkfEWutE+2OFpOe54ranFN2M5XWprzrM/BK4qxZWGFO9ixPpWVot5LOqGWMIWHSuiAby+pFVOKiSpMERUOOw9auB4VXkoMj0rKLBSd55+tMlnXjHSsvaW6Fctye6kXJ2fnWTdOztgk/Srfm54qrPHwWyc9qblcErGfcQbgcjpWHqSGPpXQ7iPlIqle2ZlBIHFFykjnfPcRENyGXBHrWYbGSNJTpiQtDIMS2MwzHJ7g9Ub3Fb72hT5WGOfSqxi8ksy9etbQquOqE433JvDHiS501TbQme+SNSZbB1JubcDk7f+eiAdxzXd2UlrrVkt3p8qyxn+6eQfQjqDXnU8UOoYZi8N4v+ruIm2yIfYioY7m/0LUluJJjbySMMahGN0Eq4wBPGOhz1Yc1pKMKyutGJNw9Dt79ntXKyDIqnvil74NXNO8Q2utvHZanbfYL913IWOY5x/ejbuD1rJ1XTp7SdvLzx2rlcZRdpI2TT2LDxg/d6+tVZ0KE/wAqrW926/ezx1qd7oORu79DRYLFSUMSc5qEow5NayvG4PQ+9QzohHHWp5A5mUEkI47VMpOQR0qFoX528ilUkYGDmp5bFc1zo4poDZE5X7mNvfdWLNOqggjAPFSWfzEqetQanaMrZU5Bq/NEXsFtMvmID92kvJXYkIOpxx6UWtuSmO/rVlYMdau5LZRkYgDJwT60tpJycHnNF0BuxnmlsrR/MychCeuKizHdGhEjSttQZz1Pap3t/s6k4ySOT6VahCQxDkAe9VrqX7QNo4Whe6K9zKkvkMnl5bbnk0rWodRJEQrdQR/WllsSDkDg11PhDwbqOsAy24xF6kcGrjeWlhSajqc6s94FA3NxRXpB+HmpA4yvHtRVeyI9ujHsJ/LGAVNaLqbhCSMn2rire8dGHeun03UVZACcHHQ1ztNnUmipcac3mjBOCcfSqF5bzWs7oRkDofWupR1mfn8vWmX1ksoBPLYxz6UXsTKF9UcrAzHaGrUspvKcA1Bc25gbp071GkgY9efSmjNqxtOVkRsVVCEPg561DBOF46itGIB8ZoauCEXhegzULglumM1YKkE06MAEE54pDI4o3Y4KkVbjgkUZ24x60C4SMZJOfQUj3YYcKfxNVZIWpZKPsw5GKkghjbg5b61SS4c8ButId56k5pKaQcrNMpDGQcKPqajnuogjBX/IViylg33jxSSS5XFNy7BaxZe73NwSR7mlEzEZWs0McmrtryvzGspNlJIe5cjjPNQqWz85pbmXy19KjgO88EnvTs2gvYlC7uO1U20+CS6TzVHXOTV8ELUM4LcqelaU5KLImrnQ2mjw/ZWZQp9CBWLqObZ9nUVYtNaaKBY92MdaqXN1HdSuxNdVRpq5hFO5Q3FycjFUr52jYjHatIlVP16VDcpHL97rXO0aopWk5ZcnPNSNMfukkg0nkrH900yTFRfU0tdFiKEOck89qsGAbdpH41mw3JibDDIq+t2HHOcdqUk2CZnXlp8xKgk1lXFpuHIroi2W+YVXuohzxQm0VucbdWTRudvA60kVy1vGUlG+M9Vbmty7hBJrGu4Cy4q4yuJrsMGjmW1zoqwyW7n99Y3DEo3OcqeqN6EVJputXNvPJayieYRAbrC5wLhOeqN/y0X9arWM8tjNlSdvpmty6jsNesxHfxhmUfJKvDxn1BrqhUuuWeqM3HrHQnt1s9Tha4spAT0ZT8rIfRhTPsw4UjDDisPUdO1fTw10UlvIUAC31soE8fu46OMCn6fr4mUfa5IZVBx58J4H+8vVaJYe65qbuSqlnaRux2e0HFVLqF1b5c1rWs6ug5BU9D1B/GkuUBGVrl5mtGaoxY5TGMNxirEXlSDnGfWnvAsp+bpWdeRNE37stz6USdykWiu18xnIFTTtuj2kds1RtzIR8wqxGWIIJ4HPNXG2xMkRRzhOM8VK9xlSP0FUponWYKAeTkVoWlqFXc2Cf5U+Ugjt7Fnl8yX7p6CtOdkhi5wD2FQtNsG1eT61TuAzZLHP1obsK1xxneVjzkelCl0bOO9QWrhXGavs8RGBzms7lk0DowAbg1778OLq0bw/EkLIrqOR0r57LAAlaSDX9Q00n7JM6+1aU5qLM6lNyPq03MAPMsf/AH0KK+TW8Z60WJ+1NRW3tomXsZDRKAwGatxXmwgMOOxFVjb7sEio2iCjg1yWsdVzprDUCAMnK/yrftb0SYAIIPr2rgIC6EYNXkvHTvg0cpSn0O0ubeOdDtIzXO3tiUYlAQfatHTbrfbRyEhlbK5z3q1IUc4Xr6Gk4tDupHM7XjPzZqxb32w7TyK3bjT1liJXGe9cpe2sltK2Acd6dyLM6O3uRJ/ECPSrRxjjjIrjYL3y2wTzWvb3zEAZz6ZpMEjY2ZOaGwOoqvFdAgAnmrK5br3pAR+ZgkEc0onOKkdQPc1XcYxjqamw0xJX3YPeqr5XJ7elTYwxoddyGhMGiuj/ADfWraSFFzxWeoKyY/WpnkBHJpsS0JpT5vPem20gEvHBHFRxOTzik27WyBz1oTsFjUdN3IFIgHeiBt6Amkl+XnAx0pNdQXYguLRJAccH2rPngeFspkDvWh5wDdeOlSTL5sRo57DsZCyMV+Y/So9zFzzkVK0bRs2elMyFfcOlWpC5R8isAOetM8skc8CrAKsMduoqOSXaealsaK4hBODVhIvLX1GaFYEEk8UolGMDnIppiaHKA2fSh4yV6ZFRLJtbg1egYOh71WjDVGDdxFcnHBrMliLNgiupvIRlivQ1lmAE8jHvUlJmHJbDHIqgxe1fchOK6GaD61QubTcSMVcXYTVzovBetxEiOU8+hra1jwnomtS/areBbS9I5ntxsb6+h/GvM2ikt2DRkhge1dd4Z14/KlySCBjr1rVSad0Q1fcydX0DWNCO+ALdwDlpbX5Wx/tRng/hVO115JOJf4fvNGMbfqh5FenSyrcxpjHPWuc17w7Dexl3ijMo5WQHa6/Q9atzUtKiuTZr4WY32iKSPfA6uvbYc1CdrDLGsO4sL6wnJjk81c54YJJ/310b8av6cmpX1wsYspirISJCoQcHoeetTOikuaErr8RxqNu0lY0bYoWwMVZ8nMgKjrUVvo+oxy4ezmAH+zn+VXJ/NgjIa3mAHX92TWSTKlboMuLVVjLKcsp71k3V15eVT5R3q89y8kbcOgHGCprFnkG4gkdcc1o5CSZNDcF2BNWZZA6kEVm2uN+M8Z9a3IrPeu4VOg2yilru5B4qKeN0bPPFaf2eSPgKeeKp3E4SQoRyKOVBcS2cEYbvU72yyr/Wq6bW5FPDuucZHepcbARHS0zRU3nyf3v0opAaiRbVPP8A9aojDzmpm6CkU80mBC6ALwMVUmJxxirlx2qjL900JhY6Pw1q+l2eg6nZ39u0l5KN0D4yAcfpWTp2qsHHmOePWsr+IVFJw7YqpS5lYIqzPRbTUkcAZ5PvUssEd0OMEn1rkdJJMYyTXRaex3Dk1m0aozdT0UgFo/ve1ZGJbc4fPHrXoMgBjGQDxWHqaqYzlR09KBSRi2t4N3UDmtWG+GcFq5ycAO2ABU0BO8cmmiDqEu1kXnrmpIyrdDXPRMd/U1p2pJxkmkxmk8SlcAflVYr1BPHrU5+7UJ/1ZqeoyrKpDZFR7dwyOvepLj/WLTIPvGmGw9F2jGaceXB9KsEDYOO1QP0FIRZjkCrn+VNkmyp5qsv3xS/w00xNBnnmp/O2p83IqA9BSSdR9KloaY5mD+hqnPGBkgcGn/xinN9w0DKIlZHwTkdqkcb0PYZ6mq0/3vxq1HzJGD021aVwEUquBvIbvkVJDDJcyiO3w7nooPJqrPyTn1qFSVkXaSOe1C1B7FiTcpwcgjgg9qsWkhUjH0qbVeWRjySvJ9ao2/U/WjZgtUak77o1xxWfJ8uSOnpVmXpVWX+lG4kVGkyzDgimyR7hkjkelNH3vwq5B0X6UxvQyZ4sg9PyqBLQxRm7x8oOxM/xN/gK0r4DI4qXWCf7O0Zc/KLdiB2GXNXDXUlkGj640L+VOxyTwSa6+1vVnUAgHI615bcdPxrqfDTExLkn86dxWNfW9MWZCyjvnIrm4opIH2XA+XPyn1ruUGRzzWN4gVdvQflVxipPUluxR3oiDYxX2U4qlcT3avuS5nj/AN2QihT8r/WpLnlVz6VFTTYuJJb6neBmY3k5c9y2f51Uv7m8MkkjShy7AvvVTk/lUDcNxVq55tWz6VCk2W4oqfbZAwaSC1c88GBauWutIMI9naD3VCv8jWY4/dCqZ/1lOMmTKKR2EN5GzB2jVhuzt3EdumapXraO+4HTblZD0dLzOPwK1nWZOByelJecZxWidjPlRo20Om5wft8akgKSUbHrnpVl4dF8kp9sv1l3cMbUMMfg1c/AxPc9a0YOV5p83kFvMnNtooOP7bl/8AH/AMaKh2j0FFF12HbzP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Julian White, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14246=[""].join("\n");
var outline_f13_58_14246=null;
var title_f13_58_14247="Chronic irritant contact dermatitis 2";
var content_f13_58_14247=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59959%7EDERM%2F50299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59959%7EDERM%2F50299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Chronic irritant contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema, fissuring, and scaling resulting from repeated exposure to irritants.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic irritant contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ill-defined dry, scaly patches with fissuring on the finger in a patient with chronic irritant contact dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kulthanan K. Siriraj Hospital, Mahidol University, Bangkok, Thailand.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14247=[""].join("\n");
var outline_f13_58_14247=null;
var title_f13_58_14248="Tranexamic acid: Drug information";
var content_f13_58_14248=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tranexamic acid: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?9/51/10037?source=see_link\">",
"    see \"Tranexamic acid: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/49/8982?source=see_link\">",
"    see \"Tranexamic acid: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cyklokapron&reg;;",
"     </li>",
"     <li>",
"      Lysteda&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F229861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cyklokapron&reg;;",
"     </li>",
"     <li>",
"      Tranexamic Acid Injection BP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F229898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifibrinolytic Agent;",
"     </li>",
"     <li>",
"      Antihemophilic Agent;",
"     </li>",
"     <li>",
"      Hemostatic Agent;",
"     </li>",
"     <li>",
"      Lysine Analog",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F229863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Elective cesarean section, blood loss reduction (unlabeled use):",
"     </b>",
"     I.V.: 1000 mg over 5 minutes at least 10 minutes prior to skin incision (Gungorduk, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Hereditary angioedema (HAE) (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Long-term prophylaxis:",
"     </i>",
"     Oral: 1000-1500 mg 2-3 times daily; reduce to 500 mg/dose once or twice daily when frequency of attacks reduces (Gompels, 2005; Levy, 2010)",
"     <b>",
"      or",
"     </b>",
"     25 mg/kg/dose administered 2-3 times daily (Bowen, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Short-term prophylaxis (eg, for dental work):",
"     </i>",
"     Oral: 75 mg/kg/day divided 2-3 times daily for 5 days before and 2 days after the event (Bowen, 2004)",
"     <b>",
"      or",
"     </b>",
"     1000 mg 4 times/day for 48 hours before and after procedure (Gompels, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Treatment of acute HAE attack:",
"     </i>",
"     Oral, I.V.: 25 mg/kg/dose (maximum single dose: 1000 mg) every 3-4 hours (maximum: 75 mg/kg/day) (Bowen, 2004)",
"     <b>",
"      or",
"     </b>",
"     1000 mg 4 times/day for 48 hours (Gompels, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Menorrhagia:",
"     </b>",
"     Oral: 1300 mg 3 times/day (3900 mg/day) for up to 5 days during monthly menstruation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Orthognathic surgery, blood loss reduction (unlabeled use):",
"     </b>",
"     I.V.: 20 mg/kg over 15 minutes prior to incision (Choi, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of dental procedure bleeding in patients on oral anticoagulant therapy (unlabeled use):",
"     </b>",
"     Oral rinse: 4.8% solution: Hold 10 mL in mouth and rinse for 2 minutes then spit out. Repeat 4 times/day for 2 days after procedure.",
"     <b>",
"      Note:",
"     </b>",
"     Patient should not eat or drink for 1 hour after using oral rinse  (Carter, 2003).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of perioperative bleeding associated with cardiac surgery (unlabeled use):",
"     </b>",
"     I.V.:  Loading dose of 30 mg/kg over 30 minutes (total loading dose includes a test dose administered over the first 10 minutes followed by the remainder of dose) prior to incision, followed by 16 mg/kg/hour until sternal closure; add an additional 2 mg/kg to cardiopulmonary bypass circuit (Fergusson, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Loading dose of 10 mg/kg over 20 minutes prior to incision followed by 2 mg/kg/hour continued for 2 hours after transfer to ICU; add a prime dose of 50 mg for a 2.5 L cardiopulmonary bypass circuit; maintenance infusion adjusted for renal insufficiency (Nuttall, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Loading dose of 10-15 mg/kg over 10-15 minutes, followed by 1-1.5 mg/kg/hour. The authors suggest adding 2&ndash;2.5 mg/kg to cardiopulmonary bypass circuit; however, amounts have varied widely in clinical trials (Gravlee, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of perioperative bleeding associated with spinal surgery (eg, spinal fusion) (unlabeled use):",
"     </b>",
"     I.V.: 2000 mg over 20 minutes prior to incision  followed by 100 mg/hour during surgery and for 5 hours postoperatively (Elwatidy, 2008)",
"     <b>",
"      or",
"     </b>",
"     10 mg/kg prior to incision followed by 1 mg/kg/hour for the remainder of the surgery; discontinue at time of wound closure (Wong, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Total knee replacement surgery, blood loss reduction (unlabeled use):",
"     </b>",
"     I.V.: 10 mg/kg over 30 minutes before inflation of tourniquet and 3 hours after first dose (Camarasa, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     10 mg/kg over 10 minutes before inflation of tourniquet with a second dose (10 mg/kg) administered immediately after tourniquet release (Lozano, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     10 mg/kg administered 30 minutes before deflation of tourniquet followed by 1 mg/kg/hour beginning at the end of the operation and continuing for 6 hours postoperatively (Alvarez, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Tooth extraction in patients with hemophilia (in combination with appropriate factor replacement therapy):",
"     </b>",
"     I.V.: 10 mg/kg immediately before surgery, then 10 mg/kg/dose 3-4 times/day; may be used for 2-8 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Transurethral prostatectomy, blood loss reduction (unlabeled use):",
"     </b>",
"     Oral: 2000 mg 3 times/day on the operative and first postoperative day (Rannikko, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Trauma-associated hemorrhage (unlabeled use):",
"     </b>",
"     I.V.: Loading dose: 1000 mg over 10 minutes, followed by 1000 mg over the next 8 hours.",
"     <b>",
"      Note:",
"     </b>",
"     Clinical trial included patients with significant hemorrhage (SBP &lt;90 mm Hg, heart rate &gt;110 bpm, or both) or those at risk of significant hemorrhage. Treatment began within 8 hours of injury (CRASH-2 Trial Collaborators, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Traumatic hyphema (unlabeled use):",
"     </b>",
"     Oral: 25 mg/kg administered 3 times/day for 5-7 days (Rahmani, 1999; Vangsted, 1983; Varnek, 1980).",
"     <b>",
"      Note:",
"     </b>",
"     This same regimen may also be used for secondary hemorrhage after an initial traumatic hyphema event.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F229883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/49/8982?source=see_link\">",
"      see \"Tranexamic acid: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Hereditary angioedema (HAE) (unlabeled use):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Long-term prophylaxis:",
"     </i>",
"     20-40 mg/kg/day in 2-3 divided doses (maximum dose: 3000 mg/day) (Farkas, 2007)",
"     <b>",
"      or",
"     </b>",
"     50 mg/kg/day (or 1000-2000 mg/day; depending on age and size of patient); may consider alternate-day regimen or twice-weekly regimen when frequency of attacks reduces; diarrhea may be a dose-limiting side effect (Gompels, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Short-term prophylaxis:",
"     </i>",
"     20-40 mg/kg/day in 2-3 divided doses (maximum dose: 3000 mg/day) (Farkas, 2007)",
"     <b>",
"      or",
"     </b>",
"     500 mg 4 times/day (Gompels, 2005).",
"     <b>",
"      Note:",
"     </b>",
"     For short-term prophylaxis (eg, dental work), initiate 2-5 days before and continue for 2 days after the procedure (Bowen, 2004; Gompels, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of perioperative bleeding associated with cardiac surgery (unlabeled use):",
"     </b>",
"     I.V.: 10 mg/kg given over 30 minutes prior to incision, 10 mg/kg while on cardiopulmonary bypass, and 10 mg/kg administered after protamine reversal (Chauhan, 2004; Chauhan, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Loading dose of 100 mg/kg over 15 minutes prior to incision, followed by 10 mg/kg/hour infusion (continued until ICU transport); add 100 mg/kg to pump reservoir when cardiopulmonary bypass initiated (Reid, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of perioperative bleeding associated with craniosynostosis surgery (unlabeled use):",
"     </b>",
"     I.V.: Loading dose of 50 mg/kg over 15 minutes prior to incision, followed by 5 mg/kg/hour (Goobie, 2011)",
"     <b>",
"      or",
"     </b>",
"     15 mg/kg over 15 minutes prior to incision, followed by 10 mg/kg/hour until skin closure (Dadure, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of perioperative bleeding associated with spinal surgery (eg, spinal fusion) (unlabeled use):",
"     </b>",
"     Children and Adolescents: I.V.: 10 mg/kg given over 15 minutes prior to incision followed by 1 mg/kg/hour for the remainder of the surgery; discontinue at time of wound closure (Neilipovitz, 2001; Verma, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     100 mg/kg over 15 minutes prior to incision followed by 10 mg/kg/hour until skin closure (Sethna, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     30 mg/kg over 20 minutes prior to incision followed by 1 mg/kg/hour during surgery and for 5 hours postoperatively (Elwatidy, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Tooth extraction in patients with hemophilia (in combination with appropriate factor replacement therapy):",
"     </b>",
"     Children and Adolescents:  I.V.: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Traumatic hyphema (unlabeled use):",
"     </b>",
"     Oral: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F229864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F229865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       I.V. formulation:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Tooth extraction in patients with hemophilia:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine 1.36-2.83 mg/dL: Maintenance dose of 10 mg/kg/dose twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine 2.83-5.66 mg/dL: Maintenance dose of 10 mg/kg/dose once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine &gt;5.66 mg/dL: Maintenance dose of 10 mg/kg/dose every 48 hours",
"     <b>",
"      or",
"     </b>",
"     5 mg/kg/dose once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cardiac surgery",
"     </i>",
"     (the following dose adjustments have been recommended [Nuttall, 2008]):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine 1.6-3.3 mg/dL: Reduce maintenance infusion to 1.5 mg/kg/hour (based on a 25% reduction from 2 mg/kg/hour)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine 3.3-6.6 mg/dL: Reduce maintenance infusion to 1 mg/kg/hour (based on a 50% reduction from 2 mg/kg/hour)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Serum creatinine &gt;6.6 mg/dL: Reduce maintenance infusion to 0.5 mg/kg/hour (based on a 75% reduction from 2 mg/kg/hour)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Oral formulation:",
"      </i>",
"     </b>",
"     <i>",
"      Heavy menstrual bleeding:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Serum creatinine &gt;1.4-2.8 mg/dL: 1300 mg twice daily (2600 mg/day) for up to 5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Serum creatinine 2.9-5.7 mg/dL: 1300 mg once daily for up to 5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Serum creatinine &gt;5.7 mg/dL: 650 mg once daily for up to 5 days",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F229847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 100 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cyklokapron&reg;: 100 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lysteda&trade;: 650 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F229834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F229850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: May be administered by direct I.V. injection at a maximum rate of 100 mg/minute; use plastic syringe only for I.V. push",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     In general, tranexamic acid loading doses are diluted in 50-250 mL and are administered over 5-30 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Administer without regard to meals. Should be swallowed whole; do not break, chew, or crush.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F229905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Compatible with dextrose, saline, electrolyte, amino acid, or dextran solutions, heparin;",
"     <b>",
"      incompatible",
"     </b>",
"     with solutions containing penicillin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F229849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for injection: Short-term use (2-8 days) in hemophilia patients to reduce or prevent hemorrhage and reduce need for replacement therapy during and following tooth extraction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Treatment of cyclic heavy menstrual bleeding",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F10435704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Trauma-associated hemorrhage; treatment of traumatic hyphema; topical treatment (mouth rinse) of bleeding associated with dental procedures in patients on oral anticoagulant therapy; prevention of perioperative bleeding associated with cardiac surgery; prevention of bleeding associated with craniosynostosis surgery, extracorporeal membrane oxygenation (ECMO), orthognathic surgery, spinal surgery (eg, spinal fusion), total knee replacement surgery, or transurethral prostatectomy; reduction of blood loss associated with cesarean delivery; hereditary angioedema (long-term prophylaxis)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F229906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cyklokapron&reg; may be confused with cycloSPORINE",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F229896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Injection:",
"     </b>",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (with rapid I.V. injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Giddiness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Allergic dermatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Unusual menstrual discomfort",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Headache (50%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (21%), muscle pain (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Nasal/sinus symptoms (25%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Fatigue (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Hematologic: Anemia (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (7%), muscle cramps/spasms (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      All formulations:",
"     </b>",
"     &lt;1% (Limited to important or life-threatening): Allergic skin reaction, anaphylactic shock, anaphylactoid reactions, cerebral thrombosis, deep vein thrombosis (DVT), diarrhea, dizziness, nausea, pulmonary embolism, renal cortical necrosis, retinal artery/vein obstruction, seizure, ureteral obstruction, visual disturbances (including impaired color vision and loss), vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F229853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for injection: Hypersensitivity to tranexamic acid or any component of the formulation; acquired defective color vision; active intravascular clotting; subarachnoid hemorrhage",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Hypersensitivity to tranexamic acid or any component of the formulation; active thromboembolic disease (eg, cerebral thrombosis, DVT, or PE); history of thrombosis or thromboembolism, including retinal vein or retinal artery occlusion; intrinsic risk of thrombosis or thromboembolism (eg, hypercoagulopathy, thrombogenic cardiac rhythm disease, thrombogenic valvular disease)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F229838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Severe hypersensitivity reactions have been reported rarely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Visual defects (eg, color vision change, visual loss) and retinal venous and arterial occlusions have been reported; discontinue treatment if changes in vision occur; prompt ophthalmic examination should be performed by an ophthalmologist. Use of the injection is contraindicated in patients with acquired defective color vision since this would prohibit monitoring one endpoint as a measure of ophthalmic toxicity. Ligneous conjunctivitis has been reported with the oral formulation, but usually resolves upon discontinuation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure: Seizures have been reported with use; most often with intraoperative use (eg, open chamber cardiac surgery) and in older patients (Murkin, 2010).  The mechanism by which tranexamic acid use results in seizures may be secondary to neuronal gamma aminobutyric acid (GABA) inhibition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic events: Venous and arterial thrombosis or thromboembolism, including central retinal artery/vein obstruction, has been reported. Use the injection with caution in patients with thromboembolic disease; oral formulation is contraindicated in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ureteral obstruction: Use the injection with caution in patients with upper urinary tract bleeding, ureteral obstruction due to clot formation has been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Disseminated intravascular coagulation (DIC): Use with extreme caution in patients with DIC requiring antifibrinolytic therapy; patients should be under strict supervision of a physician experienced in treating this disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dosage modification may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Subarachnoid hemorrhage: Use oral formulation with caution in patients with subarachnoid hemorrhage; cerebral edema and infarction may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vascular disease: Use with caution in patients with uncorrected cardiovascular or cerebrovascular disease due to the complications of thrombosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anti-inhibitor coagulant complex/factor IX complex concentrates: Concurrent use is not recommended due to the increased risk of thrombosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hormonal contraceptives: Patients taking hormonal contraceptives were excluded from clinical trials for heavy menstrual bleeding. Risk vs benefit should be weighed before using hormonal contraceptives concurrently with oral tranexamic acid; risk of thromboembolism (eg, MI, stroke) may be further increased, particularly in patients who are obese or &gt;35 years of age and smoke. Avoid use of oral formulation in patients taking higher than approved doses of hormonal contraceptives.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tretinoin, oral: Use oral tranexamic acid with caution in patients taking tretinoin; concurrent use may exacerbate procoagulant effects.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F229842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-inhibitor Coagulant Complex: Antifibrinolytic Agents may enhance the thrombogenic effect of Anti-inhibitor Coagulant Complex.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): May enhance the thrombogenic effect of Tranexamic Acid. Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): May enhance the thrombogenic effect of Tranexamic Acid. Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fibrinogen Concentrate (Human): Antifibrinolytic Agents may enhance the adverse/toxic effect of Fibrinogen Concentrate (Human). Specifically, the risk for thrombosis may be increased. Fibrinogen Concentrate (Human) may enhance the adverse/toxic effect of Antifibrinolytic Agents. Specifically, the risk for thrombosis may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tretinoin (Systemic): May enhance the thrombogenic effect of Antifibrinolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F229843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F7679524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. There are no adequate and well-controlled studies in pregnant women. Tranexamic acid crosses the placenta and concentrations within cord blood are similar to maternal concentrations. Use only if the potential benefit justifies the potential risk to the fetus. Lysteda&trade; is not indicated for use in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F229869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F17917995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tranexamic acid is excreted in breast milk. Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F9660606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take tablet without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Cyklokapron Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (10 mL): $104.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Tranexamic Acid Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (10 mL): $79.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Lysteda Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     650 mg (30): $174.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tranexamic Acid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     650 mg (30): $156.43",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F7679531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection: Ophthalmic examination (visual acuity, color vision, eye-ground, and visual fields) at baseline and regular intervals during the course of therapy in patients being treated for longer than several days",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Amchafibrin (ES);",
"     </li>",
"     <li>",
"      Caprilon (FI);",
"     </li>",
"     <li>",
"      Ciclokapron (VE);",
"     </li>",
"     <li>",
"      Cyklokapron (AE, AT, AU, BH, CH, CY, DE, DK, EE, EG, FI, GB, IE, IQ, IR, JO, KW, LB, LY, NL, NO, NZ, OM, QA, SA, SE, SG, SY, YE, ZA);",
"     </li>",
"     <li>",
"      Espercil (CN);",
"     </li>",
"     <li>",
"      Exacyl (BE, CZ, FR, HN, LU, PL);",
"     </li>",
"     <li>",
"      Fimoplas (PH);",
"     </li>",
"     <li>",
"      Hemoclot (PH);",
"     </li>",
"     <li>",
"      Hemostan (PH);",
"     </li>",
"     <li>",
"      Hexakapron (IL);",
"     </li>",
"     <li>",
"      Kalnex (ID);",
"     </li>",
"     <li>",
"      Nexa (ID);",
"     </li>",
"     <li>",
"      Qualixamin (HK);",
"     </li>",
"     <li>",
"      Ronex (ID);",
"     </li>",
"     <li>",
"      Tiren (MY);",
"     </li>",
"     <li>",
"      Tramic (TH);",
"     </li>",
"     <li>",
"      Tranarest (IN);",
"     </li>",
"     <li>",
"      Tranex (IT);",
"     </li>",
"     <li>",
"      Tranexam (EC, RU, TW);",
"     </li>",
"     <li>",
"      Tranexic (TW);",
"     </li>",
"     <li>",
"      Tranexid (ID);",
"     </li>",
"     <li>",
"      Transamin (BR, CL, HK, JP, KP, MY, PE, PK, TH, TW);",
"     </li>",
"     <li>",
"      Transamina (UY);",
"     </li>",
"     <li>",
"      Transic (TH);",
"     </li>",
"     <li>",
"      Tranxa (ID);",
"     </li>",
"     <li>",
"      Trenaxin (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F229837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis; it also inhibits the proteolytic activity of plasmin",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     With reduction in plasmin activity, tranexamic acid also reduces activation of complement and consumption of C1 esterase inhibitor (C1-INH), thereby decreasing inflammation associated with hereditary angioedema.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F229852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 9-27 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~3%, primarily to plasminogen",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral:  ~45%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~2-11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Oral: ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&gt;95% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alvarez JC, Santiveri FX, Ramos I, et al, &ldquo;Tranexamic Acid Reduces Blood Transfusion in Total Knee Arthroplasty Even When a Blood Conservation Program is Applied,&rdquo;",
"      <i>",
"       Transfusion",
"      </i>",
"      , 2008, 48(3):519-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18067499/pubmed\" id=\"18067499\" target=\"_blank\">",
"        18067499",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Astedt B, &ldquo;Clinical Pharmacology of Tranexamic Acid,&rdquo;",
"      <i>",
"       Scand J Gastroenterol Suppl",
"      </i>",
"      , 1987, 137:22-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/3321402/pubmed\" id=\"3321402\" target=\"_blank\">",
"        3321402",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bowen T, Cicardi M, Farkas H, et al, &ldquo;Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema,&rdquo;",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      , 2004, 114(3):629-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15356569/pubmed\" id=\"15356569\" target=\"_blank\">",
"        15356569",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Camarasa MA, Oll&eacute; G, Serra-Prat M, et al, &ldquo;Efficacy of Aminocaproic, Tranexamic Acids in the Control of Bleeding During Total Knee Replacement: A Randomized Clinical Trial,&rdquo;",
"      <i>",
"       Br J Anaesth",
"      </i>",
"      , 2006, 96(5):576-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/16531440/pubmed\" id=\"16531440\" target=\"_blank\">",
"        16531440",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carter G and Goss A. &ldquo;Tranexamic Acid Mouthwash -- A Prospective Randomized Study of a 2-Day Regimen vs 5-Day Regimen to Prevent Postoperative Bleeding in Anticoagulated Patients Requiring Dental Extractions,&rdquo;",
"      <i>",
"       Int J Oral Maxillofac Surg",
"      </i>",
"      , 2003, 32(5):504-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/14759109/pubmed\" id=\"14759109\" target=\"_blank\">",
"        14759109",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chauhan S, Bisoi A, Kumar N, et al, \"Dose Comparison of Tranexamic Acid in Pediatric Cardiac Surgery,\"",
"      <i>",
"       Asian Cardiovasc Thorac Ann",
"      </i>",
"      , 2004, 12(2):121-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15213077/pubmed\" id=\"15213077\" target=\"_blank\">",
"        15213077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chauhan S, Das SN, Bisoi A, et al, \"Comparison of Epsilon Aminocaproic Acid and Tranexamic Acid in Pediatric Cardiac Surgery,\"",
"      <i>",
"       J Cardiothorac Vasc Anesth",
"      </i>",
"      , 2004, 18(2):141-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15073700/pubmed\" id=\"15073700\" target=\"_blank\">",
"        15073700",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      CRASH-2 Trial Collaborators, &ldquo;Effects of Tranexamic Acid on Death, Vascular Occlusive Events, and Blood Transfusion in Trauma Patients With Significant Haemorrhage (CRASH-2): A Randomized, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2010, 376(9734):23-32.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Choi WS, Irwin MG, and Samman N, &ldquo;The Effect of Tranexamic Acid on Blood Loss During Orthognathic Surgery: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2009, 67(1):125-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/19070758/pubmed\" id=\"19070758\" target=\"_blank\">",
"        19070758",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dadure C, Sauter M, Bringuier S, et al, &ldquo;Intraoperative Tranexamic Acid Reduces Blood Transfusion in Children Undergoing Craniosynostosis Surgery: A Randomized Double-Blind Study,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 2011, 114(4):856-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/21358317/pubmed\" id=\"21358317\" target=\"_blank\">",
"        21358317",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ducloy-Bouthors A, Jude B, Duhamel A, et al, &ldquo;High-Dose Tranexamic Acid Reduces Blood Loss in Postpartum Heamorrhage,&rdquo;",
"      <i>",
"       Crit Care",
"      </i>",
"      , 2011, 15(2):R117.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/21496253/pubmed\" id=\"21496253\" target=\"_blank\">",
"        21496253",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eaton MP, \"Antifibrinolytic Therapy in Surgery for Congenital Heart Disease,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2008, 106(4):1087-100.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18349177/pubmed\" id=\"18349177\" target=\"_blank\">",
"        18349177",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Elwatidy S, Jamjoom Z, Elgamal E, et al, &ldquo;Efficacy and Safety of Prophylactic Large Dose of Tranexamic Acid in Spine Surgery: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study,&rdquo;",
"      <i>",
"       Spine",
"      </i>",
"      , 2008, 33(24):2577-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/19011538/pubmed\" id=\"19011538\" target=\"_blank\">",
"        19011538",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Farkas H, Varga L, Sz&eacute;plaki G, et al, &ldquo;Management of Hereditary Angioedema in Pediatric Patients,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2007, 120(3):e713-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/17724112/pubmed\" id=\"17724112\" target=\"_blank\">",
"        17724112",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fergusson DA, H&eacute;bert PC, Mazer CD, et al, &ldquo;A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 358(22):2319-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18480196/pubmed\" id=\"18480196\" target=\"_blank\">",
"        18480196",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferraris VA, Brown JR  Despotis GJ, et al, \"2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines,\"",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2011, 91(3):944-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/21353044/pubmed\" id=\"21353044\" target=\"_blank\">",
"        21353044",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gompels MM, Lock RJ, Abinun M, et al, &ldquo;C1 Inhibitor Deficiency: Consensus Document,&rdquo;",
"      <i>",
"       Clin Exp Immunol",
"      </i>",
"      , 2005, 139(3):379-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15730382/pubmed\" id=\"15730382\" target=\"_blank\">",
"        15730382",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goobie SM, Meier PM, Pereira LM, et al, &ldquo;Efficacy of Tranexamic Acid in Pediatric Craniosynostosis Surgery: A Double-Blind, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 2011, 114(4):862-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/21364458/pubmed\" id=\"21364458\" target=\"_blank\">",
"        21364458",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gravlee GP and Spiess B, \"Pharmacologic Prophylaxis for Post-Cardiopulmonary Bypass Bleeding,\"",
"      <i>",
"       Cardiopulmonary Bypass: Principles and Practice",
"      </i>",
"      , 3rd ed, Philadelphia, PA: Lippincott Williams &amp; Wilkins, 2008, 522-42.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gungorduk K, Yildirim G, Ascolu O, et al, &ldquo;Efficacy of Intravenous Tranexamic Acid In Reducing Blood Loss After Elective Cesarean Section: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study,&rdquo;",
"      <i>",
"       Am J Perinatol",
"      </i>",
"      , 2011, 28(3):233-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/20979013/pubmed\" id=\"20979013\" target=\"_blank\">",
"        20979013",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hillis LD, Smith PK, Anderson JL, et al, &ldquo;2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):2610-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/22064600/pubmed\" id=\"22064600\" target=\"_blank\">",
"        22064600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levy JH, Freiberger DJ, and Roback J, &ldquo;Hereditary Angioedema: Current and Emerging Treatment Options,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2010, 110(5):1271-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/20418292/pubmed\" id=\"20418292\" target=\"_blank\">",
"        20418292",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lozano M, Basora M, Peidro L, et al, &ldquo;Effectiveness and Safety of Tranexamic Acid Administration During Total Knee Arhthroplasty,&rdquo;",
"      <i>",
"       Vox San",
"      </i>",
"      , 2008, 95(1):39-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18363576/pubmed\" id=\"18363576\" target=\"_blank\">",
"        18363576",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Murkin JM, Falter F, Granton J, et al, &ldquo;High-Dose Tranexamic Acid is Associated With Nonischemic Clinical Seizures in Cardiac Surgical Patients,&rdquo;",
"      <i>",
"       Anesth Anal",
"      </i>",
"      , 2010, 110(2):350-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/19996135/pubmed\" id=\"19996135\" target=\"_blank\">",
"        19996135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neilipovitz DT, Murto K, Hall L, et al, &ldquo;A Randomized Trial of Tranexamic Acid to Reduce Blood Transfusion for Scoliosis Surgery,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2001, 93(1):82-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/11429344/pubmed\" id=\"11429344\" target=\"_blank\">",
"        11429344",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nilsson IM, &ldquo;Clinical Pharmacology of Aminocaproic and Tranexamic Acids,&rdquo;",
"      <i>",
"       J Clin Pathol Suppl",
"      </i>",
"      (Royal College of Pathologists), 1980, 14:41-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nuttall GA, Gutierrez MC, Dewey JD, et al, &ldquo;A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery,&rdquo;",
"      <i>",
"       J Cardiothorac Vasc Anesth",
"      </i>",
"      , 2008, 22(2):230-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18375325/pubmed\" id=\"18375325\" target=\"_blank\">",
"        18375325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rahmani B and Jahadi HR, &ldquo;Comparison of Tranexamic Acid and Prednisolone in the Treatment of Traumatic Hyphema,&rdquo;",
"      <i>",
"       Ophthalmology",
"      </i>",
"      , 1999, 106(2):375-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/9951493/pubmed\" id=\"9951493\" target=\"_blank\">",
"        9951493",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rannikko A, P&eacute;tas A, and Taari K, &ldquo;Tranexamic Acid in Control of Primary Hemorrhage During Transurethral Prostatectomy,&rdquo;",
"      <i>",
"       Urology",
"      </i>",
"      , 2004, 64(5):955-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15533485/pubmed\" id=\"15533485\" target=\"_blank\">",
"        15533485",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reid RW, Zimmerman AA, Laussen PC, et al, &ldquo;The Efficacy of Tranexamic Acid Versus Placebo in Decreasing Blood Loss in Pediatric Patients Undergoing Repeat Cardiac Surgery,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1997, 84(5):990-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/9141920/pubmed\" id=\"9141920\" target=\"_blank\">",
"        9141920",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Royston D, &ldquo;Blood-Sparing Drugs: Aprotinin, Tranexamic Acid, and Epsilon-Aminocaproic Acid,&rdquo;",
"      <i>",
"       Int Anesthesiol Clin",
"      </i>",
"      , 1995, 33(1):155-79.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/7543455/pubmed\" id=\"7543455\" target=\"_blank\">",
"        7543455",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sethna NF, Zurakowski D, Brustowicz RM, et al, &ldquo;Tranexamic Acid Reduces Intraoperative Blood Loss in Pediatric Patients Undergoing Scoliosis Surgery,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 2005, 102(4):727-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/15791100/pubmed\" id=\"15791100\" target=\"_blank\">",
"        15791100",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seto AH and Dunlap DS, &ldquo;Tranexamic Acid in Oncology,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1996, 30(7-8):868-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/8826574/pubmed\" id=\"8826574\" target=\"_blank\">",
"        8826574",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sheffer AL, Austen KF, and Rosen FS, &ldquo;Tranexamic Acid Therapy in Hereditary Angioneurotic Edema,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1972, 287(9):452-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/4558045/pubmed\" id=\"4558045\" target=\"_blank\">",
"        4558045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van der Staak FH, de Haan AF, Geven WB, et al, &ldquo;Surgical Repair of Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Hemorrhagic Complications and the Effect of Tranexamic Acid,&rdquo;",
"      <i>",
"       J Ped Surg",
"      </i>",
"      , 1997, 32(4):594-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/9126762/pubmed\" id=\"9126762\" target=\"_blank\">",
"        9126762",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vangsted P and Nielsen PJ, &ldquo;Tranexamic Acid and Traumatic Hyphaema, A Prospective Study,&rdquo;",
"      <i>",
"       Acta Ophthalmol (Copenh)",
"      </i>",
"      , 1983, 61(3):447-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/6353843/pubmed\" id=\"6353843\" target=\"_blank\">",
"        6353843",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Varnek L, Dalsgaard C, Hansen A, et al, &ldquo;The Effect of Tranexamic Acid on Secondary Haemorrhage after Traumatic Hyphaema,&rdquo;",
"      <i>",
"       Acta Ophthalmol (Copenh)",
"      </i>",
"      , 1980, 58(5):787-793.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Verma K, Errico TJ, Vaz KM, et al, &ldquo;A prospective, Randomized, Double-Blinded Single-Site Control Study Comparing Blood Loss Prevention of Tranexamic Acid (TXA) to Epsilon Aminocaproic Acid (EACA) for Corrective Spinal Surgery,&rdquo;",
"      <i>",
"       BMC Surg",
"      </i>",
"      , 2010, 10:13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/20370916/pubmed\" id=\"20370916\" target=\"_blank\">",
"        20370916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wellington K and Wagstaff AJ, \"Tranexamic Acid: A Review of Its Use in the Management of Menorrhagia,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 2003, 63(13):1417-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/12825966/pubmed\" id=\"12825966\" target=\"_blank\">",
"        12825966",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wong J, El Beheiry H, Rampersaud YR, et al, &ldquo;Tranexamic Acid Reduces Perioperative Blood Loss in Adult Patients Having Spinal Fusion Surgery,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2008, 107(5):1479-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/58/14248/abstract-text/18931202/pubmed\" id=\"18931202\" target=\"_blank\">",
"        18931202",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10011 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.80.101-2BDF7BB03E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14248=[""].join("\n");
var outline_f13_58_14248=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229860\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229861\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229898\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229863\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229883\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229864\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229865\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229847\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229834\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229850\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229905\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229849\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10435704\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229906\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229896\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229853\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229838\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300160\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229842\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229843\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7679524\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229869\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F17917995\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9660606\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324017\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7679531\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038848\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229837\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229852\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10011\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10011|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/51/10037?source=related_link\">",
"      Tranexamic acid: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/49/8982?source=related_link\">",
"      Tranexamic acid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_58_14249="CT scan fasciola hepatica";
var content_f13_58_14249=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 597px\">",
"   <div class=\"ttl\">",
"    CT scan fasciola hepatica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 577px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The CT scan of the liver reveals a focal cluster of variably sized hypodense lesions surrounding the porta hepatis in segment IV and V. The lesions are noted in image A and magnified in B. The lesions (white arrows) are&nbsp;round to oval in shape, and associated with regional adenopathy (yellow arrow). In addition, characteristic linear tracts extending along the portal triads are noted in image C and magnified in D (blue arrows). The tracts reflect the migration of the parasites. The findings are characteristic of fasciola hepatica.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14249=[""].join("\n");
var outline_f13_58_14249=null;
var title_f13_58_14250="Pancoast's syndrome and superior (pulmonary) sulcus tumors";
var content_f13_58_14250=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pancoast's syndrome and superior (pulmonary) sulcus tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Selim M Arcasoy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Steven E Schild, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Rogerio C Lilenbaum, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Brian Kavanagh, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/58/14250/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/58/14250/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superior sulcus tumors were first described in 1838, but were an obscure entity until the reports of Henry Pancoast in the first third of the 20th century [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/1\">",
"     1",
"    </a>",
"    ]. Pancoast mistakenly believed that these neoplasms arose from embryonal rests of the fifth branchial cleft; other investigators subsequently recognized the pulmonary origin of the vast majority of these malignancies.",
"   </p>",
"   <p>",
"    Since Pancoast's original reports, the terms \"Pancoast's tumors\", \"superior sulcus tumors\", or \"superior pulmonary sulcus tumors\" have been applied to neoplasms located at the apical pleuropulmonary groove, adjacent to the subclavian vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The actual pulmonary sulcus comprises the thoracic costovertebral gutter on either side of the vertebral column and is limited by the arch of the first rib superiorly and the diaphragmatic insertion inferiorly. Tumors located at the upper part of the pulmonary sulcus near the thoracic inlet may correctly be regarded as superior sulcus tumors, although the inferior margins of the superior sulcus are not well defined.",
"   </p>",
"   <p>",
"    Here we will review the diagnosis and management of tumors arising within the superior sulcus. General issues regarding lung cancer and management of stage II and stage III non-small cell lung cancer (NSCLC) are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=see_link\">",
"     \"Management of stage I and stage II non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"     \"Management of stage III non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions in the superior sulcus may result in shoulder and arm pain (in the distribution of the C8, T1, and T2 dermatomes), Horner's syndrome, and weakness and atrophy of the muscles of the hand, a constellation of symptoms referred to as Pancoast's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4\">",
"     4",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef68096 \" href=\"UTD.htm?24/3/24625\">",
"     figure 1",
"    </a>",
"    ). The majority of patients with superior sulcus tumors present with one or more of these complaints. Due to the peripheral location of the tumor, pulmonary symptoms such as cough, hemoptysis, and dyspnea are uncommon until late in the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Shoulder pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common initial symptom of superior sulcus tumors is shoulder pain, present in 44 to 96 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5-11\">",
"     5-11",
"    </a>",
"    ]. Pain is produced by invasion of the brachial plexus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    extension of the tumor into the parietal pleura, endothoracic fascia, first and second ribs, or vertebral bodies. Pain can progress and radiate up to the head and neck, or down to the medial aspect of the scapula, axilla, anterior chest, or ipsilateral arm in the distribution of the ulnar nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients frequently receive treatment for presumed cervical osteoarthritis or shoulder bursitis, resulting in a delay in diagnosis of five to ten months in some series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/8,12-14\">",
"     8,12-14",
"    </a>",
"    ]. Pain ultimately becomes persistent and of such severity that the patient may need to support the involved arm with the uninvolved hand in order to obtain relief [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,6,11\">",
"     2,6,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Horner's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Horner's syndrome consists of ipsilateral ptosis with narrowing of the palpebral fissure, miosis, enophthalmos, and anhidrosis. It is caused by involvement of the paravertebral sympathetic chain and the inferior cervical (stellate) ganglion (",
"    <a class=\"graphic graphic_figure graphicRef56089 \" href=\"UTD.htm?17/25/17809\">",
"     figure 2",
"    </a>",
"    ). Its prevalence in patients with superior sulcus tumors has ranged from 14 to 50 percent in different series (and up to 83 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,7,8,10,12,14-16\">",
"     5,7,8,10,12,14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ipsilateral flushing and increased sweating of the face may occur before the development of the full Horner's syndrome, presumably due to irritation of the sympathetic chain by the tumor prior to frank invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4\">",
"     4",
"    </a>",
"    ]. Ipsilateral complex regional pain syndrome (reflex sympathetic dystrophy) and facial pain similar to paroxysmal hemicrania rarely may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Contralateral facial sweating and flushing, especially with exercise, due to an excessive response by the intact sympathetic pathway have also been reported; this phenomenon is known as the Harlequin sign (",
"    <a class=\"graphic graphic_picture graphicRef52477 \" href=\"UTD.htm?43/44/44739\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=see_link\">",
"     \"Horner's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Neurologic complications involving the upper extremity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extension of tumor to the C8 and T1 nerve roots results in upper extremity neurologic findings in approximately 8 to 22 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4,10\">",
"     4,10",
"    </a>",
"    ]. Involvement of these nerve roots may result in weakness and atrophy of the intrinsic muscles of the hand, or pain and paresthesia of the fourth and fifth digits and the medial aspect of the arm and forearm. Abnormal sensation and pain in the T2 territory (the axilla and medial aspect of the upper arm) may also be an early finding, and the triceps reflex may be lost [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Superior sulcus tumors invade the intervertebral foramina early in the course of disease in approximately 5 percent of patients and may cause spinal cord compression and paraplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4\">",
"     4",
"    </a>",
"    ]. Approximately 25 percent of patients ultimately develop spinal cord compromise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=see_link\">",
"     \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supraclavicular lymph node enlargement and prominent weight loss are each observed in approximately 25 to 35 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4,10\">",
"     4,10",
"    </a>",
"    ]. Superior sulcus tumors may produce a phrenic or recurrent laryngeal neuropathy or superior vena cava syndrome in 5 to 10 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/4,10\">",
"     4,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overwhelming majority of superior sulcus tumors are NSCLCs, mainly squamous cell carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,8,15,21-24\">",
"     2,8,15,21-24",
"    </a>",
"    ], although adenocarcinomas predominate in some series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Small cell carcinomas account for approximately 5 percent of cases in most series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,9,25,27,28\">",
"     5,9,25,27,28",
"    </a>",
"    ]. Although NSCLC predominates as the cause of superior sulcus tumors, less than 5 percent of all NSCLCs arise in this region [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,21\">",
"     5,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of lesions other than lung cancer rarely arise in the superior sulcus and cause Pancoast's syndrome. The differential diagnosis of superior sulcus mass lesions includes adenoid cystic carcinoma, hemangiopericytoma, mesothelioma, lymphoma, plasmacytoma, and metastatic malignancies from the cervix, larynx, liver, bladder, and thyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/29-37\">",
"     29-37",
"    </a>",
"    ]. Lymphomatoid granulomatosis, vascular aneurysms, amyloid nodules, cervical rib syndrome, and various infections (eg, tuberculosis, fungi, hydatid cysts, sequelae of bacterial pneumonia) can also result in Pancoast's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/38-52\">",
"     38-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the wide variety of diseases that potentially can produce Pancoast's syndrome, a histologic diagnosis is mandatory prior to definitive treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic findings of superior sulcus tumors include a unilateral apical cap of more than 5 mm, asymmetry of bilateral apical caps of more than 5 mm, an apical mass, and bone destruction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/8,11,53\">",
"     8,11,53",
"    </a>",
"    ]. Lordotic chest views and upper thoracic and lower cervical spine radiographs may be helpful in the visualization of the tumor (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67213 \" href=\"UTD.htm?18/24/18831\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Computed tomography (CT) of the chest provides additional information about a superior sulcus tumor and its extension, including the presence of satellite pulmonary nodules, parenchymal disease, and mediastinal lymphadenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78372 \" href=\"UTD.htm?40/29/41439\">",
"     image 2",
"    </a>",
"    ). CT is limited, however, in the evaluation of brachial plexus, subclavian vessel, and chest wall involvement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"     \"Role of imaging in the staging of non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the comparative value of magnetic resonance imaging (MRI) over CT for detection of chest wall invasion is not clearly established, many studies suggest that MRI is more accurate [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/55-62\">",
"     55-62",
"    </a>",
"    ]. MRI is especially useful in documenting involvement of the brachial plexus and subclavian vessels, and evaluating vertebral bodies and the spinal canal for tumor extension (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56298 graphicRef64987 graphicRef75753 \" href=\"UTD.htm?19/1/19479\">",
"     image 3A-C",
"    </a>",
"    ). A magnetic resonance angiogram may be useful for detecting vascular involvement of the subclavian artery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although some studies have suggested that MRI is superior to CT in the detection of mediastinal lymph node involvement, the accuracy of these two methods is generally similar [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Studies evaluating the efficacy of CT staging of mediastinal lymph node metastases for non-Pancoast NSCLC have reported sensitivity and specificity of 60 to 70 percent. PET-CT is more accurate for mediastinal lymph node evaluation than CT alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3910?source=see_link\">",
"     \"Magnetic resonance imaging of the thorax\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The location of superior sulcus tumors allows the majority to be diagnosed by percutaneous needle biopsy. This technique can be performed via a posterior or cervical approach with the use of biplane fluoroscopy, ultrasonography, or CT to localize the lesion. Diagnostic yields of more than 90 percent are reported [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/15,66,67\">",
"     15,66,67",
"    </a>",
"    ]. Video-assisted thoracoscopy (VATS) or thoracotomy can be performed if less invasive techniques are nondiagnostic.",
"   </p>",
"   <p>",
"    In contrast, the peripheral location of superior sulcus tumors decreases the diagnostic yield of bronchoscopy and sputum cytology. Fiberoptic bronchoscopy with cytology and biopsies provides a diagnosis in 30 to 40 percent of cases, but unexpected endobronchial tumors may occasionally be detected, significantly altering therapeutic decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/8,14,68\">",
"     8,14,68",
"    </a>",
"    ]. The yield of sputum cytology for the diagnosis of superior sulcus tumors is generally around 15 percent, although higher figures have occasionally been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/12,15,68\">",
"     12,15,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Staging and preoperative assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superior sulcus tumors are staged in the same way as NSCLCs located elsewhere in the thorax (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"UTD.htm?19/28/19914\">",
"     figure 3",
"    </a>",
"    ). They are typically T3 or T4 lesions, depending on whether the tumor extends only as far as the chest wall or invades the brachial plexus, mediastinal structures, or vertebral bodies. In the absence of metastases to scalene nodes, supraclavicular nodes, contralateral mediastinal nodes (",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"UTD.htm?19/28/19914\">",
"     figure 3",
"    </a>",
"    ), or distant sites, the tumors usually fall into the category of stage IIB (T3,N0), IIIA (T3,N1-2, or T4, N0-1), or IIIB (T4,N2) disease, classified according to the",
"    <span class=\"nowrap\">",
"     AJCC/UICC",
"    </span>",
"    7th staging system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Accurate staging of superior sulcus tumors is critical so that optimal therapy may be provided and unnecessary morbidity avoided. Distant metastatic spread should be diligently sought by history, physical examination, blood tests, and radiographic survey. CT of the chest and upper abdomen should be performed to evaluate the mediastinum, liver, and adrenal glands for possible metastatic foci. PET scanning is necessary for preoperative evaluation of mediastinal lymph nodes as well as distant metastases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Mediastinoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staging CT and MRI cannot definitively establish the presence or absence of mediastinal invasion or nodal metastasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/69-71\">",
"     69-71",
"    </a>",
"    ], and surgical staging of the mediastinum should generally be undertaken prior to attempts at curative surgery.",
"   </p>",
"   <p>",
"    However, a negative positron emission tomography (PET) scan appears highly accurate in predicting an uninvolved mediastinum. Furthermore, PET scanning may also be the most sensitive test for identifying the presence of distant metastases in liver, adrenal gland and other lymph nodes. PET scans are routinely performed as a component of the staging evaluation, and if the mediastinum appears uninvolved, surgical staging of the mediastinum prior to definitive surgery may not be necessary. However, this is not a uniformly accepted strategy. This topic is discussed in detail elsewhere. Endobronchial ultrasound (EBUS) is a useful tool for establishing mediastinal metastasis, especially with enlarged or PET positive lymph nodes in the mediastinum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"     \"Role of imaging in the staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=see_link\">",
"     \"Endobronchial ultrasound: Indications, advantages, and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Brain imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET scans are of limited utility in detecting brain metastases. Therefore, MRI or CT scans of the brain provide complementary staging information. We recommend routine preoperative brain imaging with MRI (CT if the patient cannot undergo MRI) for superior sulcus tumors because of the high propensity for brain metastasis from bronchogenic carcinoma in this location [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluation for resectability is only worthwhile if the patient can tolerate and agrees to the surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=see_link\">",
"     \"Preoperative evaluation for lung resection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although superior sulcus tumors were considered categorically unresectable and resistant to radiotherapy (RT) until the mid-1950s, multimodality therapy has been shown to be the optimal approach for the treatment of these tumors. Initially, this included surgery with preoperative RT. Further results from patients with Pancoast's tumors and from patients with stage II to III NSCLC have demonstrated the importance of chemotherapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemoradiotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Surgery with preoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;RT followed by en bloc extended surgical resection was the most common treatment for superior sulcus tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,7,8,10,14,23,24,27,70,73-81\">",
"     2,7,8,10,14,23,24,27,70,73-81",
"    </a>",
"    ]. Preoperative RT decreases the size of the tumor, thereby facilitating resection. In addition, RT can reduce the number of viable tumor cells, theoretically limiting tumor dissemination and implantation during surgery. Although the advantage of preoperative RT compared to surgery alone has not been definitively demonstrated, this approach was the standard for decades. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"     \"Management of stage III non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal dose of RT is unclear. Although a survival benefit has been shown with doses &gt;50 Gy compared to &lt;50 Gy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5\">",
"     5",
"    </a>",
"    ], a linear correlation between radiation dose and outcome is not evident [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/82\">",
"     82",
"    </a>",
"    ]. Moderate dose RT (30 to 50 Gy in 10 to 28 fractions) is generally recommended in the preoperative setting. While no specific regimen has been shown to be superior, we recommend avoidance of split-course RT, as the break in treatment may allow tumor repopulation to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/83\">",
"     83",
"    </a>",
"    ]. Areas of gross disease as well as those potentially involved by microscopic tumor are generally included in the treatment field [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgery is generally undertaken two to four weeks after the completion of RT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,6,22\">",
"     2,6,22",
"    </a>",
"    ]. This is typically carried out through en bloc resection of the tumor and the chest wall, and, depending upon the extent of local invasion, may require resection of the paravertebral sympathetic chain, stellate ganglion, lower trunks of the brachial plexus, subclavian artery, or portions of the thoracic vertebrae. One of two surgical approaches may be utilized:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The posterior approach, also termed the Paulson operation, is performed via a long incision along the medial edge of the scapula starting between the second or third thoracic vertebra and the scapula, extending underneath its inferior tip, and ending at the anterior axillary line [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,84,85\">",
"       2,84,85",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The anterior transcervical approach involves a long L-shaped incision that extends from the mandibular angle along the anterior border of the sternocleidomastoid muscle down to the suprasternal notch and laterally under the medial half of the clavicle [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/84,86,87\">",
"       84,86,87",
"      </a>",
"      ]. This technique is generally used for tumors located anteriorly at the thoracic inlet, particularly those invading the subclavian vessels. A variation of this approach, the anterior \"hemi-clamshell\" incision, permits sparing of the clavicle [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/88-90\">",
"       88-90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The extent of lung resection is determined by the size and location of the primary tumor and the patient's underlying pulmonary function. Lobectomy is generally considered the preferable procedure for lung cancers, with fewer local recurrences and better survival when compared with sublobar resections [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/23,78,84\">",
"     23,78,84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A combined thoracic-neurosurgical approach is necessary in treating tumors that invade the brachial plexus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the spine [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/16,79,91-93\">",
"     16,79,91-93",
"    </a>",
"    ]. Recent advances in spinal instrumentation have allowed more complete resection of tumors involving the vertebral body [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/91-93\">",
"     91-93",
"    </a>",
"    ]. Surgery is contraindicated by extensive invasion of the brachial plexus, the intervertebral foramina, or soft tissues at the base of the neck; by mediastinal perinodal involvement; and by venous obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/2,6,11,14,94\">",
"     2,6,11,14,94",
"    </a>",
"    ]. Involvement of the vertebral bodies, subclavian artery, and spread to the ipsilateral supraclavicular lymph nodes are relative, but not absolute contraindications in the opinion of some authors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/71,86,92\">",
"     71,86,92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the standard potential complications of lung resection, extirpation of superior sulcus tumors may result in chylothorax, ulnar nerve paralysis secondary to resection of the C8 nerve root, Horner's syndrome (if not present preoperatively) due to resection of the stellate ganglion and the sympathetic chain, or a cerebrospinal fluid leak and meningitis. Resection of T1 and T2 nerve roots generally does not result in major clinical sequelae. Reported surgical mortality rates are approximately 4 to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/14,23,24,27,75,76,78,89,95\">",
"     14,23,24,27,75,76,78,89,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;After induction RT, approximately 50 percent of patients with T3 disease are able to undergo complete (R0) resection. Overall five-year survival rates for patients with superior sulcus tumors treated with preoperative RT and extended surgical resection average 30 percent (",
"    <a class=\"graphic graphic_table graphicRef63051 \" href=\"UTD.htm?21/16/21774\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/95-97\">",
"     95-97",
"    </a>",
"    ]. Although these data seem better than the five-year survival rates reported for patients treated with primary RT (0 to 29 percent), selection bias results in many patients who are poor surgical candidates being referred for radiation alone [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, five-year survival rates are better in patients with uninvolved lymph nodes (30 to 40 percent), and are less than 10 percent in those with incomplete resection, mediastinal nodal involvement, or T4 vertebral body invasion. More recent series suggest an improved outcome for patients with vertebral invasion due to advances in surgical technique [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/91\">",
"     91",
"    </a>",
"    ]. Paradoxically, ipsilateral supraclavicular metastases may represent local disease extension rather than distant spread, with at least some reports indicating a better prognosis than for patients with N2 mediastinal nodes (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two-thirds of patients will experience recurrent disease and of these two-thirds are locoregional [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/26\">",
"     26",
"    </a>",
"    ]. Despite this, systemic metastases are the most common cause of death.",
"   </p>",
"   <p>",
"    Metastatic involvement of the brain is particularly frequent, and this has prompted some to recommend prophylactic cranial irradiation (PCI), particularly for younger patients with large cell or adenocarcinoma histology [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/9,72,96\">",
"     9,72,96",
"    </a>",
"    ]. However, this strategy has not been widely adopted as a standard treatment.",
"   </p>",
"   <p>",
"    In a large randomized trial conducted by the Radiation Therapy Oncology Group that was prematurely discontinued because of poor accrual, PCI was associated with a prolongation of progression-free survival, but there was no difference in overall survival [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/99\">",
"     99",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H23#H23\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Prophylactic cranial irradiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Intraoperative/postoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    postoperative RT has been utilized with variable results. Although results from single-institution, nonrandomized case series suggest a beneficial role for intraoperative interstitial irradiation with little morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/100,101\">",
"     100,101",
"    </a>",
"    ], other series fail to document any survival benefit from intraoperative brachytherapy in patients with either completely or incompletely resected disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, some retrospective series have suggested a survival benefit from postoperative RT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/7,96\">",
"     7,96",
"    </a>",
"    ]; however, most reports have failed to demonstrate improved survival [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/23,73,79\">",
"     23,73,79",
"    </a>",
"    ]. This mirrors the experience in patients with non-Pancoast NSCLCs, in whom postoperative RT consistently decreases local recurrence rates but may not influence survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Postoperative RT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The routine use of postoperative RT is recommended in patients who have unresectable or incompletely resected tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/21,78,100\">",
"     21,78,100",
"    </a>",
"    ]. The utility of postoperative RT for patients with residual tumor after initial resection was supported by a study of 18 patients with incompletely resected superior sulcus tumors, in whom survival appeared improved by the addition of postoperative RT and approached that of patients who had resection margins free of tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/7\">",
"     7",
"    </a>",
"    ]. Postoperative RT is an important component of treatment for patients with incomplete resections, providing at least some chance for long-term survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Induction chemotherapy and chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with locally advanced, stage III NSCLC, randomized trials have demonstrated an improvement in survival when induction chemotherapy precedes definitive RT. Concurrent chemotherapy plus RT rather than sequential treatment provides an additional survival advantage. The success of these approaches in the treatment of non-Pancoast, locally advanced, stage III NSCLC has led to their use in patients with superior sulcus tumors and defined a new standard of care for these tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"     \"Management of stage III non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there are no randomized trials comparing induction chemoradiotherapy with preoperative RT or surgery alone for patients with superior sulcus tumors, several studies have focused on this approach in patients with superior sulcus tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/73,102-110\">",
"     73,102-110",
"    </a>",
"    ]. The potential value of this is illustrated by the following results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest prospective study was conducted in North America as a cooperative intergroup study, and evaluated concurrent chemotherapy (two cycles of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      ) and thoracic RT (45 Gy in 25 fractions) followed by resection three to five weeks later, and two additional cycles of postoperative chemotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/104\">",
"       104",
"      </a>",
"      ]. Eligible patients had pathologically proven T3-4, N0-1 NSCLC presenting in the superior sulcus, and all underwent staging mediastinoscopy. Patients with positive N2 lymph node metastases were excluded from the study.",
"      <br/>",
"      <br/>",
"      Mature results from this study found that 80 percent of patients underwent thoracotomy and 76 percent had a complete resection of tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/108\">",
"       108",
"      </a>",
"      ]. The overall five-year survival rate for the entire series was 44 percent. Patients with a complete pathologic response at resection had a significantly better prognosis than those with either microscopic or gross residual disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar results were seen in a Japanese study that utilized two cycles of chemotherapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31123?source=see_link\">",
"     vindesine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    concurrent with split course RT (45 Gy in 27 daily fractions). This was followed by surgery two to four weeks after completion of induction therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/107\">",
"     107",
"    </a>",
"    ]. There were three treatment-related deaths. Of the 76 enrolled patients, 57 underwent surgery (76 percent), of whom 51 (68 percent) had a complete (R0) resection. There were 12 complete pathologic responses. The disease-free and overall survival rates at five years were 45 and 56 percent, respectively.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A single institution study from France enrolled 107 patients with Pancoast tumors and treated with induction chemoradiotherapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      ). Patients with bulky N2 and N3 disease were excluded. Of these, 72 had a thoracotomy and all but one had macroscopic complete resections. There were 21 pneumonectomies performed, and four patients died of surgical complications. A pathological complete response or microscopic residual disease was observed in 40 percent of all surgical participants. After induction therapy, 61 percent of pathological N2 positive participants (28 of 46) were downstaged to",
"      <span class=\"nowrap\">",
"       pN0/N1.",
"      </span>",
"      Overall survival for the entire cohort was 55 and 40 percent at two and three years, respectively, with a median survival time of 26.7 months [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/109\">",
"       109",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A series of 38 medically operable patients from the Netherlands Cancer Institute were treated with thoracic radiotherapy (66 Gy in 2.75",
"      <span class=\"nowrap\">",
"       Gy/fraction)",
"      </span>",
"      and concurrent daily",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      6",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       .",
"      </span>",
"      After restaging, 22 underwent resection. All resections were complete. A pathological complete response was observed in 13 patients (62 percent). The two-year and five-year survival of this selected group was 70 and 37 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/110\">",
"       110",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although a randomized trial comparing induction chemoradiotherapy with preoperative radiation therapy or surgery alone has not been conducted, a retrospective review of 35 patients from a single institution found that concurrent chemoradiotherapy with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based regimen followed by surgery resulted in improved survival rates (93 versus 49 percent at two years and 84 versus 49 percent at four years, compared to induction RT followed by surgery) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/106\">",
"     106",
"    </a>",
"    ]. There was also a higher rate of complete or near complete pathologic response with concurrent chemoradiotherapy (13 of 15 [87 percent] versus 7 of 20 [35 percent]). Similarly, another center utilizing a trimodality approach for Pancoast tumors observed a pathologic complete response in 40 percent in 36 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/103\">",
"     103",
"    </a>",
"    ]. The overall median survival was 2.6 years, including eight years for those with a pathologic complete response.",
"   </p>",
"   <p>",
"    These results are better than those obtained with either preoperative RT or surgery alone. As a result, induction chemoradiotherapy followed by surgery has been adopted by most centers as the standard of treatment for Pancoast tumors without distant or mediastinal metastases.",
"   </p>",
"   <p>",
"    Although the optimal regimen has not been established, a reasonable choice is that used in the North America Intergroup study [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/104\">",
"     104",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concurrent thoracic radiotherapy (RT) (45 Gy over five weeks in daily 1.8 Gy fractions) and chemotherapy, consisting of two cycles of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      on days 1, 8, 29, and 36) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      on days 1 to 5 and 29 to 33). Some physicians have advocated increasing the thoracic radiotherapy dose to 60 to 66 Gy.",
"     </li>",
"     <li>",
"      Thoracotomy for tumor resection three to five weeks after completion of chemoradiotherapy, if there is no evidence of distant metastases or local progression",
"     </li>",
"     <li>",
"      Two additional postoperative courses of chemotherapy with a platinum-based doublet",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lung intergroup completed a new trial (SWOG-S0220) in patients with Pancoast tumor based upon Southwest Oncology Group (SWOG) 9504 and determined that consolidation chemotherapy with single agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    following surgery was not feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/111\">",
"     111",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H32#H32\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Concurrent chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Primary RT and chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;RT as a sole primary treatment modality is suitable for patients with metastatic tumors or poor performance status, providing palliation of pain in up to 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,9,112\">",
"     5,9,112",
"    </a>",
"    ]. A dose of 60 to 66 Gy is generally recommended for definitive treatment of unresectable disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/11,25,76\">",
"     11,25,76",
"    </a>",
"    ]. However a lower dose (eg, 30 Gy) is reasonable for palliation in those with distant metastases.",
"   </p>",
"   <p>",
"    Five-year survival rates up to 40 percent have been reported for selected patients treated definitively with radical RT for localized superior sulcus tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,9,73,76\">",
"     5,9,73,76",
"    </a>",
"    ]. However, it is difficult to compare results with RT alone to those obtained with combined modality therapy, since many studies of primary RT have included patients with unfavorable prognostic factors and unresectable tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/76\">",
"     76",
"    </a>",
"    ]. Furthermore, many series include patients treated before the era of imaging with CT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    MRI, who were thus less adequately staged.",
"   </p>",
"   <p>",
"    Analyses of retrospective series have given conflicting results regarding the role of surgery. Some retrospective series have not documented inferior survival rates when patients treated with RT only were compared to those undergoing RT followed by surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/9,24,25,70,73,76\">",
"     9,24,25,70,73,76",
"    </a>",
"    ]. In contrast, in a series of 143 patients with superior sulcus tumors at the M D Anderson Cancer Center, the use of surgery as a part of a multidisciplinary approach was a significant predictor of five-year survival for patients with superior sulcus tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While resection is generally accepted as a component of treatment for locally advanced NSCLC, its value is uncertain in patients with stage IIIA (N2) disease (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). Interim reports of the major randomized prospective study addressing the value of resection when added to chemoradiotherapy have failed to demonstrate a statistically significant survival advantage for the addition of resection to chemoradiotherapy for locally advanced non-Pancoast NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Common side effects of RT include fatigue, esophagitis, localized lung fibrosis, and skin irritation. Less commonly patients develop symptomatic pneumonitis. Rare complications include skin fibrosis with shoulder immobility; myelitis and brachial neuritis may result in weakness and pain in the hand, arm, or shoulder [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,82\">",
"     5,82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24090?source=see_link\">",
"     \"Radiation-induced lung injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38437?source=see_link\">",
"     \"Complications of peripheral nerve irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Concurrent chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with locally advanced, unresectable (eg, N2, N3) disease and those who are medically inoperable but fit enough to receive chemotherapy should be offered chemoradiotherapy. In the setting of non-Pancoast stage III NSCLC, concurrent chemoradiotherapy has been shown to be superior to RT alone and has become the standard of care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H32#H32\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Concurrent chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PROGNOSTIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to tumor stage, several clinical and histologic features are prognostically important in patients with superior sulcus tumors. The presence of Horner's syndrome, extension of the tumor into the base of the neck, vertebral bodies or the great vessels, or involvement of the mediastinal lymph nodes is associated with a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,14,70,71,73,75,77,78,95\">",
"     5,14,70,71,73,75,77,78,95",
"    </a>",
"    ]. Longer duration of symptoms has also been found to adversely affect the prognosis, probably because of an association with more advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A good performance status (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"     table 3",
"    </a>",
"    ) and weight loss of no more than 5 percent of total body weight are associated with better survival [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/10,25\">",
"     10,25",
"    </a>",
"    ]. Local control of the tumor by radiation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgery as well as the achievement of pain relief after treatment are encouraging and suggest a better prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/5,7,14,25,27,71,72,75,78\">",
"     5,7,14,25,27,71,72,75,78",
"    </a>",
"    ]. Most studies have not found an association between histologic subtype and survival [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/7,9,10,14,27,75,76,78\">",
"     7,9,10,14,27,75,76,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     POSTTHERAPY SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence from these studies does not establish a clear cut benefit for aggressive surveillance following treatment with curative intent. Guidelines from the American Society of Clinical Oncology [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/114\">",
"     114",
"    </a>",
"    ] and the National Comprehensive Cancer Network (NCCN) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/58/14250/abstract/115\">",
"     115",
"    </a>",
"    ] differ in their use of imaging studies. We suggest a history, physical examination, and chest x-ray every three to four months for the first two years, then every six months through year five, and annually thereafter. Chest CT scan is substituted for a chest x-ray once a year. When planning the posttreatment surveillance strategy, care should be taken to limit the number of CT scans if possible, particularly in younger individuals, given concerns about second malignancies induced by radiation exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=see_link&amp;anchor=H29#H29\">",
"     \"Management of stage I and stage II non-small cell lung cancer\", section on 'Post therapy surveillance'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superior sulcus tumors are characterized by a distinct constellation of presenting signs and symptoms due to their location. Most of these tumors are NSCLCs. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical presentation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H7\">",
"     'Pathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The management of Pancoast tumors is similar to that of other locally advanced NSCLCs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with no metastatic disease, we recommend concurrent chemoradiotherapy as the initial step in patient management (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This is followed by surgical resection if there is no evidence of distant metastases or local progression. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Induction chemotherapy and chemoradiotherapy'",
"      </a>",
"      above.) Although the optimal regimen has not been established, a reasonable choice is that used in the North America Intergroup study:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Concurrent thoracic radiotherapy (RT) (45 Gy over five weeks in daily 1.8 Gy fractions) and chemotherapy, consisting of two cycles of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      on days 1, 8, 29, and 36) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      on days 1 to 5, and 29 to 33). Some physicians have advocated increasing the thoracic radiotherapy dose to 60 to 66 Gy.",
"     </li>",
"     <li>",
"      Thoracotomy for tumor resection in patients without N2 metastases, three to five weeks after completion of chemoradiotherapy, if there is no evidence of distant metastases or local progression.",
"     </li>",
"     <li>",
"      Two additional postoperative courses of chemotherapy, with a platinum-based chemotherapy doublet.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who are medically inoperable or who have locally advanced, unresectable disease, we recommend definitive chemoradiotherapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Concurrent chemoradiotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have distant metastatic disease or a poor performance status, RT can be used to treat symptoms due to the Pancoast tumor. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Primary RT and chemoradiotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with locally advanced or metastatic disease, systemic chemotherapy may be useful to palliate symptoms and extend survival duration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=see_link\">",
"       \"Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whenever possible, patients with superior sulcus tumors should be enrolled in prospective clinical trials so that the optimal therapy may be determined.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/1\">",
"      Pancoast, HK. Superior pulmonary sulcus tumor. JAMA 1932; 99:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/2\">",
"      Paulson DL. Carcinomas in the superior pulmonary sulcus. J Thorac Cardiovasc Surg 1975; 70:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/3\">",
"      Teixeira JP. Concerning the Pancoast tumor: what is the superior pulmonary sulcus? Ann Thorac Surg 1983; 35:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/4\">",
"      Arcasoy SM, Jett JR. Superior pulmonary sulcus tumors and Pancoast's syndrome. N Engl J Med 1997; 337:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/5\">",
"      Van Houtte P, MacLennan I, Poulter C, Rubin P. External radiation in the management of superior sulcus tumor. Cancer 1984; 54:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/6\">",
"      Urschel HC Jr. Superior pulmonary sulcus carcinoma. Surg Clin North Am 1988; 68:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/7\">",
"      Shahian DM, Neptune WB, Ellis FH Jr. Pancoast tumors: improved survival with preoperative and postoperative radiotherapy. Ann Thorac Surg 1987; 43:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/8\">",
"      Miller JI, Mansour KA, Hatcher CR Jr. Carcinoma of the superior pulmonary sulcus. Ann Thorac Surg 1979; 28:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/9\">",
"      Komaki R, Roh J, Cox JD, Lopes da Conceicao A. Superior sulcus tumors: results of irradiation of 36 patients. Cancer 1981; 48:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/10\">",
"      Komaki, R. Preoperative radiation therapy for superior sulcus lesions. Chest Surg Clin North Am 1991; 1:13.",
"     </a>",
"    </li>",
"    <li>",
"     Grover FL, Komaki R. Superior sulcus tumors. In: Thoracic Oncology, 2nd, Roth JA, Ruckdeschel JC, Weisenburger TH (Eds), WB Saunders, Philadelphia 1995. p.225.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/12\">",
"      Hepper NG, Herskovic T, Witten DM, et al. Thoracic inlet tumors. Ann Intern Med 1966; 64:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/13\">",
"      Ziporyn T. Upper body pain: possible tipoff to Pancoast tumor. JAMA 1981; 246:1759, 1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/14\">",
"      Anderson TM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986; 4:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/15\">",
"      Walls WJ, Thornbury JR, Naylor B. Pulmonary needle aspiration biopsy in the diagnosis of Pancoast tumors. Radiology 1974; 111:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/16\">",
"      Sundaresan N, Hilaris BS, Martini N. The combined neurosurgical-thoracic management of superior sulcus tumors. J Clin Oncol 1987; 5:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/17\">",
"      Derbekyan V, Novales-Diaz J, Lisbona R. Pancoast tumor as a cause of reflex sympathetic dystrophy. J Nucl Med 1993; 34:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/18\">",
"      Delreux V, Kevers L, Callewaert A. [Paroxysmal hemicrania preceding Pancoast's syndrome]. Rev Neurol (Paris) 1989; 145:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/19\">",
"      Umeki S, Tamai H, Yagi S, et al. [Harlequin syndrome (unilateral flushing and sweating attack) due to a spinal invasion of the left apical lung cancer]. Rinsho Shinkeigaku 1990; 30:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/20\">",
"      Marangoni C, Lacerenza M, Formaglio F, et al. Sensory disorder of the chest as presenting symptom of lung cancer. J Neurol Neurosurg Psychiatry 1993; 56:1033.",
"     </a>",
"    </li>",
"    <li>",
"     Ginsberg RJ, Payne DG, Shamji F. Superior sulcus tumors. In: Comprehensive Textbook of Thoracic Oncology, Aisner J (Ed), Williams &amp; Wilkins, Baltimore 1996. p.375.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/22\">",
"      Fuller DB, Chambers JS. Superior sulcus tumors: combined modality. Ann Thorac Surg 1994; 57:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/23\">",
"      Hilaris BS, Martini N, Wong GY, Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 1987; 67:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/24\">",
"      Devine JW, Mendenhall WM, Million RR, Carmichael MJ. Carcinoma of the superior pulmonary sulcus treated with surgery and/or radiation therapy. Cancer 1986; 57:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/25\">",
"      Komaki R, Mountain CF, Holbert JM, et al. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation. Int J Radiat Oncol Biol Phys 1990; 19:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/26\">",
"      Jones DR, Detterbeck FC. Pancoast tumors of the lung. Curr Opin Pulm Med 1998; 4:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/27\">",
"      Maggi G, Casadio C, Pischedda F, et al. Combined radiosurgical treatment of Pancoast tumor. Ann Thorac Surg 1994; 57:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/28\">",
"      Johnson DH, Hainsworth JD, Greco FA. Pancoast's syndrome and small cell lung cancer. Chest 1982; 82:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/29\">",
"      Hatton MQ, Allen MB, Cooke NJ. Pancoast syndrome: an unusual presentation of adenoid cystic carcinoma. Eur Respir J 1993; 6:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/30\">",
"      Chong KM, Hennox SC, Sheppard MN. Primary hemangiopericytoma presenting as a Pancoast tumor. Ann Thorac Surg 1993; 55:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/31\">",
"      Amin R. Bilateral Pancoast's syndrome in a patient with carcinoma of the cervix. Gynecol Oncol 1986; 24:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/32\">",
"      Chang CF, Su WJ, Chou TY, Perng RP. Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report. Jpn J Clin Oncol 2001; 31:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/33\">",
"      Rabano A, La Sala M, Hernandez P, Barros JL. Thyroid carcinoma presenting as Pancoast's syndrome. Thorax 1991; 46:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/34\">",
"      Brenner B, Carter A, Freidin N, et al. Pancoast's syndrome in multiple myeloma. Acta Haematol 1984; 71:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/35\">",
"      Chen KT, Padmanabhan A. Pancoast syndrome caused by extramedullary plasmacytoma. J Surg Oncol 1983; 24:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/36\">",
"      Mills PR, Han LY, Dick R, Clarke SW. Pancoast syndrome caused by a high grade B cell lymphoma. Thorax 1994; 49:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/37\">",
"      Arcasoy SM, Bajwa MK, Jett JR. Non-Hodgkin's lymphoma presenting as Pancoast's syndrome. Respir Med 1997; 91:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/38\">",
"      White HD, White BA, Boethel C, Arroliga AC. Pancoast's syndrome secondary to infectious etiologies: a not so uncommon occurrence. Am J Med Sci 2011; 341:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/39\">",
"      Dolan G, Smith J, Reilly JT. Extrapulmonary lymphomatoid granulomatosis presenting as Pancoast's syndrome. Postgrad Med J 1991; 67:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/40\">",
"      Vandenplas O, Mercenier C, Trigaux JP, Delaunois L. Pancoast's syndrome due to Pseudomonas aeruginosa infection of the lung apex. Thorax 1991; 46:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/41\">",
"      Gallagher KJ, Jeffrey RR, Kerr KM, Steven MM. Pancoast syndrome: an unusual complication of pulmonary infection by Staphylococcus aureus. Ann Thorac Surg 1992; 53:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/42\">",
"      VAMOS G, PAPP A. [Pancoast's syndrome and pulmonary tuberculosis]. Schweiz Z Tuberc Pneumonol 1960; 17:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/43\">",
"      Stanley SL Jr, Lusk RH. Thoracic actinomycosis presenting as a brachial plexus syndrome. Thorax 1985; 40:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/44\">",
"      Collins PW, de Lord C, Newland AC. Pancoast's tumour due to aspergilloma. Lancet 1990; 336:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/45\">",
"      Simpson FG, Morgan M, Cooke NJ. Pancoast's syndrome associated with invasive aspergillosis. Thorax 1986; 41:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/46\">",
"      Mitchell DH, Sorrell TC. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis 1992; 14:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/47\">",
"      Ziomek S, Weinstein W, Margulies M, Braun RA. Primary pulmonary cryptococcosis presenting as a superior sulcus tumor. Ann Thorac Surg 1992; 53:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/48\">",
"      Gotterer N, Lossos I, Breuer R. Pancoast's syndrome caused by primary pulmonary hydatid cyst. Respir Med 1990; 84:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/49\">",
"      Aletras H, Papaconstantinou C. Pancoast's syndrome following an intrapleural rupture of a hepatic echinococcus cyst. Scand J Thorac Cardiovasc Surg 1982; 16:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/50\">",
"      Rong SH. Carotid pseudoaneurysm simulating Pancoast tumor. AJR Am J Roentgenol 1984; 142:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/51\">",
"      Gibney RT, Connolly TP. Pulmonary amyloid nodule simulating pancoast tumor. J Can Assoc Radiol 1984; 35:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/52\">",
"      Urschel JD, Hameed SM, Grewal RP. Neurogenic thoracic outlet syndromes. Postgrad Med J 1994; 70:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/53\">",
"      Takasugi JE, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging 1989; 4:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/54\">",
"      Hamlin DJ, Burgener FA. CT, including sagittal and coronal reconstruction, in the evaluation of pancoast tumors. J Comput Tomogr 1982; 6:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/55\">",
"      Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989; 170:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/56\">",
"      Pennes DR, Glazer GM, Wimbish KJ, et al. Chest wall invasion by lung cancer: limitations of CT evaluation. AJR Am J Roentgenol 1985; 144:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/57\">",
"      Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/58\">",
"      Webb WR, Sostman HD. MR imaging of thoracic disease: clinical uses. Radiology 1992; 182:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/59\">",
"      Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986; 160:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/60\">",
"      McLoud TC, Filion RB, Edelman RR, Shepard JA. MR imaging of superior sulcus carcinoma. J Comput Assist Tomogr 1989; 13:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/61\">",
"      Webb WR. The role of magnetic resonance imaging in the assessment of patients with lung cancer: a comparison with computed tomography. J Thorac Imaging 1989; 4:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/62\">",
"      Rapoport S, Blair DN, McCarthy SM, et al. Brachial plexus: correlation of MR imaging with CT and pathologic findings. Radiology 1988; 167:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/63\">",
"      Laissy JP, Soyer P, Sekkal SR, et al. Assessment of vascular involvement with magnetic resonance angiography (MRA) in Pancoast syndrome. Magn Reson Imaging 1995; 13:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/64\">",
"      Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 1985; 90:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/65\">",
"      Heelan RT, Martini N, Westcott JW, et al. Carcinomatous involvement of the hilum and mediastinum: computed tomographic and magnetic resonance evaluation. Radiology 1985; 156:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/66\">",
"      Paulson DL, Weed TE, Rian RL. Cervical approach for percutaneous needle biopsy of Pancoast tumors. Ann Thorac Surg 1985; 39:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/67\">",
"      Yang PC, Lee LN, Luh KT, et al. Ultrasonography of Pancoast tumor. Chest 1988; 94:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/68\">",
"      Maxfield RA, Aranda CP. The role of fiberoptic bronchoscopy and transbronchial biopsy in the diagnosis of Pancoast's tumor. N Y State J Med 1987; 87:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/69\">",
"      Remmen HJ, Lacquet LK, Van Son JA, et al. Surgical treatment of Pancoast tumor. J Cardiovasc Surg (Torino) 1993; 34:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/70\">",
"      Stanford W, Barnes RP, Tucker AR. Influence of staging in superior sulcus (Pancoast) tumors of the lung. Ann Thorac Surg 1980; 29:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/71\">",
"      Wright CD, Moncure AC, Shepard JA, et al. Superior sulcus lung tumors. Results of combined treatment (irradiation and radical resection). J Thorac Cardiovasc Surg 1987; 94:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/72\">",
"      Komaki R, Derus SB, Perez-Tamayo C, et al. Brain metastasis in patients with superior sulcus tumors. Cancer 1987; 59:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/73\">",
"      Attar S, Krasna MJ, Sonett JR, et al. Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg 1998; 66:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/74\">",
"      Hilaris BS, Martini N, Luomanen RK, et al. The value of preoperative radiation therapy in apical cancer of the lung. Surg Clin North Am 1974; 54:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/75\">",
"      Sartori F, Rea F, Calabr&ograve; F, et al. Carcinoma of the superior pulmonary sulcus. Results of irradiation and radical resection. J Thorac Cardiovasc Surg 1992; 104:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/76\">",
"      Neal CR, Amdur RJ, Mendenhall WM, et al. Pancoast tumor: radiation therapy alone versus preoperative radiation therapy and surgery. Int J Radiat Oncol Biol Phys 1991; 21:651.",
"     </a>",
"    </li>",
"    <li>",
"     Paulson DL. Technical considerations in stage III disease: The superior sulcus lesion. In: International Trends in General Thoracic Surgery, Delarue NC, Eschapasse H (Eds), WB Saunders, Philadelphia 1985. Vol I, p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/78\">",
"      Ginsberg RJ, Martini N, Zaman M, et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 1994; 57:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/79\">",
"      Martinod E, D'Audiffret A, Thomas P, et al. Management of superior sulcus tumors: experience with 139 cases treated by surgical resection. Ann Thorac Surg 2002; 73:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/80\">",
"      Beyer DC, Weisenburger T. Superior sulcus tumors. Am J Clin Oncol 1986; 9:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/81\">",
"      Ahmad K, Fayos JV, Kirsh MM. Apical lung carcinoma. Cancer 1984; 54:913.",
"     </a>",
"    </li>",
"    <li>",
"     Temeck BK, Okunieff PG, Pass HI. Chest wall disease including superior sulcus tumors. In: Lung Cancer: Principles and Practice, Pass HI, Mitchell JB, Johnson DH, Turrisi AT (Eds), Lippincott-Raven Publishers, Philadelphia 1996. p.585.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/83\">",
"      Mantell BS. Superior sulcus (Pancoast) tumours: results of radiotherapy. Br J Dis Chest 1973; 67:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/84\">",
"      Ginsberg RJ. Resection of a superior sulcus tumor. Chest Surg Clin N Am 1995; 5:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/85\">",
"      Kent MS, Bilsky MH, Rusch VW. Resection of superior sulcus tumors (posterior approach). Thorac Surg Clin 2004; 14:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/86\">",
"      Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/87\">",
"      Macchiarini P. Resection of superior sulcus carcinomas (anterior approach). Thorac Surg Clin 2004; 14:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/88\">",
"      Masaoka A, Ito Y, Yasumitsu T. Anterior approach for tumor of the superior sulcus. J Thorac Cardiovasc Surg 1979; 78:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/89\">",
"      Korst RJ, Burt ME. Cervicothoracic tumors: results of resection by the \"hemi-clamshell\" approach. J Thorac Cardiovasc Surg 1998; 115:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/90\">",
"      Rusca M, Carbognani P, Bobbio P. The modified \"hemi-clamshell\" approach for tumors of the cervicothoracic junction. Ann Thorac Surg 2000; 69:1961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/91\">",
"      Gandhi S, Walsh GL, Komaki R, et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 1999; 68:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/92\">",
"      York JE, Walsh GL, Lang FF, et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 1999; 91:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/93\">",
"      Bilsky MH, Vitaz TW, Boland PJ, et al. Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. J Neurosurg 2002; 97:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/94\">",
"      Shaw RR. Pancoast's tumor. Ann Thorac Surg 1984; 37:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/95\">",
"      Rusch VW, Parekh KR, Leon L, et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 2000; 119:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/96\">",
"      Komaki R, Roth JA, Walsh GL, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2000; 48:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/97\">",
"      Pfannschmidt J, Kugler C, Muley T, et al. Non-small-cell superior sulcus tumor: results of en bloc resection in fifty-six patients - non-small-cell pancoast. Thorac Cardiovasc Surg 2003; 51:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/98\">",
"      Valli&egrave;res E, Karmy-Jones R, Mulligan MS, Wood DE. Pancoast tumors. Curr Probl Surg 2001; 38:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/99\">",
"      Gore EM, Bae K, Wong SJ, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 2011; 29:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/100\">",
"      Hilaris BS, Nori D. The role of external radiation and brachytherapy in unresectable non-small cell lung cancer. Surg Clin North Am 1987; 67:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/101\">",
"      van Geel AN, Jansen PP, van Klaveren RJ, et al. High relapse-free survival after preoperative and intraoperative radiotherapy and resection for sulcus superior tumors. Chest 2003; 124:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/102\">",
"      Mart&iacute;nez-Monge R, Herreros J, Aristu JJ, et al. Combined treatment in superior sulcus tumors. Am J Clin Oncol 1994; 17:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/103\">",
"      Kwong KF, Edelman MJ, Suntharalingam M, et al. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg 2005; 129:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/104\">",
"      Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001; 121:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/105\">",
"      Barnes JB, Johnson SB, Dahiya RS, et al. Concomitant weekly cisplatin and thoracic radiotherapy for Pancoast tumors of the lung: pilot experience of the San Antonio Cancer Institute. Am J Clin Oncol 2002; 25:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/106\">",
"      Wright CD, Menard MT, Wain JC, et al. Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus. Ann Thorac Surg 2002; 73:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/107\">",
"      Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008; 26:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/108\">",
"      Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007; 25:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/109\">",
"      Pourel N, Santelmo N, Naafa N, et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg 2008; 33:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/110\">",
"      Kappers I, van Sandick JW, Burgers JA, et al. Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection. Eur J Cardiothorac Surg 2009; 36:741.",
"     </a>",
"    </li>",
"    <li>",
"     MJ Kraut, J Moon, CR Thomas, et al. Docetaxel is not feasible as consolidation therapy after cisplatin/etoposide/concurrent radiotherapy followed by surgical resection for pancoast tumors: preliminary results of SWOG 0220.  Poster presentation,  IASLC, 13th World Conference of Lung Cancer (July 31-August 4, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/112\">",
"      Hagan MP, Choi NC, Mathisen DJ, et al. Superior sulcus lung tumors: impact of local control on survival. J Thorac Cardiovasc Surg 1999; 117:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/113\">",
"      Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009; 374:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/58/14250/abstract/114\">",
"      Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4605 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14250=[""].join("\n");
var outline_f13_58_14250=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Shoulder pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Neurologic complications involving the upper extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Staging and preoperative assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Mediastinoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Brain imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Surgery with preoperative RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Intraoperative/postoperative RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Induction chemotherapy and chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Primary RT and chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Concurrent chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PROGNOSTIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      POSTTHERAPY SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4605\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4605|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/24/18831\" title=\"diagnostic image 1\">",
"      Pancoast tumor PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/29/41439\" title=\"diagnostic image 2\">",
"      Pancoast tumor CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/0/5\" title=\"diagnostic image 3A\">",
"      Pancoast tumor MRI I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/25/23967\" title=\"diagnostic image 3B\">",
"      Pancoast tumor MRI II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/57/25488\" title=\"diagnostic image 3C\">",
"      Pancoast tumor MRI III",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4605|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/3/24625\" title=\"figure 1\">",
"      Dermatomal innervation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/25/17809\" title=\"figure 2\">",
"      Paravertebral sympathetic chain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/28/19914\" title=\"figure 3\">",
"      IASLC lymph node map",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4605|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/44/44739\" title=\"picture 1\">",
"      Harlequin sign",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4605|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/41/37533\" title=\"table 1\">",
"      Lung cancer TMN staging 7th edition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/16/21774\" title=\"table 2\">",
"      Superior sulcus tumor survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2236\" title=\"table 3\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=related_link\">",
"      Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38437?source=related_link\">",
"      Complications of peripheral nerve irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=related_link\">",
"      Endobronchial ultrasound: Indications, advantages, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=related_link\">",
"      Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3910?source=related_link\">",
"      Magnetic resonance imaging of the thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=related_link\">",
"      Management of stage I and stage II non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=related_link\">",
"      Management of stage III non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=related_link\">",
"      Pathology of lung malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=related_link\">",
"      Preoperative evaluation for lung resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24090?source=related_link\">",
"      Radiation-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=related_link\">",
"      Role of imaging in the staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_58_14251="Histol grading post preop chemo";
var content_f13_58_14251=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Histologic grading of the effect of preoperative chemotherapy on primary osteosarcoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        Little or no effect identified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        Areas of acellular tumor osteoid, necrotic, or fibrotic material attributable to the effect of chemotherapy, with other areas of histologically viable tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        Predominant areas of acellular tumor osteoid, necrotic, or fibrotic material attributable to the effect of chemotherapy, with only scattered foci of histologically viable tumor cells identified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        No histologic evidence of viable tumor identified within the entire specimen",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rosen G, et al. Primary osteogenic sarcoma: eight year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 1983; 106 (suppl):55. Copyright &copy; 1983 Springer-Verlag.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14251=[""].join("\n");
var outline_f13_58_14251=null;
var title_f13_58_14252="Common street names cocaine";
var content_f13_58_14252=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common street names for cocaine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Cocaine base (smokable)",
"       </td>",
"       <td>",
"        Base, black rock, crack, electric kool-aid, rock, gravel, purple caps, Scotty, scramble, supercoke, twinkie, window pane, yam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine HCl",
"       </td>",
"       <td>",
"        Aspirin, Big C, blow, coconut, coke, devil's dandruff, flake, Florida snow, foo-foo dust, happy dust, lady, nose candy, white dragon, white lady, yao",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine paste",
"       </td>",
"       <td>",
"        Basuco, bazooka, pasta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine in vagina",
"       </td>",
"       <td>",
"        Balling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin",
"       </td>",
"       <td>",
"        Belushi, bipping, blanco, boy-girl, dynamite, goof ball, he-she, murder one, sandwich, snowball, speedball",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + marijuana",
"       </td>",
"       <td>",
"        51, banano, bazooka, blunt, C &amp; M, candy sticks, caviar, champagne, cocktail, cocoa puff, crack bash, dirties, geek-joint, Greek, lace, P-dogs, premos, primo, Sherman stick, woo blunts, woolie",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + MDMA (ecstasy)",
"       </td>",
"       <td>",
"        Bumping up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + MDMA + LSD",
"       </td>",
"       <td>",
"        Candy flipping on a string",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + methamphetamine",
"       </td>",
"       <td>",
"        Croak, shabu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + methcathinone",
"       </td>",
"       <td>",
"        Wild cat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + morphine",
"       </td>",
"       <td>",
"        C &amp; M",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + PCP",
"       </td>",
"       <td>",
"        Beam me up Scottie, space ball, space base, space dust",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + tobacco",
"       </td>",
"       <td>",
"        Cigamos, coolie, geek-joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + marijuana + PCP",
"       </td>",
"       <td>",
"        Jim Jones, speed boat, squirrel, wickie",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin + tobacco",
"       </td>",
"       <td>",
"        Flamethrowers, primos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin + methamphetamine +flunitrazepam + alcohol",
"       </td>",
"       <td>",
"        Five-way",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note that street names change over time and may differ by location. The same name may refer to more than one drug.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14252=[""].join("\n");
var outline_f13_58_14252=null;
var title_f13_58_14253="Structure of ER";
var content_f13_58_14253=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F59876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F59876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Structure of estrogen receptor (ER)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 164px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A to F represent different domains of the ER. Numbers represent amino acids from amino to carboxy termini.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ellis MJ, Hayes DF, Lippman ME. Treatment of metastatic breast cancer. In: Diseases of the Breast, 2nd ed, Harris JR (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2000. Copyright &copy; 2000 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14253=[""].join("\n");
var outline_f13_58_14253=null;
var title_f13_58_14254="Deaths from cardiovascular disease";
var content_f13_58_14254=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F83597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F83597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    Deaths from cardiovascular disease, US, 1900 to 2008",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 290px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: NHLBI Fact Book, 2011. National Heart Lung and Blood Institute. Available at: file://www.nhlbi.nih.gov/about/factbook/toc.htm.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14254=[""].join("\n");
var outline_f13_58_14254=null;
var title_f13_58_14255="Specimen collection methods I";
var content_f13_58_14255=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78605%7EID%2F54592%7EID%2F67280%7EID%2F82682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=17\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78605%7EID%2F54592%7EID%2F67280%7EID%2F82682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=17\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Microbiology specimen handling and collection - I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Specimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume",
"       </td>",
"       <td class=\"subtitle1\">",
"        Storage temperature*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"       <td class=\"subtitle1\">",
"        See UpToDate topic review",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Blood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Routine",
"       </td>",
"       <td rowspan=\"2\">",
"        Blood culture vials",
"       </td>",
"       <td>",
"        Adults: 20-30 mL",
"       </td>",
"       <td rowspan=\"2\">",
"        25&deg;C",
"       </td>",
"       <td rowspan=\"2\">",
"        Obtain 2-3 sets",
"       </td>",
"       <td rowspan=\"2\">",
"        Technique of obtaining blood cultures for the detection of bacteremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children: 1-5 mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Dimorphic fungi",
"       </td>",
"       <td rowspan=\"2\">",
"        Lysis centrifugation tube",
"       </td>",
"       <td rowspan=\"2\">",
"        10-20 mL",
"       </td>",
"       <td rowspan=\"2\">",
"        25&deg;C",
"       </td>",
"       <td>",
"        Lysis centrifugation tubes should be processed within eight hours s",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yeasts (eg, Candida) should be detectable using many modern routine media and blood culture systems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mycobacterial",
"       </td>",
"       <td>",
"        BacT/ALERT MB or Bactec MycoF/Lytic&nbsp;or lysis centrifugation tube",
"       </td>",
"       <td>",
"        10-20 mL",
"       </td>",
"       <td>",
"        25&deg;C",
"       </td>",
"       <td>",
"        Obtain one specimen",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Catheter (vascular)",
"        </strong>",
"       </td>",
"       <td>",
"        Cleanse skin around insertion site with alcohol. Send catheter tip (5 cm) in sterile container",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4&deg;C",
"       </td>",
"       <td>",
"        Also obtain two peripheral blood cultures",
"       </td>",
"       <td>",
"        Diagnosis and management of central venous catheter- related infections",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Cerebrospinal fluid",
"        </strong>",
"       </td>",
"       <td rowspan=\"5\">",
"        Sterile tube",
"       </td>",
"       <td class=\"sublist1_start\">",
"        At least 1-5 mL:",
"       </td>",
"       <td rowspan=\"5\">",
"        4&deg;C",
"       </td>",
"       <td rowspan=\"5\">",
"        Transport routine cultures at 25&deg;C, viral cultures at 4&deg;C (on ice). Also send extra fluid to store for possible future testing",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Bacterial &ge;1 mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Viral &ge;1 mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        AFB &ge;2 mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fungal &ge;2 mL",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Other fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peritoneal, pericardial, pleural, synovial",
"       </td>",
"       <td>",
"        Sterile container or direct inoculation to blood culture vials",
"       </td>",
"       <td>",
"        At least 1-10 mL, but send as much fluid as possible",
"       </td>",
"       <td>",
"        4&deg;C",
"       </td>",
"       <td>",
"        Never send swab dipped in fluid",
"       </td>",
"       <td>",
"        Joint aspiration or injection: Technique and indications",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * If immediate processing is not possible.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Microbiology specimen handling and collection - II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Specimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume",
"       </td>",
"       <td class=\"subtitle1\">",
"        Storage temperature*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Genital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fluids -&nbsp;endometrial, amniotic, pelvic (culdocentesis)",
"       </td>",
"       <td>",
"        Sterile anaerobic container",
"       </td>",
"       <td>",
"        1-10 mL",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        Anaerobic culture is appropriate only for specimens obtained without traversing colonized areas (eg, vagina).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chlamydia trachomatis",
"       </td>",
"       <td>",
"        Swab or chlamydia transport medium",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        Choice of swab depends upon test method (culture, EIA, DFA, molecular amplification). For culture specimens, avoid cotton swab on wooden stick.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Herpes simplex virus",
"       </td>",
"       <td>",
"        Swab in viral transport media",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        <span style=\"line-height: 115%; font-family: calibri,sans-serif; font-size: 11pt;\">",
"         Choice of swab depends upon test method (culture, DFA, molecular amplification).",
"        </span>",
"        For culture specimens, avoid cotton swab on wooden stick and calcium alginate swab.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neisseria gonorrheae",
"       </td>",
"       <td>",
"        Inoculate selective medium or transport kit immediately",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25&ordm;C",
"       </td>",
"       <td>",
"        For culture specimens, use CO2 transport kits or devices and do not refrigerate.",
"        <span style=\"line-height: 115%; font-family: calibri,sans-serif; font-size: 11pt;\">",
"         For molecular detection, use rayon or Dacron-tipped swab.",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vaginal",
"       </td>",
"       <td>",
"        Swab",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        For Trichomonas, Candida, etc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Genitourinary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prostate",
"       </td>",
"       <td>",
"        Prostatic massage specimens in sterile container",
"       </td>",
"       <td>",
"        1-5 mL",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * If immediate processing is not possible.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Microbiology specimen handling and collection - III",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Specimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume",
"       </td>",
"       <td class=\"subtitle1\">",
"        Storage temperature*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"       <td class=\"subtitle1\">",
"        See UpToDate topic review",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        Lower respiratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Expectorated sputum",
"       </td>",
"       <td>",
"        Sterile container",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25&deg;C",
"       </td>",
"       <td>",
"        Rinse mouth first, use Gram stain to screen for suitability",
"       </td>",
"       <td>",
"        Sputum cultures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bronchoscopy fluid",
"       </td>",
"       <td>",
"        Sterile container",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25&deg;C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Sputum cultures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        Upper respiratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Nasal",
"       </td>",
"       <td>",
"        Insert premoistened swab into nares",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        25&deg;C",
"       </td>",
"       <td>",
"        For detection of nasal carriage of S. aureus or",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Place into transport media",
"       </td>",
"       <td>",
"        Group A streptococci only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Nasopharynx",
"       </td>",
"       <td>",
"        Insert calcium alginate",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        25&deg;C",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine swabs may not support growth of some organisms (eg, B. pertussis). Use calcium alginate or dacron/rayon swabs",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine swabs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Swab into posterior nasopharynx via nose, inoculate medium at bedside or transport swab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Throat",
"       </td>",
"       <td>",
"        Swab posterior pharynx and tonsils",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25&deg;C",
"       </td>",
"       <td>",
"        Inform laboratory if identification of organisms other than group A beta hemolytic streptococci is indicated (eg, N. gonorrheae)",
"       </td>",
"       <td>",
"        Throat cultures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        Stool",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Routine culture",
"       </td>",
"       <td>",
"        Sterile wide-mouth container or enteric transport system",
"       </td>",
"       <td>",
"        &gt;2 grams",
"       </td>",
"       <td>",
"        4&deg;C (25&deg;C if enteric transport system used)",
"       </td>",
"       <td>",
"        Do not send specimens for routine culture on patients who develop diarrhea after 3 days of hospitalization; only send for C. difficile toxin",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        C. difficile toxin",
"       </td>",
"       <td>",
"        Sterile wide-mouth container",
"       </td>",
"       <td>",
"        &gt;5 mL (soft or liquid)",
"       </td>",
"       <td>",
"        4&deg;C for &le;24h, -20&deg;C for &gt;24h",
"       </td>",
"       <td>",
"        Test of choice for patients who develop diarrhea after if &ge;3 days of hospitalization",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ova and parasite examination",
"       </td>",
"       <td>",
"        Sterile wide-mouth container, or commercial transport system",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25&deg;C in fixative",
"       </td>",
"       <td>",
"        Fresh specimens should be examined immediately; Do not send specimens on patients who develop diarrhea after 3 days of hospitalization",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * If immediate processing is not possible.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Microbiology specimen handling and collection - IV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Specimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume",
"       </td>",
"       <td class=\"subtitle1\">",
"        Storage temperature*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"       <td class=\"subtitle1\">",
"        See UpToDate topic review",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Tissue",
"       </td>",
"       <td>",
"        Transport in sterile container. Keep moist - add sterile (non-bacteriostatic saline) if necessary.",
"       </td>",
"       <td>",
"        As much as possible",
"       </td>",
"       <td>",
"        25&ordm;C",
"       </td>",
"       <td>",
"        Tissue itself provides much better yield than swabs",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        Urine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clean catch or straight catheter",
"       </td>",
"       <td>",
"        Midstream urine in sterile wide-mouth container",
"       </td>",
"       <td>",
"        &ge;1 mL for routine culture (&gt;20 mL for fungal or mycobacterial culture)",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        Always send urinalysis as well",
"       </td>",
"       <td>",
"        Urine sampling and culture in the diagnosis of urinary tract infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Indwelling catheter",
"       </td>",
"       <td>",
"        Disinfect specimen port with alcohol, remove 5-10 mL of urine with needle and syringe, and transfer into sterile container",
"       </td>",
"       <td>",
"        &ge;1 mL for routine culture (&gt;20 mL for fungal or mycobacterial culture)",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        Always send urinalysis as well",
"       </td>",
"       <td>",
"        Urine sampling and culture in the diagnosis of urinary tract infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Suprapubic aspirate",
"       </td>",
"       <td>",
"        Sterile container",
"       </td>",
"       <td>",
"        &ge;1 mL for routine culture (&gt;20 mL for fungal or mycobacterial culture)",
"       </td>",
"       <td>",
"        4&ordm;C",
"       </td>",
"       <td>",
"        Always send urinalysis as well",
"       </td>",
"       <td>",
"        Urine sampling and culture in the diagnosis of urinary tract infection",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * If immediate processing is not possible.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_58_14255=[""].join("\n");
var outline_f13_58_14255=null;
